var title_f33_22_34144="Gram stain abscess 11B answer";
var content_f33_22_34144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sulfur granules of actinomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gram stain of aspirate from oral abscess (x1000). Actinomyces frequently grows in aggregates, termed \"sulfur granules.\" Note the branching, Gram positive filaments on the edge of this granule. Actinomyces is a fastidious obligate anaerobe requiring anaerobic culture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34144=[""].join("\n");
var outline_f33_22_34144=null;
var title_f33_22_34145="Overdrive pacing";
var content_f33_22_34145=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effect of overdrive pacing on spontaneous automaticity of Purkinje fiber",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The more rapid discharge from the sinus node produces overdrive suppression of Purkinje fiber automaticity. Microelectrode recording from a Purkinje fiber at baseline shows a maximum diastolic potential of -77 mV. During overdrive pacing, the membrane becomes hyperpolarizaed and maximum diastolic potential increases to -85 mV, resulting in part from the accumulation of sodium ions, activation of the sodium-potassium pump, and an increased influx of potassium as sodium is extruded. After the cessation of overdrive pacing, the onset of the next spontaneous action potential is delayed since the slow of phase 4 diastolic depolarization is reduced and the more negative diastolic potential increases in the time required to reach threshold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34145=[""].join("\n");
var outline_f33_22_34145=null;
var title_f33_22_34146="LV pressure diastolic dysfunct";
var content_f33_22_34146=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular pressure tracing in diastolic dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The left ventricular pressure is initially recorded with a scale of 0 to 200 mmHg and then at 0 to 40 mmHg. Although the systolic and diastolic pressures are normal, the pressure waveform in diastole is abnormal; there is a continuing decline of pressure over the mid-diastolic period (as opposed to the gradual rise seen in normal subjects) with the pressure nadir occurring midway through the diastolic period and there is a prominent \"a\" wave generated by left atrial contraction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kern MJ. ACC Current Journal Review, 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34146=[""].join("\n");
var outline_f33_22_34146=null;
var title_f33_22_34147="Methacholine: Patient drug information";
var content_f33_22_34147=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methacholine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=see_link\">",
"     see \"Methacholine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Provocholine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Methacholine Omega;",
"     </li>",
"     <li>",
"      Provocholine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10015998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is for use only during an asthma test. It is given by breathing in liquid only. You will be closely watched by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used during an asthma test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methacholine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma or wheezing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a beta blocker drug (eg, atenolol, nadolol, or propranolol).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695970",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a liquid (solution) by a special machine (nebulizer) into the lungs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016009\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10832 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-C0D21FD3A5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34147=[""].join("\n");
var outline_f33_22_34147=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193940\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193941\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015998\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016000\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015999\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016004\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016005\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016007\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016002\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016003\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016008\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016009\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/32/10756?source=related_link\">",
"      Methacholine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_22_34148="Tolbutamide: Patient drug information";
var content_f33_22_34148=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tolbutamide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/49/42774?source=see_link\">",
"     see \"Tolbutamide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F228919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Tolbutamide&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022580\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691404",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower blood sugar in patients with high blood sugar (diabetes).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tolbutamide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Acidic blood problem or type 1 diabetes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697009",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 80 or older, use this drug with care. You could be more sensitive to low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam and visit the foot doctor every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696750",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not drive if your blood sugar has been low. There is a greater chance of you having a crash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very low blood sugar or very high blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be used alone or with other high blood sugar (diabetes) drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11101 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-853D91569B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34148=[""].join("\n");
var outline_f33_22_34148=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228919\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022580\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022579\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022584\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022585\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022587\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022582\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022583\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022588\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022589\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?41/49/42774?source=related_link\">",
"      Tolbutamide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_22_34149="CT appearance PPNAD";
var content_f33_22_34149=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F78837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F78837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT appearance PPNAD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Adrenal CT scan of a 20-year-old female with PPNAD, Cushing's syndrome, and family history of Carney's complex. Note the right adrenal (A) of normal size but with discrete bead-like nodules (arrow). In the left adrenal (B) a larger 1.5 cm nodule was present (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andre Lacroix, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34149=[""].join("\n");
var outline_f33_22_34149=null;
var title_f33_22_34150="Epidemiology and pathology of extrapulmonary and miliary tuberculosis";
var content_f33_22_34150=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and pathology of extrapulmonary and miliary tuberculosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/22/34150/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/22/34150/contributors\">",
"     John Bernardo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/22/34150/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/22/34150/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/22/34150/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/22/34150/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/22/34150/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Miliary tuberculosis (TB) refers to clinical disease resulting from the hematogenous dissemination of Mycobacterium tuberculosis. The term miliary was coined in 1700 by John Jacobus Manget, who likened the appearance of the involved lung, with its surface covered with firm small white nodules, to numerous millet seeds (",
"    <a class=\"graphic graphic_picture graphicRef76174 \" href=\"mobipreview.htm?7/6/7269\">",
"     picture 1",
"    </a>",
"    ). Miliary TB can arise as a result of progressive primary infection or via reactivation of a latent focus with subsequent spread. Originally a pathologic and then a radiographic description, the term miliary TB is now used to denote all forms of progressive, widely disseminated hematogenous TB, even if the classical pathologic or radiologic findings are absent.",
"   </p>",
"   <p>",
"    The disease usually is classified as pulmonary or extrapulmonary; in the United States reporting criteria for extrapulmonary TB require evidence for multiple sites of disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a miliary pattern reported on chest radiography.",
"   </p>",
"   <p>",
"    The epidemiology and pathology of miliary TB will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of miliary TB are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20826?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7622732\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of tuberculosis (TB) and the miliary form of the disease have been altered by the introduction of effective chemotherapy, the HIV epidemic, and immigration patterns. Of 11,182 incident cases reported in the United States in 2010, extrapulmonary TB accounted for approximately 22 percent of cases; miliary disease was reported in 299 (2.7 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This reflected a minor increase from 1.8 percent of reported cases in 2006. Worldwide, estimates of its incidence are hampered largely by incomplete reporting and imprecise diagnostic criteria; it is estimated that miliary TB accounts for 1 to 2 percent of all cases of TB in immunocompetent persons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology of miliary disease varies in different case series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior to the availability of antituberculous therapy, 20 percent of TB autopsy cases at Boston City Hospital had evidence of miliary disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/4\">",
"       4",
"      </a>",
"      ]. By the 1970s, with the availability of antituberculous therapy, the incidence had fallen to 0.7 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Data from the Centers for Disease Control and Prevention in the early 1980s (after the availability of antituberculous therapy but prior to the HIV epidemic) reported 1.3 percent of TB cases had evidence of miliary disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the midst of the HIV epidemic during the mid 1980s, the percentage of miliary TB was higher among HIV-infected patients than HIV-negative patients (38 versus 8 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Risk for developing miliary TB appeared to be highest among patients with the lowest CD4 counts [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a public health clinic in Ireland in the 1990s, miliary disease accounted for 4 percent of TB cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The HIV epidemic has played a significant role in increasing the prevalence of miliary TB. Between 1999 and 2006 in England and Wales, an almost fivefold increase in the number of miliary cases was observed (38 to 180 cases); HIV coinfection was most strongly associated with miliary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/11\">",
"     11",
"    </a>",
"    ]. Other factors, such as the emergence of drug-resistant or multidrug-resistant strains, have also contributed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7622739\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for the development of miliary TB include age and underlying medical conditions, especially HIV infection. However, a significant percentage of cases described in the literature have no demonstrable high-risk condition for dissemination; miliary TB should never be excluded as a clinical diagnosis because an underlying medical illness is absent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7622746\">",
"    <span class=\"h3\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants are highly susceptible to miliary TB, presumably due to their relatively immature immune systems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/13-17\">",
"     13-17",
"    </a>",
"    ]. In a study from Puerto Rico, miliary disease or meningitis occurred more frequently among children &lt;6 years than among children &gt;7 years of age (1 versus 0.4 percent respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/14\">",
"     14",
"    </a>",
"    ]. In another series from South Africa, miliary TB accounted for more hospital admissions among children than adults (8 versus 1 percent); 52 percent of cases occurred in children &lt;1 year of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Miliary TB has been described more frequently among elderly adults in the post-antibiotic era than the pre-antibiotic era; this group is likely at increased risk due to relative waning of cellular immunity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, the rise of HIV has led to increased prevalence of miliary TB among young adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7622753\">",
"    <span class=\"h3\">",
"     Medical conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The percentage of patients with miliary TB and some identifiable underlying medical condition in various studies ranged from 38 to 70 percent. The most common conditions include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/19-25\">",
"     19-25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Alcohol abuse",
"     </li>",
"     <li>",
"      Malignancy",
"     </li>",
"     <li>",
"      Human immunodeficiency virus (HIV) infection",
"     </li>",
"     <li>",
"      Corticosteroids or other iatrogenic immunosuppression (eg, TNF-&alpha; blocking agents)",
"     </li>",
"     <li>",
"      Connective tissue disease (with or without iatrogenic immunosuppression)",
"     </li>",
"     <li>",
"      Renal failure",
"     </li>",
"     <li>",
"      Diabetes",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Weight loss",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    malnutrition are important components of a number of these conditions but have not been addressed separately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/19-23\">",
"     19-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7622760\">",
"    <span class=\"h3\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men outnumber women in most series of miliary TB (",
"    <a class=\"graphic graphic_table graphicRef77719 \" href=\"mobipreview.htm?36/31/37372\">",
"     table 1",
"    </a>",
"    ); it is uncertain whether this reflects a greater prevalence of TB among men. It is also uncertain whether African-Americans are more likely to progress from infection to disseminated disease, since control for the relative contributions of socioeconomic factors, such as living conditions, nutrition, access to care, and comorbidities, is needed for proper data interpretation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7623073\">",
"    <span class=\"h2\">",
"     Mechanisms of disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Miliary tuberculosis (TB) can arise as a result of progressive primary infection or via reactivation of a latent focus with subsequent spread. Rarely, iatrogenic infection can occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Progressive primary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;After establishing a focus of infection in the lung, tuberculous bacilli can disseminate via the lymphatics and hematogenously (",
"    <a class=\"graphic graphic_algorithm graphicRef66301 \" href=\"mobipreview.htm?29/40/30350\">",
"     algorithm 1",
"    </a>",
"    ). There is a predilection for spread to the most vascular organs, such as the liver, spleen, bone marrow, and brain. These distant foci usually heal by granulomatous encapsulation over weeks to months, containing viable organisms. Failure of these foci to heal within the first six months after primary infection leads to progressive primary disease. Many patients with progressive TB have underlying medical or iatrogenic conditions that impair the development of effective cell mediated immunity intended to contain the primary infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Reactivation of a latent focus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Miliary TB may result from reactivation of a latent focus of infection with subsequent erosion into adjoining lymphatics or blood vessels, leading to dissemination of viable organisms. Reactivation may occur at any time after the primary infection; most commonly it occurs years or decades later, in association with demonstrable waning of specific immune responses, or in the presence of a high risk condition associated with progressive TB. (See",
"    <a class=\"local\" href=\"#H7622739\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Iatrogenic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, miliary TB may occur as a result of iatrogenic exposure. Disseminated TB has been reported after extracorporeal shock wave lithotripsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/27,28\">",
"     27,28",
"    </a>",
"    ], urethral catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/29\">",
"     29",
"    </a>",
"    ], and cardiac valve homograft placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/30\">",
"     30",
"    </a>",
"    ]. TB has also been transmitted by solid organ transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7623207\">",
"    <span class=\"h2\">",
"     Clinicopathologic patterns of disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classically, the clinical and pathologic patterns of miliary TB have been divided into three groups: acute miliary TB, late generalized TB, and anergic (nonreactive) TB. These terms can be confusing because there is considerable overlap among the categories. Acute miliary TB is primarily a clinical term; this entity can be seen in the immediate post-primary period, or in immunocompromised children or adults. It is usually observed within the first two to six months following exposure, although progression may be more rapid in neonates and children under the age of one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/33\">",
"     33",
"    </a>",
"    ]. During one TB outbreak in an HIV housing facility in San Francisco, 11 of 30 HIV-infected residents (37 percent) who were exposed to an infectious pulmonary case of TB developed TB disease within 106 days; in one HIV-infected contact, TB was diagnosed within four weeks of exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Late generalized TB is primarily a pathologic term, referring to hematogenous dissemination without evidence of an active primary focus. Patients with an acute miliary presentation may in fact have evidence of late generalized disease on histopathology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7623214\">",
"    <span class=\"h3\">",
"     Acute miliary tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute (generalized) miliary TB has a relatively rapid clinical course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/4,35\">",
"     4,35",
"    </a>",
"    ]. Prior to the availability of effective chemotherapy for TB, most cases of acute miliary TB resulted from progressive primary disease, most cases of acute miliary TB resulted from progressive primary disease. The pathologic hallmark of acute miliary TB is a caseating granulomatous reaction, with a smaller number of organisms than other forms of miliary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/4,35\">",
"     4,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7623221\">",
"    <span class=\"h3\">",
"     Late generalized tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late generalized TB refers hematogenous spread that occurs after the primary or post-primary period. In one autopsy series of 100 patients with late generalized TB from 1937 to 1959, patients had relatively chronic, clinically non-specific presentations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/36\">",
"     36",
"    </a>",
"    ]. In this study, late generalized TB was frequently associated with chronic pulmonary TB. Since the availability of chemotherapy for TB, however, foci responsible for hematogenous spread are extrapulmonary in some cases, and are thus more difficult to detect.",
"   </p>",
"   <p>",
"    A subset of late generalized TB is labeled cryptic miliary TB. This term refers to patients in whom the illness is even more indolent and who may demonstrate an attenuated histologic response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7623228\">",
"    <span class=\"h3\">",
"     Anergic tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anergic TB is defined histologically by the absence of granulomata. In some cases, microabscesses containing large numbers of bacilli with a predominantly neutrophilic response are observed, although, in general, anergic TB is relatively difficult to establish based on histology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/38\">",
"     38",
"    </a>",
"    ]. Tissue stains and cultures are generally more sensitive diagnostic tools.",
"   </p>",
"   <p>",
"    Anergic (non-reactive) TB is a relatively uncommon form of miliary disease. The clinical spectrum ranges from overwhelming sepsis to non-specific or typhoidal presentations. Most of the described cases are older patients with presumed reactivation TB. Granulomas in immunocompromised patients with TB may share similar characteristics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Host and pathogen factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major determinants of TB dissemination include mycobacterial virulence factors and host immune defenses. The high susceptibility of infants to miliary TB has led some investigators to speculate that the developing immune system may lack critical elements for initiating protective responses to M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. After initial infection, the development of specific cell-mediated immunity appears to be critical in limiting disseminated disease. Cytokines, including TNF-&alpha;, IL-12 and interferon gamma, are essential for granuloma development and protective immunity to M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34150/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22378?source=see_link\">",
"     \"Microbiology and pathogenesis of tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/17/43289?source=see_link\">",
"     \"Immunology of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8445244\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Miliary tuberculosis (TB) refers to clinical disease resulting from the hematogenous dissemination of Mycobacterium tuberculosis that affects multiple organs and systems. Miliary TB can arise as a result of progressive primary infection or via reactivation of a previously-contained latent focus with subsequent spread. Miliary TB accounts for approximately 3 percent of incident cases in the United States, with increased representation among infants and young children and in individuals with concomitant immunosuppression. Extrapulmonary TB accounts for approximately 20 percent of cases. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7622732\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for the development of miliary TB include extremes of age and underlying medical conditions. Infants are highly susceptible to miliary TB, presumably due to their relatively immature immune systems. Elderly adults are also at increased risk for miliary TB due to relative waning of cellular immunity. Underlying medical conditions conferring increased risk for miliary TB include alcohol abuse, malignancy, HIV infection, immunosuppression (including chronic corticosteroid use and TNF-&alpha; inhibitors), connective tissue disease, renal failure, diabetes, and pregnancy. (See",
"      <a class=\"local\" href=\"#H7622739\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After establishing a primary focus of infection in the lung, tuberculous bacilli can disseminate via the lymphatics and hematogenously to the most vascular organs, such as the liver, spleen, bone marrow, and brain. These distant foci usually heal by granulomatous encapsulation over weeks to months. Failure of these foci to heal within the first six months after primary infection leads to progressive primary disease. Healed, latent foci can reactivate at any time after the primary infection; most commonly, reactivation occurs years or decades after primary infection, in association with waning of cellular immune responses or other risk factors. (See",
"      <a class=\"local\" href=\"#H7623073\">",
"       'Mechanisms of disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute (generalized) miliary TB has a relatively rapid clinical course. This entity can be seen in the immediate post-primary period",
"      <strong>",
"       or",
"      </strong>",
"      as a result of reactivation of a chronic focus; prior to the availability of anti-TB chemotherapy, most cases resulted from progressive primary disease. The pathologic hallmark of acute miliary TB is a caseating granulomatous reaction. (See",
"      <a class=\"local\" href=\"#H7623214\">",
"       'Acute miliary tuberculosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Late generalized TB refers hematogenous spread that occurs after the primary or post-primary period. Prior to the availability of effective TB chemotherapy late generalized TB was frequently associated with chronic pulmonary TB. (See",
"      <a class=\"local\" href=\"#H7623221\">",
"       'Late generalized tuberculosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     CDC. Reported Tuberculosis in the United States, 2010. CDC; US Department of Health and Human Services, Atlanta, GA 2011.",
"    </li>",
"    <li>",
"     file://www.cdc.gov/tb/statistics/reports/2010/pdf/report2010.pdf (Accessed on April 24, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/3\">",
"      Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005; 5:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/4\">",
"      CHAPMAN CB, WHORTON CM. Acute generalized miliary tuberculosis in adults. N Engl J Med 1946; 235:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/5\">",
"      Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) 1984; 63:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/6\">",
"      Rieder HL, Kelly GD, Bloch AB, et al. Tuberculosis diagnosed at death in the United States. Chest 1991; 100:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/7\">",
"      Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/8\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-1999. A 37-year-old man with fever and diffuse lymphadenopathy. N Engl J Med 1999; 340:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/9\">",
"      Lado Lado FL, Barrio G&oacute;mez E, Carballo Arceo E, Cabarcos Ort&iacute;z de Barr&oacute;n A. Clinical presentation of tuberculosis and the degree of immunodeficiency in patients with HIV infection. Scand J Infect Dis 1999; 31:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/10\">",
"      O'Reilly P, McDonnell T. The spectrum of mycobacterial disease in a Dublin teaching hospital. Ir Med J 1999; 92:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/11\">",
"      Kruijshaar ME, Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax 2009; 64:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/12\">",
"      Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/13\">",
"      Snider DE Jr, Rieder HL, Combs D, et al. Tuberculosis in children. Pediatr Infect Dis J 1988; 7:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/14\">",
"      Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/15\">",
"      Hussey G, Chisholm T, Kibel M. Miliary tuberculosis in children: a review of 94 cases. Pediatr Infect Dis J 1991; 10:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/16\">",
"      Smith S, Jacobs RF, Wilson CB. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 1997; 131:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/17\">",
"      Cruz AT, Starke JR. Clinical manifestations of tuberculosis in children. Paediatr Respir Rev 2007; 8:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/18\">",
"      Braun MM, Cot&eacute; TR, Rabkin CS. Trends in death with tuberculosis during the AIDS era. JAMA 1993; 269:2865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/19\">",
"      Aguado JM, Herrero JA, Gavald&aacute; J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/20\">",
"      Mu&ntilde;oz P, Palomo J, Mu&ntilde;oz R, et al. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995; 21:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/21\">",
"      Sakhuja V, Jha V, Varma PP, et al. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/22\">",
"      Nishizaki T, Yanaga K, Soejima Y, et al. Tuberculosis following liver transplantation: report of a case and review of the literature. Transpl Int 1996; 9:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/23\">",
"      Nagasawa M, Maeda H, Okawa H, Yata J. Pulmonary miliary tuberculosis and T-cell abnormalities in a severe combined immunodeficient patient reconstituted with haploidentical bone marrow transplantation. Int J Hematol 1994; 59:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/24\">",
"      Munt PW. Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore) 1972; 51:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/25\">",
"      Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 1990; 89:291.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control. Extrapulmonary tuberculosis in the United States 1969-1973. DHEW publication no CDC 78-8260. Atlanta: Department of Health, Education and Welfare, 1978.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/27\">",
"      Morano Amado LE, Amador Barciela L, Rodriguez Fernandez A, et al. Extracorporeal shock wave lithotripsy complicated with miliary tuberculosis. J Urol 1993; 149:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/28\">",
"      Federmann M, Kley HK. Miliary tuberculosis after extracorporeal shock-wave lithotripsy. N Engl J Med 1990; 323:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/29\">",
"      Yekanath H, Gross PA, Vitenson JH. Miliary tuberculosis following ureteral catheterization. Urology 1980; 16:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/30\">",
"      Anyanwu CH, Nassau E, Yacoub M. Miliary tuberculosis following homograft valve replacement. Thorax 1976; 31:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/31\">",
"      Qunibi WY, al-Sibai MB, Taher S, et al. Mycobacterial infection after renal transplantation--report of 14 cases and review of the literature. Q J Med 1990; 77:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/32\">",
"      Miller RA, Lanza LA, Kline JN, Geist LJ. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med 1995; 152:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/33\">",
"      PERRY TL. Natural history and pathogenesis of miliary and meningeal tuberculosis in children; analysis of 163 cases. Pediatrics 1950; 5:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/34\">",
"      Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/35\">",
"      Stead WW. Pathogenesis of tuberculosis: clinical and epidemiologic perspective. Rev Infect Dis 1989; 11 Suppl 2:S366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/36\">",
"      Slavin RE, Walsh TJ, Pollack AD. Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras. Medicine (Baltimore) 1980; 59:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/37\">",
"      Proudfoot AT, Akhtar AJ, Douglas AC, Horne NW. Miliary tuberculosis in adults. Br Med J 1969; 2:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/38\">",
"      O'BRIEN JR. Non-reactive tuberculosis. J Clin Pathol 1954; 7:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/39\">",
"      de Noronha AL, B&aacute;fica A, Nogueira L, et al. Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production. Pathol Res Pract 2008; 204:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/40\">",
"      Altare F, Jouanguy E, Lamhamedi S, et al. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 1998; 10:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34150/abstract/41\">",
"      Jouanguy E, D&ouml;ffinger R, Dupuis S, et al. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999; 11:346.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8029 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.181.191-AA596B28AF-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34150=[""].join("\n");
var outline_f33_22_34150=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8445244\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7622732\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7622739\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7622746\">",
"      - Age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7622753\">",
"      - Medical conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7622760\">",
"      - Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7623073\">",
"      Mechanisms of disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Progressive primary disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Reactivation of a latent focus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Iatrogenic infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7623207\">",
"      Clinicopathologic patterns of disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7623214\">",
"      - Acute miliary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7623221\">",
"      - Late generalized tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7623228\">",
"      - Anergic tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Host and pathogen factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8445244\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8029\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8029|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?29/40/30350\" title=\"algorithm 1\">",
"      Pathogenesis of miliary TB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8029|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/6/7269\" title=\"picture 1\">",
"      Millet seeds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8029|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/31/37372\" title=\"table 1\">",
"      Clinical series of miliary TB",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/21/20826?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of extrapulmonary and miliary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/17/43289?source=related_link\">",
"      Immunology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22378?source=related_link\">",
"      Microbiology and pathogenesis of tuberculosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_22_34151="Pimozide: Pediatric drug information";
var content_f33_22_34151=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pimozide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?6/20/6472?source=see_link\">",
"    see \"Pimozide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/48/4869?source=see_link\">",
"    see \"Pimozide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F7290571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information. For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F209993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Orap&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F209994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Pimozide&reg;;",
"     </li>",
"     <li>",
"      Orap&reg;;",
"     </li>",
"     <li>",
"      PMS-Pimozide",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1031138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antipsychotic Agent, Typical",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1031168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/20/6472?source=see_link\">",
"      see \"Pimozide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Slow titration is recommended to improve tolerability; use lowest effective dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &le;12 years: Initial: 0.05 mg/kg (maximum: 1 mg/dose) once daily (preferably at bedtime); gradually titrate dose every 1-2 weeks as tolerated; may increase dose every third day if needed; maintenance: 2-4 mg once daily; maximum: 10 mg/day or 0.2 mg/kg/day (whichever is less)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &gt;12 years and Adults: Initial: 1-2 mg/day in divided doses; gradually titrate dose every 1-2 weeks as tolerated; may increase dose every other day if needed; maintenance: 7-10 mg/day in divided doses; maximum: 10 mg/day or 0.2 mg/kg/day (whichever is less)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Reduction of dose is necessary in patients with liver disease",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F209972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orap&reg;: 1 mg, 2 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F209957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5945666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered without regard to meals",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F5945665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at controlled room temperature at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Dispense in a tight, light-resistant container.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1031139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Suppression of severe motor and phonic (vocal) tics in patients with Tourette's disorder who have failed to respond satisfactorily to standard treatment and whose daily life function and/or development is severely compromised by the presence of motor and phonic tics (FDA approved in ages &ge;2 years and adults)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     A trial of standard treatment is currently recommended before a trial of pimozide because of pimozide&rsquo;s potential cardiac toxicity. See also Scahill, 2006 for the Tourette Syndrome Association Medical Advisory Board: Practice Committee&rsquo;s treatment guidelines.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F14100513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F210038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Abnormal ECG",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Akathisia, akinesia, behavior changes, depression, dreams abnormal, drowsiness, headache, hyperkinesias, insomnia, nervousness, sedation, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Appetite increased, constipation, diarrhea, dysphagia, salivation increased, taste disturbance, thirst, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Handwriting change, muscle tightness, myalgia, rigidity, stooped posture, torticollis, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Accommodation decreased, photophobia, visual disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening (some reported  for other than Tourette's disorder): Anorexia, blurred vision, cataracts, chest pain, diaphoresis, dizziness, excitement; extrapyramidal symptoms (dystonia, pseudoparkinsonism, tardive dyskinesia); GI distress, gingival hyperplasia (case report), hemolytic anemia, hyper-/hypotension, hyponatremia, libido decreased, nausea, neuroleptic malignant syndrome, orthostatic hypotension, nocturia, palpitation, periorbital edema, polyuria, QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation, seizure, skin irritation, syncope, tachycardia, ventricular arrhythmia, vomiting, weight gain/loss",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1031143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pimozide or any component; simple tics or tics other than Tourette's disorder; patients receiving medications that can cause motor and phonic tics (eg, amphetamines, methylphenidate, pemoline) until these medications can be withdrawn to determine whether or not the drug (rather than Tourette&rsquo;s Disorder) is causing the tics; severe toxic CNS depression; coma; history of cardiac arrhythmias; congenital long QT syndrome; concurrent use with QT",
"     <sub>",
"      c",
"     </sub>",
"     -prolonging agents; hypokalemia or hypomagnesemia; concurrent use of drugs that are inhibitors of cytochrome P450 CYP3A4, including azole antifungals (itraconazole, ketoconazole), macrolide antibiotics [ie, clarithromycin, erythromycin (",
"     <b>",
"      Note:",
"     </b>",
"     The manufacturer lists azithromycin and dirithromycin in its list of contraindicated macrolides; however, these drugs do not inhibit CYP3A4 and are not expected to interact with pimozide)], citalopram, escitalopram, nefazodone, sertraline, protease inhibitors (eg, atazanavir, indinavir, nelfinavir, ritonavir, saquinavir), and other less potent inhibitors of CYP3A4 (eg, fluvoxamine, zileuton)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5945664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause anticholinergic effects (confusion, agitation, constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased GI motility, urinary retention, BPH, xerostomia, or visual problems. Use with caution in patients with narrow-angle glaucoma; condition may be exacerbated by cholinergic blockade; screening is recommended. Use with caution in patients with myasthenia gravis; condition may be exacerbated by cholinergic blockade. Relative to neuroleptics, pimozide has a moderate potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May be moderately sedating, use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Pimozide may have a tumorigenic potential; a dose-related increase in pituitary tumors was observed in studies of mice; full significance in humans is unknown; however, this finding should be considered when deciding to use pimozide chronically in a young patient. Limited information about the use of pimozide in children &lt;12 years of age exists.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Avoid abrupt discontinuation after prolonged use; abrupt discontinuation in patients receiving maintenance treatment may result in transient dyskinetic signs in some patients; these dyskinetic movements may not be distinguishable from tardive dyskinesia (except for duration).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1031144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May alter cardiac conduction; sudden unexplained deaths have occurred in patients taking high doses (~1 mg/kg); deaths may be due to prolongation of the QT interval predisposing patients to ventricular arrhythmias; monitor ECG at baseline and periodically during dosage titration; correct any hypokalemia prior to initiation of therapy and maintain normal serum potassium during therapy. May cause hypotension at high doses (minimal hypotension at adult doses &lt;5 mg/day) or orthostatic hypotension. Use with caution in patients with autonomic instability, hypovolemia, cerebrovascular or cardiovascular disease, or concurrent medications which may predispose to hypotension/bradycardia). Do not use in Parkinson&rsquo;s disease. Use with caution in patients with hemodynamic instability; bone marrow suppression (use of antipsychotic agents has been associated with neutropenia, leukopenia, and agranulocytosis; monitor patients with history of low WBC or drug-induced leukopenia or neutropenia); predisposition to seizures (antipsychotics may lower the seizure threshold); predisposition to seizures; subcortical brain damage; severe cardiac, hepatic, renal, or respiratory disease; patients with hypersensitivity to other antipsychotic drugs.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Esophageal dysmotility and aspiration have been associated with antipsychotic use; use with caution in patients at risk of pneumonia (ie, Alzheimer's disease). Use with caution in breast cancer or other prolactin-dependent tumors (may elevate prolactin levels). May alter temperature regulation. May mask other conditions or toxicity of other drugs due to antiemetic effects. May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia (risk of these reactions is high relative to other neuroleptics, and is dose-dependent; to decrease risk of tardive dyskinesia: Use smallest dose and shortest duration possible; evaluate continued need periodically; risk of dystonia is increased with the use of high potency and higher doses of conventional antipsychotics and in males and younger patients). Use may be associated with neuroleptic malignant syndrome (NMS); monitor for mental status changes, fever, muscle rigidity, and/or autonomic instability; may also be associated with increased CPK, myogloburia, and acute renal failure; discontinue use if these symptoms occur; NMS may recur upon rechallenge.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Leukopenia, neutropenia, and agranulocytosis (sometimes fatal) have been reported in clinical trials and postmarketing reports with antipsychotic use; presence of risk factors (eg, pre-existing low WBC or history of drug-induced leuko/neutropenia) should prompt periodic blood count assessment. Discontinue therapy at first signs of blood dyscrasias or if absolute neutrophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     An increased risk of death has been reported with the use of antipsychotics in elderly patients with dementia-related psychosis",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; most deaths seemed to be cardiovascular (eg, sudden death, heart failure) or infectious (eg, pneumonia) in nature; pimozide is not approved for this indication.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F210026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C19 (weak), CYP2D6 (weak), CYP2E1 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F209966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May decrease the metabolism of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): May diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). Management: Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Crizotinib: May enhance the QTc-prolonging effect of Pimozide. Crizotinib may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Weak): May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Efavirenz: May enhance the arrhythmogenic effect of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Enzalutamide: May decrease the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: May increase the serum concentration of Pimozide. The active metabolite aprepitant is likely responsible for this effect.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May enhance the QTc-prolonging effect of Pimozide. Macrolide Antibiotics may decrease the metabolism of Pimozide. This mechanism may not apply to azithromycin.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Pimozide. Mifepristone may increase the serum concentration of Pimozide. Management: Avoid pimozide during and 2 weeks following mifepristone for treatment of hyperglycemia in Cushing's syndrome. The interaction magnitude could be lower with single doses used to terminate pregnancy, but neither effect has been studied clinically.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nefazodone: May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the metabolism of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the adverse/toxic effect of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zileuton: May increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1031157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;display:inline\">",
"     Grapefruit juice may increase pimozide serum concentrations; avoid use.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F209967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F7883517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in some animal reproduction studies. Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization. There are no adequate and well-controlled studies in pregnant women. Use only if potential benefit justifies risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1031174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     ECG should be performed at baseline and periodically thereafter, especially during dosage adjustment; vital signs; serum potassium; magnesium, sodium; renal and hepatic function; height, weight, BMI; mental status, abnormal involuntary movement scale (AIMS), extrapyramidal symptoms (EPS) screening; CBC with differential (patients with a history of low WBC or drug-induced leukopenia or neutropenia)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1031159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pimozide, a diphenylbutylperidine conventional antipsychotic, is a potent centrally-acting dopamine receptor antagonist; effects which result in its characteristic neuroleptic effects",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F4930441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action: Within one week",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Maximum effect: 4-6 weeks",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Duration: Variable",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1031161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: &gt;50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; significant first-pass effect; metabolized primarily via N-dealkylation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tourette&rsquo;s disorder (Sallee, 1987):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 6-13 years (n=4): Mean &plusmn; SD: 66 &plusmn; 49 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults 23-39 years (n=7): Mean &plusmn; SD: 111 &plusmn; 57 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Schizophrenia: Adults: Mean: 55 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 6-8 hours; range: 4-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1031178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/48/4869?source=see_link\">",
"      see \"Pimozide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use exactly as directed; do not increase dose or frequency. It may take 2-3 weeks to achieve desired results; do not discontinue without consulting prescriber. Avoid alcohol, caffeine, other prescription and nonprescription medications not approved by prescriber. Avoid grapefruit juice. Maintain adequate hydration unless instructed to restrict fluid intake. This medication may cause changes in the rhythm of the heart; deaths have been reported in patients taking high doses; an ECG prior to starting treatment and periodically thereafter is required. This medication may cause excess drowsiness, restlessness, dizziness, or blurred vision (use caution driving or when engaging in tasks requiring alertness until response to drug is known); constipation, dry mouth, anorexia. Report persistent CNS effects (eg, trembling fingers, altered gait or balance, excessive sedation, seizures, unusual muscle or facial movements, anxiety, abnormal thoughts, confusion, personality changes); unresolved constipation or GI effects; breast swelling (male and female); decreased sexual ability; vision changes; respiratory difficulty; palpitations, unusual cough or flu-like symptoms; or worsening of condition.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F5945667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Twenty-two children 7-16 years of age (mean age: 10.2 years) with Tourette's disorder were enrolled in a randomized, double-blind, crossover study of pimozide versus haloperidol; both medications were initiated at 1 mg/day and increased on a flexible dosage schedule of 2 mg/week within a 4-week time period; the mean effective pimozide dose was 3.4 mg/day (range: 1-6 mg/day); pimozide was found to be more effective than placebo while haloperidol was not; more adverse effects, including extrapyramidal reactions were observed with haloperidol (Sallee, 1997).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In a multicenter, double-blind, parallel-group comparative study, 50 patients 11-50 years of age were treated for Tourette's disorder with pimozide (n=24; median age: 23.5  years) versus risperidone (n=26); a fixed-dose titration of pimozide from 1 mg/day to 2 mg/day was used for the first week of therapy; this was followed by a flexible dosing period of 7 weeks; doses were increased by &le;1 mg/week up to a maximum of 6 mg/day and were given once daily; final pimozide dose: 1-6 mg/day (mean: 2.9 mg/day); both drugs significantly improved tics; although there was no difference in efficacy between drugs, risperidone was better tolerated (Bruggeman, 2001).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     In a randomized, double-blind, crossover pediatric trial of patients with Tourette&rsquo;s disorder and chronic motor tic disorder (n=19; age: 7-17 years), risperidone was shown to be superior to pimozide in decreasing tic severity scores, but was associated with greater weight gain; pimozide was initiated at 1 mg/day, administered at bedtime; the dose was titrated weekly if needed to a maximum of 4 mg/day; final dosage of pimozide ranged from 1-4 mg/day (mean: 2.4 mg/day); initial risperidone dosage was 0.5 mg twice daily; doses were titrated to a maximum of 4 mg/day (2 mg/dose twice daily); final dosage of risperidone ranged from 1-4 mg/day (mean: 2.5 mg/day) (Gilbert, 2004).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bruggeman R, van der Linden C, Buitelaar JK, et al, &ldquo;Risperidone Versus Pimozide in Tourette's Disorder: A Comparative Double-Blind Parallel-Group Study,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2001, 62(1):50-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/11235929/pubmed\" id=\"11235929\" target=\"_blank\">",
"        11235929",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bruun RD, &ldquo;Subtle and Under-Recognized Side Effects of Neuroleptic Treatment in Children With Tourette's Disorder,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1988, 145(5):621-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/2895987/pubmed\" id=\"2895987\" target=\"_blank\">",
"        2895987",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gilbert DL, Batterson JR, Sethuraman G, et al, \"Tic Reduction With Risperidone Versus Pimozide in a Randomized, Double-Blind, Crossover Trial,\"",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 2004, 43(2):206-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/14726728/pubmed\" id=\"14726728\" target=\"_blank\">",
"        14726728",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jankovic J, \"Tourette&rsquo;s Syndrome,\"",
"      <i>",
"       NEJM",
"      </i>",
"      , 2001, 345(16):1184-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/11642235/pubmed\" id=\"11642235\" target=\"_blank\">",
"        11642235",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jimenez-Jimenez FJ and Garcia-Ruiz PJ, \"Pharmacological Options for the Treatment of Tourette&rsquo;s Disorder,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 2001, 61(15):2207-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/11772131/pubmed\" id=\"11772131\" target=\"_blank\">",
"        11772131",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kr&auml;henb&uuml;hl S, Sauter B, Kupferschmidt H, et al, &ldquo;Case Report: Reversible QT Prolongation With Torsade de Pointes in a Patient With Pimozide Intoxication,&rdquo;",
"      <i>",
"       Am J Med Sci",
"      </i>",
"      , 1995, 309(6):315-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/7771501/pubmed\" id=\"7771501\" target=\"_blank\">",
"        7771501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Larkin C, &ldquo;Epileptogenic Effect of Pimozide,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1983, 140(3):372-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/6402945/pubmed\" id=\"6402945\" target=\"_blank\">",
"        6402945",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Muller-Vahl JT, \"The Treatment of Tourette&rsquo;s Syndrome: Current Opinions,\"",
"      <i>",
"       Expert Opin Pharmacother",
"      </i>",
"      , 2002, 3(7):899-914.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/12083990/pubmed\" id=\"12083990\" target=\"_blank\">",
"        12083990",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Pimozide (Orap) Contraindicated With Clarithromycin (Biaxin&trade;) and Other Macrolide Antibiotics,&rdquo;",
"      <i>",
"       FDA Medical Bulletin",
"      </i>",
"      , October 1996, 3.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sallee FR, Dougherty D, Sethuraman G, et al, \"Prolactin Monitoring of Haloperidol and Pimozide Treatment in Children With Tourette's Syndrome,\"",
"      <i>",
"       Biol Psychiatry",
"      </i>",
"      , 1996, 40(10):1044-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/8915564/pubmed\" id=\"8915564\" target=\"_blank\">",
"        8915564",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sallee FR, Nesbitt L, Jackson C, et al, &ldquo;Relative Efficacy of Haloperidol and Pimozide in Children and Adolescents With Tourette's Disorder,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1997, 154(8):1057-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/9247389/pubmed\" id=\"9247389\" target=\"_blank\">",
"        9247389",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sallee FR, Pollock BG, Stiller RL, et al, \"Pharmacokinetics of Pimozide in Adults and Children With Tourette's Syndrome,\"",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1987, 27(10):776-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/3480904/pubmed\" id=\"3480904\" target=\"_blank\">",
"        3480904",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Scahill L, Erenberg G, Berlin CM Jr, et al, \"Contemporary Assessment and Pharmacotherapy of Tourette Syndrome,\"",
"      <i>",
"       NeuroRx",
"      </i>",
"      , 2006, 3(2):192-206.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/22/34151/abstract-text/16554257/pubmed\" id=\"16554257\" target=\"_blank\">",
"        16554257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13017 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-18C9BB78CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34151=[""].join("\n");
var outline_f33_22_34151=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7290571\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209993\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209994\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031138\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031168\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209972\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209957\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5945666\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5945665\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031139\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14100513\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210038\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031143\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5945664\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031144\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F210026\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209966\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031157\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F209967\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7883517\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031174\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031159\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4930441\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031161\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1031178\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5945667\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13017\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13017|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/20/6472?source=related_link\">",
"      Pimozide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/48/4869?source=related_link\">",
"      Pimozide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_22_34152="Keratosis pilaris fair skin";
var content_f33_22_34152=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60786%7EDERM%2F68488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60786%7EDERM%2F68488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratosis pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFFAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5fpaTFLQMKKBS4pgApabSigBaKKKQBRRRQAmaKULk08x8UAMopSDSCgB6VIKhXrUq9KllIVqZTz0ph9qQ2MIxQKcRmmCqRLAUYpaKYgFFFFACYpe1GKKAEAoFLRQAUnWloxQAmKDS0UAJigdRQKWgBwPFOWmDrTxWkRMd2pKcKKsWw2jNKaSlYYopcUgpaomwtOAJpoNPFMGFFBooEGKKUUlAB3oNAoNADKCOaVhzSUANNIac3FNNIZXpaMUVzlhS0oFGKAEpKdgUYFACUD3pcCjFACUuKAKfigByLxT8e9C9KWrEMdOMioSMVZPSoWHPFSxjV609aZinrUMpD6awp45FIwpDI8U0jBqSmMKYmhhoFLzSjrTJDFOC0CgmmMQ9KSg5oHTmlcBMUYopefSi4hMUYo59KOfSi4Cd6UA0c0uDQAlFLjPekouACnoeaZSoeaqLsJomAoIpyEd6cRW+5JEaBUm0UhGKVihtFFAoEAp4NNp4FMTAdOaDS0UxBSGlooAbmkOTz2pxGaMYFADO9L096XHNBwKRQw989aaadTTUsRvz+D9Tj5RYpB7Niq8nhXVkA/0YEH0cV7a1sg+6ACf1pq2ZIxtxXNzM6/ZI8SPhfV1GTaED/eFM/wCEd1Xp9jfP1Fe6f2cpALHJ9KFsowuNoGOgpczD2SPDo/DWrODi0Ix13MBUb+H9URSTZyHHpXupsQQAFGT6im/2cASOMEU+YXskeBvpt6v3rSYf8ANQG3mU4aGUH3U19BjTl+UYXFMfTFBPyJ16kZzRzB7I+e8bTzx9afx617vPocDk74Yj7lBk1Xm8OWLH57SMnt+7HNLmD2VjxNORTsGvYW8IafIeLNAwHpTH8F6fwTaKD9cZq/aWJ9keQEcc0xga9dl8D6fPgiAR45JVqqSeAtPMhVRcH02mk5pj9kzyoClFenv8ObU/dmuF9sioX+HMOMrdy5+g4pXF7OR50veg813zfD04BS9YDvlKib4f3IbAulK/7lK5Xs5HCEYpCK7OfwFfoSYpYmXtnINVJPBGsr92OJzjPD4p3JcGcqRRW/N4T1qM4NmT/usKrSeHdWT71hPg+1NMlxfYyaK0JNH1KLHmWFyM9PkNQNZXKnDW0wPoYzRcVitRT2RlOGRh9VIpvHc0AJRS8HvS4oENopeKCKBiUUuBRigBo4pCKeBRigQwClAFO20Y4oAelOyc01OlPxW8XoS0APHQ0oOab3pcU7isGKQinAGjBHancBAKfim0vancA70tJzilAouIMUlOxTe9MAoPSg5opDEprU40mKQDDSGnkU0jmpGfS6Wx5YkZz90DoKna3UDIB+p7VdMQzlgAO1NI3YBBx2FcZ37srrEo7ZNMEDE4GBVyOAs2WPPYCpTEq4UDLEdaQWM5oigIGM5wcUxbTL7mHA/Sr7RFDgAscdfSnwxMze2OmKC9kZ8ibc7V6eg61LFGoUEgc/jWn9mBGCeKjSxCsSevoTRqS2mUxChYlUUc5z3NI0KmTnbjHpmtQxKBgr+PpTfs8MIZ1Xk+9VexK1M2O3BU8EeppH09XzvJY9a1bZFdcnIz0zSzLhOASCcelS3cpK2hjQ2kSDbEAAO2eDUjQjYQFHscVprAu0hR0pJLZgpbdj/PehFWuzFe33Bdx2Y7CnCBChX734VcSL7QrCNjjOMiprWwMDMGZmJ5yaC7IyoLJOScgn1qX7EuAF2gE9PWtSW15O8c+vpR5ChgxOAOhNArXMpdNbeAwLjp04ApWsYowC8e3tW4h2jGDkUjxsyk4A56UXIau9TEXT4mXcFBIHTFD2EQTDRgmtnyHKAbWHcnpTFgkJJI2j2NHMLkMGbTo8qAqgdgeahOjI2SRnJ4yK3JjHHKokRmY8DArQihJQbFA4zj1FHMNwaRxU/hyI/8sY29MgHms+XwpZEASW0BJ7FK9GEAAUtjnrVc2gaUlEUgnBJOafMSlfc80ufCGmyZ3WUbEDG7biqkngHTXJK2ZX6EivWGsAVwVKr1pr2ijPIB+lHMDimeQS/DrTgwGydcdcMaryfDm08zAkuFA9GBBr2M2ys4yBwc9ODRJYBhgr9AO9HMLkXY8YHw2ty//H1c/TaKjm+HELkC3u54yBzvAOfevX5tNYY8vO7uCcU2Oz2sTJgH1p3Y/ZRaPG0+HDDIe9ds9CqDrVaT4b34wYrqEg9N6kGvb108BvkGTjp6VIunE5LocdOaOYToxseCH4fasHx5lvt7nniq8vgTWU3ELCyjjO/Fe/vaReYys3zdaBYRlMAMc9h3p85PsY9T55/4RDWFJ/0UHHowpreFdZRQRZM2SeFYE19EvpUYBZgAB3xioJNPVmzbooU4qlUsL2EWfPbeF9aWMudOn2g4JGKiOgasBk6dc4z2XNfRS2ADBWwxBzx6+9Nl08Jgq3HcGn7UX1ddz54XQNVIydOuVAzklDUD6Ze55srhVHTKHivo9LLcmE3HPXnpUU1iFUblXA65HWn7UPq/mfN/2K6BObaYf8ANBtJwuTBMB6lDX0b9gVwD5fPcjjimyacmMFCRngGn7YX1fzPnLyXXqjZ/3TSbGX7wx9a+jP7IgdseUB68CmSaBb5B8pD9VFP2wvq/mfOpBHrSdBzkfhX0O/h63JP7mIZ5ztFQv4ct5JHDWsJXH8WP5Ue2D6s+58/cetJXv/8AwithgsLOEHuQo5pg8Kac7sZLCIDgDEYo9qL6u+54ER60iivfB4M0xmObKHH8OE5qSHwjYRBitpD05+QUe1D2DXU8AdcdWA9s1Gete/f8InpROf7PhVwf7lIPCGmH7unwn0wgpe0QewZ2LbQFQcuf73WpxESoz2/DNLBEH3MyMuf88VMyBc5OcDgHrXOdb0K5zEAgO5j1xTwNqp0GalSMFWODn2oMALbnILD9PpQK6IPLYO27G3sM1Ko29Fx3xQtvI8mWYCLqFHUn1NTeXuLgsMdMdqBtoS2jeQs8uAOwHaorosqjbEzNnjHerRXbEFUKqj/PFGGAznpx60Ebu5VjjbjeDk9jzipvJIAbb9M1YC7VIcj8O1DkAgAFj1680r3LSIEi2xku4JPOMU6KAHLl2cHkCnRLMwPmgJzkAelOG+dmWNioz1xyff6UmXYnSFWXhAB6Ed6bLEgx8gx3NTWy/wAIDHjr7Uk0e1fvfN1x6fWghR1M5vlcCNNqjrxUjLmPKfM2c7fU1Zgi3EjBZux9Ksi0RDnIGKCna5jJBLdKftamIA5G1ucVK0aKo45Az0rRaDdhicrj06U0x4OEAOOuOfzoHe+xVgXgMFIB6AipfsYd97sucEYbkD3q3EmFBYoDnp1zTY4GDszvuDfwgcCkMheKPy9sTEnGM4qotvMspLuCvYVoqgIynCg9hTdpLYK4H8qATsVDE+QxjUenvUogYsPlIXHWrgiwvyr+ZppLq/RM+lAtWQfYI5UAlzt6mnrbpHJlf5VYhjlkOcgj0qRoyqENjPtQS77NlCdEOd546kA1nX+jteqkiXMsCqQ3yHGfrWvBG/nNlV2DpxVnzU3FBtPaluWm6bvEy0tNsQEbbsdcjrUTxMcLghvWtibDKWUDgdqrNlcM4JLDoKoV76szng2nCByM5zTFtllBMqMCO44x9a19ingA46n2NOWIhScZB45pkORjvbKq43v+NMcHy8BjnoK1XtmkOI8fXFL9kKAeYNxxzQFzGEaA5k9eo5q3bxFmJiBJHrVvyERspFu46GpoUIQloipx0FLmQ5XaM+cMOSgIHXdVfyT/AAqC3scVppbtKf3keM981ZFqigHaPrjmi4WUTH+xdTjj16UwWxLH5V2g9K3DHvU9vTNQGHb0GWoGjMaEKuAoA7CmNbDqQrY9K1GiBJ3rwD3qGa2DpiJwg74ouNLUy40O7AQY6dKme3aaPC4HNWGtzFEcOD7mpYIcDLc+mKLlOCWqKEVpxggMR2FPazLKQExj8hWiscaglWXjr60TAZU9M/wg5zRcjlbZiLZupCsTtz09aeLRcDgk9BzWrJb8jaSSaWVGRE/vdBgcn/CjmK5WzLNuQvGc9aclodhwucjqavxwEMXYnce2eKsqmV3BcEH9KOYThYxvsnlqTtbHrUZgwGUjnrgdq3/LDdfTo1M+yrtBRRuajmEl3OeW3QkKBnOac0OOEGMd63GhwcEKWHaont1wCFJJIBouNxRVcKihkJGKrySDeM/ebpkU8gsSeSM4B96am453YI7E9cVRkvMeXKruIwoqGR3mOVOwA9T1oeImYOXYKByM8ZqZLdSQzMTgZHoKCrpaksYEa4Jz3z3pGj3MGJYL2BODTreP5Cc575PakOCcZLEcUyFqRoquwDHKY6etWg6RDGcKe+OlQW0Hzs7nJzjYP61NIyhgGGcdB1GalmtkQmQEkxrgk9WqcKd27JBx+P40zY0s24SgbeSByfxqXJBAG7Yp/M0i7dBpDFTnBGcbie/9alC7XQYyD949amiVTtJZd2M8/wCFPGQRgFwx5I9KGTciZ5IyAhLMR+AFKfnIGMtnBPYVO7Kqqka73bqT0HtTwjAEscAcHj+VICu0XlFpB87HtnpUsKNJGvmAgjoo7VYto1Eeclm6Z71NMjpEPJAJPGaES5dCqQcFQMe9RxW6oXZWILkEjP8AOrflthRJ17helCQg8pzjgZ/pQJO2xX+zI/zYJI/Wo5lWNNrthsdBxWksa8hzg47UPboQCVyB1zSGpdzNtYQVBBx3JqWTy1ONxHPQHr9anmkG3MSFh244NUliKSl5NqMc8n+VFzRK+rLMgHl/M2D7VWtrRBKkisdwPc1LMoeMBWKDsQafFbukWyOTPOc9TQNPljoyxErZJ2hVz+fvTp3QKVYgj0HWo45NoK57cnP8qeLRXctuO6mYyWt2VktV89pFG0nnk02REb5FABPXtVm6ZYIWeQEgDtzSWUUMimZc7vXNBetuZkLQ+Uoz0PYnrTkLFVJwSe5qeYqSFUdOBuqCe1Fx8ochMcjpinclR5nqCqzAhgo9xTzCyqNwLHHBFWYLeOKFYyzg44bvT5FbbwevrUtg7X0IFi4z0/rUE8M20mMir1tZvEu4sXzydxpZQG3AZHfFAtnoZkEUzffYbunAqxDBImQ7b/arOG4wMYqC4dlww5A/hHekVq3ZClUTIYnAGag3Nu3LnDd81XlvAJVjaQK2OR/KnSrNI8flOBj73H3qVzRUWtyachY2Z27cCqFvMjuW5U4zk9xWhPCNis7jaOTSwpDKh2BfSmC5UtQXbIOBkCo5IlIOF+Ye3WrMcXlRlYwePzNQSnywzDLcdqozSV9CncQpGudqhvfnms2PzFJZ3BHXArZWEXQG4EpnIqMwoZNgQsFxz60jog7aMpwKZW3gD8auLGEA43HPU9qnNqIiGU9O3anQlZfuHcR696OhDlfVEaSYOWAG78aXOZTleMcGpZI2yVUYJGAM9KaInQneOoHPoaQlZ6kD4LcrgdiBTxETgoOvWpA3LAFcjvTnJ8k+WB5g/SmDESHd/rOex9qbLGiq3lnpT7XzASZQSp7VLIqEEjjj0pXIaszLVWaXDYA+vJqQRbTtLAknoasxW6ZJHJznB6g1F9jKyFwxJznmmrlNo59BjJJOM9e9RSzeWCcgAU6R8/Qd6ilZWZd3YVoc6TvqSW+JVGOatHmMoDz3qusgUqqlcgEgZxg+9PjY8sxyex9KLj5blkMFACqQvfJ71Xmlbc4AKN3PUCngkvtB+XvnrmlIUsc8gUFxVhluh2hjyM5HoKkuIGnjcbmBIwMccVDbpIZ3diGXoFHQYq7GXEO5xmRiTt9qm5razuivaW/9nokYUtxk7jncatwB2O9gFBJAqRYjKoc4x3PpUqE4GGVTjGfQUCcr+pUnBRUWIfMx+ZyM1LE7opDFj9RUiMroWUnGMe5FEQ8xPnYAA9fQe1AX0swgkV/mKtuBx06VJFI0zMJFwnb6VaRFQAKAeO/Ye9IgDHgckdT1FKxPMhlzLJFDttY97jjnpVqFpDCC4AcjLAdqijkUMFJwB2xV6SRUiAHJ7E8UtCZbWsQQAkbnAAOfrT55QAUQjdjAAHeokulYuIzvPenQFEj3yfIp5560txcr3aHQwqEBum3nqVH+easeYjj5dmT2qJEU5YHO7nPoKeFyhKYAP5mmtAauI+xELKpZj6VWbT1nmR2Zgw/hH9a0YE6s4xjp6CplQSZ3ZX1agXO47GQY4pWMZUEqeacsMzMECfuhj5q1PIjPKgD8OTVtYk25+UEcECiwOqlsYpgRDu2g/wC01S/ZvMjGG6kfSrt4IJWUOMKDgAHqamFsscAIU/SmQ57MxZ4oo3xISxY9KWUKrBY0OMck1prChYnbwBjOOfpUdzCUxtQl24A96RcZ9DLlwmCsTO3qO1PklKxh4oi7nAx2FaSKpVdyAMRnbTWiX5QOD6YoLU11RVi3GMGRQG61JuLFVKYz1pimRpnAUbAeueKsRWreYWVyzHoB0xQJ2RG0Tlc7mZD6d8U3YQRhhjPpV0q4KglRuwP/ANVK1uScrgHGM56UyFIoSRsFIRSWNUpvMjQBk3Mxxha3fs7bDg9s89qga1dox3HUVLLhNdTnYdOie4aW4jXf0yPatIICo8tOB+ZoSwkSYu7E8ngelaHksEBA3c+nBppG1Sd2tTLmgMq424HpRBbCFv3a8D8quzWklztKMyL3xVu3tykYUjJI6kUGblZWM2VJJAFQ7cnk47VAYpVQKfm55PStRrd/MO3n9KVotwAyDjt6UrApJGYxRIV3Kdx42j1qWBY9v3Sp/wA8VZgjaWXEiYXqD2NW5bXYmEwD6etFwbWxSaCNlHTaaRLFEXdEF9gKtrbkkZBLH+H0pLjfHGQseW6YHUmi5GuyZQEDKSS3ekkU7tjDjHUU5BLIdrqVZG5X6VIXKYXBf1I6UXL5Win9hKqTEoXjr60hh8tAZTyPX1rXBJjA64HIqk0cxk3sF2f3cc0DjJt6ldSWUArnJ9aS5QbME8+1WykgIKxsVB+9jgVPNZxyFSxzj8OaBcyTRQtwDExHU81AIp1lLMQy46HtWmIoo0IUFgOgFRD5yVYYxz60xc172POomLEEdKWYpCnmSLyOneoQ8hcABdvc1ZULnDgeuD3rQEhYcSIHHBxn61JLMqYzkAnjPJqCQEoBGQBnPPemymTnbtB4wT0FItK5bmuDBGCvJJ5J54q3B86CVh97gDvVRipC5GQBj/GpIXfyyH79O2aBNKxctI8Fg5B59Kk83zGKov3eD71Wi3MANzKMZOBUoBGMHBzyOpxSsIvqwAADBsdv601YixILfMRwSaih355OATwfareeWB5JHcUE7FFy8TMQ5Cdhj86n091eFnccFsD6+9EoVsgjjPU0tvJE25YQCEGTx/Om2Xui/F5ZUAjIPOfWpwi7PQ9sVjpFM9xvSThRjrxW1D8sXJBYdKkmcVEhS1UzeYYwXxzuPAqQos29EbOBkkdAKRCXXDcsc9KS3iWEOIjy3LEnrQJPuyC3tVtUbyQ2WJJ55PtV2ODzbeNJY8E8nHH4UtjHLlnk4B4HtV4QMeFU4POc/wCcUBKbITDtXGScdf8APeq1vbyeY7TOQin5FXkn6+laMuCQivtTvmnzJuz5QwmO47/4UriUn1KEzzkpGigeue1WYyNpBwCOxPWlaOQkkj5j+nv7VnC2mOqK8qt9nxjCdQaCklLQ1bbJlCBcADczH/P6Ve8kNlScEHLdsU2Jh5nzDaqg8dfpTPNB3KFIBBJz1oMJasYklvJduqlGaMYGe2fQVJJLsdVxn3PYetMxDauFA+eRslO+cVOFGG3A57+g9qVh2Q1mYqzRgHaMjio7aV/Jxcxqsh5GOSfb2q0iuY1LEqpONuOapPI8dyyumY/lAJzSCMU9AZ0kkZBH0Gc54/GnIiFQWX2zn+VPKjJ+XcvXt16/pUcZcscx7Ez8gPUimi+UTyg2QgXK9AeM/X/GpIkDoAcDBweOv0pVtgHdsYOQc55qaS289MRuQS3akS7bEKwkPkj5ugTr0p5j2lcZ54AHOParkcaxqFIzgdaiuCypugQMTjj3oJvrYaXX7pXAPTI4JpXQAZ79z0zSyQSyRhACZSMFl6A1JHEoi8tuSP4mOcGkLRGd+6ebYjjcOoUdafICHAXdsXjp1q79jhQtJEqqcffA5OarSzhZVSVgCxHHt707lpp7FZ0KgFFYk9xmpMoURmbbnt2PtVxVZjgEEdsHp7017WJ3Uvk4UkBhx9aCuZdTOEcxmDOgEBOMk8/Wi8DoUMKgkj6A+9Xy6B1Td+8I4Xrn2FV/tEf2sxBcOfvHtx2oBO72EDFoh5mQyjkcYWnRL5iZ3BieBjsasyJFLG0Z6EjIHUe9SRW/k5VU2jkgYxQTdEMWNxRWDN0yKWWFiwU52jgEVm3OpQ2kwV/kZ+MnufpV+3mee3DJ0PvwB7UrhKnKPvEccAZX3DjqMdDUSxRygpwccnAxWoqHCxqPk7c80hhZcE4AHTAxTuLmM1I2Q8Dd+HSmtGsrkpzt6kjFXchhtOMbuADyfcVB9klN2JElRE/hUflmmguNl4jICgjqSexqtc2+fmZ8vxtA4x71enhVsIh2seeuDn1qG1Khy7MPmGMEdaYKXVFQRFQCcnGTwfyqPa8twwHK45boP/1VorC3yhW4XqOBzTL1yhJVF5PHHX3oZSlfQ8gJRQRuywHbtTLdZHuNzN8voKiCKkp3ffbt61NDIzSKq429GyeRWl7m6jbYu7QuOhPYUSRK4Ge1LKGIG04PrSeWGj2E85xkGkSvUlhU8AMrnPY1JHE+fm4BPPvUdtCIOFYZz1q5ESw55zQD7hE42nAyAcVYUAjIwT19qiYomAeGPA9qJ28sjOMNxikTuW4FIjXdg5P+TUr4brw2KqT5ZVRXKt1NDylF3ly2e9K4+VtjZm3Eqpww79vpSWUYiR1Rjlz09abbPDO52ncRwx7VaFv5m3bjA7etDNk+VWZNZ7o92QSCeoP6Vpq4aPK9/WqsUZHGdxHfGKuxwoq/IPlPPFBhOSeowMUDgkYB545FR2si3LSYBAjON2P0qW4GFOCDnk8dqr25hju1UZEjngDv7mkCs0arSxoAWGQBzVwMCqnJw3p6VWIjZeQDVO+uJ4yn2VQ5BH0FMzjFS0LF5atNPGRLtAOcL2q0pMUezcxOcg56UwgmNBj58ZY4xzVOxM7TzrLlY1HynHX1yaktK6t2Lto7eawkBK9j29yatOjJCpxkk856+xqNA8MQdRwOgNRW8rTRBpso3QD1+gqiXrqiWN1D/d2AZ61E0TvIrocIOWIps8HnoUBOfukjqKnhJijEajgAA57mgNtUSJaLJMsw/wBZGeDn+dWUuBLeGBMs4+Yt6VWtwI3dGIJP3snp7+5qx5MayeYgG8gY55980miW+5JAsjSOXYeSAcDvn1qZgkgO7BkHIH8s1Ve5RJ0ikONx4HYHPeknmMdwqxgMC2Cw7D1NSTZssbXG1V2r1OaiEbEnd8xPQ9yKr3Ana7DQsREDhgep/wDrVKTMW+TDNnO48UythilkkWJtu055/wA+tWZ5hHEWUgkDjAyahlYqSH53dcDk+4qKe6igaLzBhjgke/SnYN2TQzuqDzITz055PsaztQnnivWSIlIgC2/GQx7LjtW1IiuitG+cDcvGMimhEwUcDzj90HtSsCkk72GQzT/ZlYA+ZjJ471YikEkOHKncOijvVV5kEYikIWRxkA1Q8u7+1o6tiLGBgdKQuVS8jSigkjnmfzGbaAFXPA/GpTax/aFkmQNLjg+n0pbdQFY7tr4xUjyOuzn5cZyOp+lMhyd9CuZtt08SjOwA4Ufn+PSpAIXZnTO/pyOTn0pGkjjkyi4Ygc9/xqSVwAojPzY4XH60wv2KVzFHGTIcAk8sePwpCIZGJVThRu3DjPsadNGk8bqSGwc8enrVaJ0tWd5ZQEOAued309qSNE7rzNJbfcA2drqN30NEMUvzuzblboD+uKhbfNLESwLLhmC/4/SrE3+rK5Of4WX09KbRm2zndX0JLmfzk5B9e3Ofz4FbNjbta20cZwoHTPOc9qbdT+TDhAJJCwIX096dHNvUEOzKpzwMfmKXKazqznFReyLMquwAjfAIwSMcfjVeRXl8oxkqBnKnndx+lNdx5DANhSeB9e9V4ZJIyZHIfecdOMUWM0tC2wUookJAU9OPzzUJk8ssMg7xjHUL9PeomuRKwiJcnOWLDgegFPZ/KdQx+dlO1QAcD1NMdu46SSNFAZSAPlHHc4pHtgZEZiFO/Ix/EenPtUYm3Lst8ngk7v4T6/zq2jYIEZYkAMSR0pCfukMivHGBAu5gfyqKR1bcFXBHJYdh6VIrQlMM3T5iM8fnVfzIlcSRAs3QEDIJ+lNtDR4k0JNwshZgVHGD0+tWY8RA4HNMDDI6njNEbNvwT071o0dd29C2HJABOAKfBIwLA9eoPrVJJWd2XA2+vvV1f9UVGDnvmkFia2mQy4Qgleee1WWuvKTc/HOOKzbSJondshg3QEd6sOqum1gfTrRYGkX9olljc8Edj1pbkCRwwbJ7GqUc20bTnIHWkS53knnAPNFgUX0NFpGATYNxPBzS3AVo+hHNUftn7/y1T5hjr6e1WluojP5ROWGeAKgtQe4+zt4oHwny85PtWnb45JB6cE9qzbKTzF4G0g4xWrEAV5PJ9aZNXfUdbyM28MOuNrdMVdWTOBzjvVElwpwdxHcCkaR/LKA4Zhw3oaRly3Ls2CWbdhc81GsMTOJQMntnpmoGZlsBHIRxnc3TNTWi+VbxRM5K9VzTC1kWRcAPHGMgMcE1PuDSEKclRngcH6VTYbXLBSR6mp7eRDbqQpBJzyOlAWVi9DJwQhCqefoakQDbkcnOAcdPeqykFX2/fHduM0JIEj2uTuHJJPJzQZtEk915ThnwSffg+1Suu8hT8sjKOPb0+tZd/F9oZCrmModysPvZ7GrtkzTShXk3OmBuYDP40mXypRuJaxSQXRuMM7EFMbsYzx+Yq6kZRFU4XjJx2HvUZYIx2HLk457Z9qjM4WcJM+PlwozjH1poh3kRlXS5F1FLtZFKDIyAD1IHrWhuiSHLPuIGTnv75qC5t0dCjNllHc4A+lM2okJUtuYjbk/zoB6ksckFxEbiJCxXjc3rT/NmAUQpnHVmH3vwqHTo0gikACsc52gd/Uip1kJm2kg5x34X2pJA3Z6D280uHUneo5I7+1ZWo3F6JYhbnK5JJA+8avyuyt5akbR8wBbpUEj7MuTwR1x1+npTsODs72LLPK8Su68kZIBxlvSmxrHMhEkaNJncwem27MYyxbcf4eO30p4UI2WHGcYHX60EPQsCdEnVSzLvXrjp/h9KbJIsRZgSvy4znp7/AFqK5b+MKN4HAY9/X29qorc+bNNDKCARwx53ex9/pQKMb6li01LT7udlVkeaPkjA+X04rQS6gL+WGCydWAPOKwrO3t7S680xqrv8pOOo7VppHF5jSRnc2fvMMDFKxpNQvoaE0yw7pDtG8ZOfSqguDJAzLu68EnAC/wBKa80Y2oVYlRhv9rPamT3CCIBxsUj5h7f/AF6LGSQkrfaAAhUqeAOeT6k1LEHQliSWX5Sc8jPaoI2jMf7lSE789AewqvHdSG4MJQrGOWc8n6e1Mu19iW5mm5CAYBwcD+VKrxzGMT/MR0XHAPrUJmlMqAqgXpnPC1DPEzPvjk2FQQxHf60yl2JZNRkjuEjiQlXHysBjAq+94xjZpSoVRkjPt1xVGLytqg4LjHzE4z/hUkiCSNgzhjnauB29R7UhOzH2+pQT4RJFPHPy56/1pst0kAIfOW4VV/iPvjpSWVrFGpCKD/ujBP09qfNsCBiAAehAz+FAm430Eu2ZovkTawUjA5A+lZ1gt0oPmvucnpjpV6a4DkFuFUcDHLGoPP8AlHylIz+fvRYqMmlYuyTxDdtYDtuVsflVeXM0ZjRtsnOzb1P1NRxyAsSIwp6Dikd1GWUbicjGenvQTezJNPSO0iG9gVGTg4OT7n1pZroEkKcknscbj61QuC0o2yMc9BtHIqOGNEXqNwOSSc0rFaPVjp/OmOTJgHqAcBsdiPSkmvVgcKvmsTjnbgE+nsKtMVWMOGBYKQoPUE9zVG+uGUKRmYDG4qOv0oasVF3djzXaCeCc/wA6hmkCFQMc8U9pYlTcpyw44qIuJDuXBGO1aG0b31LEDDG48VdiAUe1Y8E85utgj/dAdavyysrKqAkd8VNypwZe3jAxjI9e9SQMDyepHeqAZsYX5j0yalWTaQCR+NURYs7lLgE4J7U8KisSF59arqiEiTnirMZIbAX6ZpXC5PHGpfIAHv71JFGgk3bcsOpqGIkTEFTzyD2FWIySvy8E8VNh8zRbjKhOByO+KmibzNxD8g5AxVOxUxAo53bjwfSpm8zcDGBs5zQS9y3CxXIdgwHOe1Nu45CrCM9QOO9JCQF+bFWA4BBz9fpSsTezuNTzJ7RLeeNECckr1NWGhaSFVTI4wGPaozkNuHbtSvcOkDGLkjpTC7k9B9ukkarGzBgOpq8jqAdnQdDVOxnMttGrRGNxnfls7j7VMZ1AVcdTheKYpp3HIChOe3QipXkjUbguWI9KqO5Lk52jsPU0SndbfKev50CRJ0QsrYwPmHp7VW06RRdvcQTgOinjPJ98H+dJErrb7HG4Z5PfFRrbpAzmLCl+Cfb0pM1VldMupdTG7R4+Fzknr/k0+8iinlVgXz1znBOar2cbkndIcE8A+ntUV4L2O7hktih2noeBQKy5tDSaJmh8qNiHfhSOv0pEaYWyRTSA7Rwx4qs7GWXzJGO5TnAPenysJxvldt3Uk9qaIDToZLZ5WMrYk4OTjFOMk5vBNFORtGAo9P6GnJL+4CkfN2rNtp51aaKWNQGJO7Hp2pFRvJtmjOzSxMsDHeeee1Ot57lreOO5ILRrhXzkBf8AH3rPX/WITITkdDx+dTSb2h2xH585HHWgOXoWrRGhmZ/MkYnkA9qtI8jA8j125wQKoWRkRP30mWA5bOfwp5dd24HaQcjPamRJalh33KueAB/F0psczLIDjDdPr75qCSVymQm5fbtVVmuvPQqRjP5D3oGo3NVmEhKFVyOQev8Ak0kt3JbhBGh2Hj5R0qlJcNEu5uOB0qSGYvAjPH8x7HjigjltqX5JN8BIGAcZ2jn8Khjv4LmJ4mWQzKcbMcAev1ps0rHOGHTsOnsKpedFCC7AIrHkkZ+maQ4q5oghOYmJX0I6fWpTtYfMQe+G7H+oqnJLkKFIIIHI4z7VEXaPn07H0/xpkuJYFwpkCyKCcY3Z5A9Kc3zDDrgZ4HqaqTXIjCyhQfQDvSPdMV8xMKw+6p5xQFgv45JItqbhxz3pbdmjjYzOWcnO5RTJrpUQSODtJwe3+frSC5V0GFyATt5/U0FXdrFxZpVVTHtQD+Hvj3ouJ2C7jn1z/hWbHeHz9jKz7uAAen1z2qW5bC7WYknqcdaBNWLEt4JCyrtO3jcDkHjoKpm8CygMcSHgIfT/AAqKFgI5BGRtPG49vpUHlK03mMDwPvbuaEi0kty+LoYKlmPqcd6je+W2YeYsjbhhQnqemarvLnG3JYd/ampM8gUOnIJy3c+lBOj1LQuGYLwFcjgdhRkKQu4lV5qszZHAwBz+PpTGmZsf3PUmkKxrpIxtysIB3R8juGz3qrdTH7RgFSwUbsdC1VpZVtoYy0G8sMswJOT6cUs5jMRaOMIyBWIBz17N71QKPU8zVOdgUhQOoq3GkaxgDjvVQOxXngkVJGjL95sig3bv1LowmSCo9Kcm1iCSBxms25R5RsR9pqxZReSiZwzDg0r6jsrXuaAUk5HIPSk2hnIJ4+lIkhJGeM05mwAynJNURctwriMBumKineUxssWdw6VFHLIc7gFXsaPtSxNjknhTx61L1Kincv2YlWJfOADfXrVhfkBJ4NVnkby8BsZFMWQhOcZ9aYm76l5pXwMDA4NWYGO3luf5VkxXEkgYbceh9antnkCNuOTzipK5TUZBKThulOjcgEnH5VnWrvGmGbIz1qYyOq4JwDwe5oQra2Lwud54zkYJFWYXj3A5HFYkSMku8ucHgg1YubkRxfLt9MngUxOKvobAXYuVIGeg6U5iNhP5GskTiVIyHDqMHIPeqOo6hdxSR/ZwrJkAgjPFK4RpuTsdEIvMRdzfMe/pUnl9Y0x0zjOTVCznkms4zKPLl/iGeKEeRbpXVvlHagizu02X418uMBiSATknpTmeM7do3E881A0owTgYqASqihNwI6LnrTBal3cE+bOcnge9IXYruP3enFUdzqcF93PX0pIpmYOyEMF4JzxmnYrlYSvPHMpjACL39/erMAY4eQ/MQep4FZ0d5m7CTK+wjjaMnNXHjLBTuCsOPb6UbDlpZMsSsEACOc9yD19qo/azMZFWNlk3gIAMgj1JqaVgSByuOfrTxLEFPGAw6D/GkKLt0M2T7XHOhVxtzhiy5zn0rWgOEAJyfSoI7mGeJfKfLd1xyAP5VLDtEgG8DPLZ70DlK+lhryhZxHkKcZAJ6/41PvB+8oLDnp0qreTcFlHzLwH74+tU7W8G4echDcjjt+NAKPMro1fPGCSQPUkdT6Usk0aLvfhOh96zy6eYCzfeOBk8VI5SaN14ZenPT60EtWLsl1H+7Zdrr39qiExaIMXUA9AT19qplwsKqgCrg4/xqrZ2vkuWlkZgcgZOODzTsCUS5LdTRS4GWHTK9c1YMXmAeac8A89qqpwCwOOcA9wKSS5CgYUyAnkAdqB37Fqc7odiMwxxxUQu2DmPDFgO/Qn1pgmZFVnPynkqByKkMiM+5QMdeelBNyKe4aGM70JVTn1NFvMspJKkc8DHX3NNupGUDK7i3GPQVFbpsBbORjIHSgas4l1iJVI+/g4NPyyRY27Seo65qvDIgGwEjtkf1pzXCqMZAIPT+tBm0yNiULMEO9v0FMhu5nDeaACo2jnt/jRJPvDbRkjnmmAoSMnLEcjPBoK9R8TqpbDZBONuelJK5Me1WPJ5OOKhJH2kEsSTgHtSyybm4xwcADoKY7akiuVTBb95nr/WoIrx2cxlMAHJc96Y8oQEgYODk1XyzIRGAW9aRaSNIT7n2McD0FJMwxgNtPYVWWVkXjAb1P0qsZ5Wd12rtJBLnrj0qRKN2bMJjit+bidT5ZlIjIAxn371QmaO2crG8jQuBKC7dWI+8aRt0a2zPdmNgCyr5W7CnjB9c+lQ3jpO+QxfAADldo47AdqbCxxEEwMYPtkH1qaKTc3X8KoKRtwDwfSrETEDBOcdzVIbReAUHgd6VpSvUZPb2qpDcyeYqhQVPGfSrbvGFBcDd70hO6FllZ4gEO3+dWLUMAN5Jbpz6VVMmBgYJ9TTlYuR8wAoHfSxfaZA4TOT0FVJfllDbN2T+VPVRkN19xSOxLD5gBihji7MuRyPJEDgAnt6VNbg7sMaoxsc5B4xUvmKgBLAevPemJmlgKuVXOelVZ7h/M2p+NNW7z0yBUbTQrKoyAx6GkxxbW5pRyqACe3vzU9tOjhsHPODj1rK8wkMCMDtimQstqPl6E9PekVo0bMkwU7TnPanSBm+V1Ab0xzVGSRHXOeQeo/nSG6jGNzcDnJP9ae4l5E32pIrhUfhe5FWo2SXPc9qzUnViCrBh61JDeRl2RThhwQBRsOSbNhAw+h/SnByoOGXJ9apNMxj+9z9KYZXYEkYHagx5bmpHLuA4BJ7GoZ1DzBtxUocVSNx5WN2doFJHN5y7hICOvH9aBqLWpqYCgjj5hjOc1VhtzbOf3mU5IH1/rUJdoYwznI/z+VQNeRyKDG3+8APu+2aLjjfoaaPiRTgHt9KkDscbhzWetwEj4UMTjn1p32nPzMTnbwvbNMlrUmuSzLtU4J9D1pqtvGGJ47VUjummYrghs9ewFKbkByvGe5Pf6UFXtoWodsYcABQf/HvxpoAec7Xywx8oHSqwBeXLN0p5kEZ3YOe+DjNAc/YddXREwj253Z+UdPrQwfygVXOT19fpUBdmfJ4x0p/mOy8nge9KwcxOGWVlVzudvXgCpI2cMCp+X+Ej+dUJwhGSeBz7ULfBlAAAHemJ3ZfMh6HkjrTRJhdpwfpWfNdFoyUIB/hAqMTnBLnnH3Qc0BymhDJJvPIKZwT0qYzJxgkYP4fhWRHfF5PKCsDkgknqP8A69TJcbgFIBx1x0pDlFmp5ochQAxPtnHtSQsY2yWBx0FZ5lzg5xjkHpzS/ajv2jn37UE2NM3SbhGQdx5HFRPhju7eoNZF1emBssNyk87OpFSLdsFDN37Y6elCHy2V0TtPtJUZwRwAelVfLD3hucc7QufYdBVbzN0rEDIBHJHAonu3jx5ak8nrQy1foaE8rrwpGW525oGQME845qpBIxwzsqseRkdKfcylkBTGV9aES+xP5/loRhWJxyeMU6OXzsBeVx0qg0oP+sI+gFC3eWxuAPdRSHbQ0JirgqQdo4/H+tIrBVCrwF7ntVJrjnOe3B9qDc9OcN3pi1sXZTgA5wSfxqAzKclQfrj/ADzUH2kMeCTio0mAlG5S0YPKg4J9eaTBXRtqZ/stuLe3hkjwdwkwSGz15PSs6/aYXGJhHG+BlU6AfhUSz2P3mtJiQP8AnrwP0qGeVXkLW6GKPA+Vjk0MS0Zw8JYMOMD+6KtDkgFsAGqKyEKDn8+9PkmySR90+vNVYOZsvCXYCF7fypWdJ0XLDH1qiswduOW7ipEUoQVIwewpblbamtblY0CE5wOO9SO+1RtGMjNZyFmPoB3qZ5DGmRyDQxLcsxPIwwQSvUk/4Us4dkIjbDetMgYsmMYz+tO3MH5bAFIObUmgDKP3pyfUdKUMsmcDIHBPvVcysGAXB9T7VNFOoGD94+lNDbe5bTCZ6fzpUZC2cDj171U3kEN2PPFOLINyhsHtnsaYrkk920TIq/xEAD3NWwSWKOMOOo681nxIxX99yO1WRKsYKDOfagptdCeGRlcqU+UDv0qnfwm6XYrMgzyf/rVKZUb5Q3NQtOsbjdkZ4oKi2ndFu2CwooIQ47IMAVPbwospkAAZhyT1xVNisibSeO9SQyiIABgT/KgTk3r1NXzAPlU7cdvSoYrnDMi5JB444/GqoZnfKsAMYpJZ1hiLOQMdaViV2NF3SRMPzxSwMkQA4HsD1rLhkR/3sbk560s7FlHlNhu59qLB5NmnNLuTgE/jVaRVaJgCFB7dCKgRmVNpfJx+FJNLkHpnt60IW2w+NmiQIpJIGeTVqKYuP3mSM9ulZkErkEybevTt+NW0uUX5WYE+mKYSuyybkROQv+NMaUs+MckcZ61CJVLFiO/eo2miaUBpFVh0GeaCUrlgSShiM4Ge3f2qXzVx83Pb3qm84zknAHHAqN7k7C2Pu9Md6AauXfPO4qOB1zjiqokuBOdrARHpk/0pouo96iMmTIyzYwFPpzSNMg+Zmwc+lK5WxdZ1DbnORjjNNkZHU7QFJrOuWMiHymKk9SOv4VHbbUjw7bmHQDnFA1HS5ZeVYlBQDrj61Kr5y5Xn19KrklwNuBgVBNcopO5gD0GO9Abl1GSTOznIyaViM5DfL04rPSb5PkbvwPSpg7BO7OT+lMfUvic8A5OBn8aYbg7cjB/rVJCMcnJB4HpUcszs5UnA6kDuaVidGywZzIVbqB09qYt2AzA4B/hUd6rGXbJ8wJPT2NBZFYEjOeuO1Fik0aaykxhv4yPX+dRMcliefU1XFyFCrkZ7HrxUM9xtkB5Y5wBnGKTEtyWaV45VKsGPX/8AVUyTEAb2APeqSS5JLAHvzzg0jSDkls9+aRTehe37xkvwOeOlQxOqOzF8sTkexrOvLnanyDBPTvSWkjspd/vdgO1O9gW1zReYK245AHTNTLMJCQSCB3qgWHOTuJ9u9NWfCMoH5UyWy/GdvJOVBJAI9aessQkHmlin8RXGQPbtWTcXJyNgGRwfeohOynBOWY5x6UhWb3OpgS3mTdDBqMidMqFIJ9qo3Z8m6KKkyDaDtlA3fpUcV+HW2hN08IaB7dkGcI/UPx/+uq+q3aPdZimEhVFR5BkB3A5NMlbnEzSkKME+nFMgmeQfMhXHbPWoi+T68cU2KRt+M4HrU31Ki9LF8ANIrk4I5HrVuO5UKRjIFZ+dxyOP6UEmPkdOlMV77mst4OmDmllvBHjzCMHr7Vlwy54YfjmnyFnwDjaOntTZSsmbdncq+CGOKklk3/KzEZ64rNtwVjG3GR07VOj7c5yTQiW1fQtpMnmHccH24zU4ZBITnkjis4tG3Q5Oc0khJHBwaY9GaZuMYBzikDfxLxnvVOKdUO1+pHXPap/NBb5eB6etAbDpXmJAQnaKtRzHaNxyRiqqzDAVyM1IEzgAk+np+dFht6WZLLt3ggnI6jrTgMld2Rt5GKgliLsFY4wc8d6EkWLCtnnpigfNpoWWfJUKenSkMwiOW/PvSQvu5BAAFV7k7n5ycc59KATvoy0tyx6H8qQTyS/LIv1zUKuoVRwQPWniTenyHI7kUAmTEsi4UgL2B7fhT0lZVJLfMvFUJZXQHYpY9uaA3mRgnhx2HegGrq5pRyhl5JAHfHJqO5uPJRiuSVGTWfExDFWbjrj0qWWVdvzEBR0zTJtZj47svu8wcDBBB4NIkyO+9Xyexqu43cLyD3x2ptuiwOx2/j6UjTToaUV2xbYwxjox9PWo0giNz57jc56e1U2nYPhTkGrCTAgCUkE9xxijchtrYuSzZxgcn1qMSPvIYj86g8xBHxyAeGqjcs5lGGYLxkCk2EFfc2XlUEHjGc5qC5PmZAONwz0qk0u+PG496ckhTnkk9yaLglYuwsAMMR6fSmy9QQ2PaqrSYxkjB7UbwYyH6jnJoFfqW3uEjQKxwBxVSQCSTIJ2t8uPUVXuJA5U4yPUVH9qG0jp2APagadi+GCj5mA9h3qTzA5yCQO5J61jiR8ne+EJBIPqKmklJQhcrnuKYmapk2jAJzjn0qBp9w3Dv3NZ32hlcEElcYyf8KPPyuWIDZ5oElYtNdtHIAwJBH5VLudlOdvTI96oPcRbVIbJ649KjN4HVAp3Z6j0pDv2L4mO07l61C0jOwGCzdTjtVSSdkzkZHShbnzBlQV980WEmXxLwuRgjt61WuJixyjZbrg9qqySlTkn3x/jULSb2JPJ+uKA5upoo2MK+Gbrz3pRdKQWA2jjnFZhn2gFc5Xv3qMynfliNo7dcUA5XNhbl3XC4AOe9I0wVQu7J9RWWk6BRvJDY6k02ScbSqDPOTQS3qaLyoTkFuPXpQJ8DcWyB69DWV9p3Z+YBR0AFPhu3ilR49hKHOGG4fiD1pDudL9oW8srJbW7tovIB3xvII2V8/f565459qz9auEutTLRSiQiNVklQcSOB8zCn20kkGnWjyX+lwCRSUWe23OBnGScfrUOu2s0e+6NxazBAiyC3TZtBHynHQg+ooJ5jihIQV2tgd6swy4wTz61lxz5BHTFTLLgZBOB1pWsO5qmdQcUxpypXGT61nb2PzA8DoalE3yjqeKYI0RIQMk/jjtViKfcq5HA7+1ZqyqyAMMj3qVDhuDnj14oHc1fOZgecenNPWbdkM3z/pWWlwu7ao9yBzUisQ5IIxTuJGtAGXJ3Ar1pzFcjJ7VnLMUUAMcD3qXeeecqecUw1LLxAspDA44qUu0aBV5wepNUvOZWVg3zrTGu8Mo6igtNmgd8mC/yj1q3DOI4wqsCQOM1kCdgAQNvt1qIkyM7LJwflP8A9alcpa6M1xM8kn3sg9KuLgrlskisa3YJn5mz6dKuQycE5z7CmTKXYviRVG4nCn2qDzog5bI+h6VWkm+U89T0qthOx+YcjFAky4Zd8jKp/WrMTsUwz5HtWYkgZnAySOSfSpYzhtxY4+vFBV7IutK2/aPu9aeJcfL1PQVW8xEXrUMjM025T8vtxQTe5ePXJYZ9MUpTenLdDxzVIvJuG3G3NODOA2080A9Cy06qxTksPaq7SuX5AIPr0/CoyxDZJxgc88mmh8k4bkDPTNAXtqWllVACevTmjzBOrCPIwT+Bqq4Ei5YgY9KZ5zKp25wPfmk+w79SaN5TgTHGCfu1KWAHGW9c9qoJIzrlmKjGT/8AWqUOix5L5HXrTCTASyec27IXsfSrUErdQQPU1QaTerYGB61D5pBG1zkHOCO1IV2zWmuY+jEA+ppiyqCCFJx61mOfMZWKkjsCaa7yhsKODx1ouHQ0JZFJ25OT04pjMQST6DnFVUY7AHIz9ae0v0I6AUyb2HJuBLNkjpzUc9xJH246800z7cqevbFQSyofvOSe6ipbBMteaWG8tt74Jps8+0YVsis8ynHBpu/nOQDjr6U7hexc8wAFs/LjpT2kKsuMKW5GO1Z6zDY3OeeTmgT7UAXA9cikgci80+FG+ojfhJSgG1MHoM1RefceWz3yTSSSxlAykHJ6elFxcxeN4rL8xOcc4qM3W4YwR/Oswz7QwZl2tjIpVuShUhfoKLsV0i8Zz5Z6AZz0ppuMEg9cc1my3QJILYPWqzXHGAwz19qBpmubj5vVuoz2pv2sg5yRkVkvceYxJ6nuKY1xgEA/iDSDmRprcPgk4OaU3bBQFKkjPFYjXeOpbPpTHu/lJBwo4NFmLmPQNNIvdMtpNWgg2RgpbySXfkGRc/dxg5AJ68Vna7qlzG95ay2qW87mNWIbIWFB8iKOmO+e9c9/a2m3VnaJqVxeWk9tGYA0MQlWVMkjgn5W5qDxLq5lv4x9mkt0S3jSFJz85jA+Vj7nrTs7E3KSO2Bg1PHPwFOdo5x2rFS4IYZfkdM1ZExyDnJ7jOM0wTNhZhtIBGDUkcnIVvujjr0rHW4JOVJx6VYSfpk5FKwc1jVWVQNmM571Kt0wx37ZrLim3Ptj5fGce1KbogKcggUWLWpqi4UspwQTVpJk7cVhx3JdcleTzU0VzncDgNnAFIZsCUY4YfWpIZipyDn2rIR1DY5P07VN5yKNwHFMm5rC4xgNk5702STeFC/KemT2qgs/HzAj04qXzsDdkjPSmyky8khA2npnk/1qRZlTjsOAfas5ZWOQD+dOjkfGGkzj6UkUmaQmDMGHTPccGp4rjAKgdeuKx/MP3d3BNWEm2HKc4/A07i6F5i25yV4I9cbTQGXjIGKqTyFwNhyepP8ASnCX5gSMe3UCi4XdiYBFkGCW7H3qVWyOSeOgJ61VMmW+Ue/0oLlsgnbnpQSpGgXSReGx+FK8yqCAeelUIT2Bzj0pTISFDHdtBxxQ2BcichMO2falRy2RuOKo+cAQWyMdqabjHIGV60XEXHyHznJ71GjuFJPQnr7VCk8ZkAz1yT6Ae9LvBU9On5UFXsSzOWVtpHpkcVHCzKq+YxYKMfhVZMruO7NNmuNo6Z9fSgSb2Lkku8YHH8vxpCd/BUD2zWe1wcFsdR60i3DkkscY4H0pXG2X2lYAKOF9ah3hDvkbPNQmYAZHPvUUkylSG6Z6etDEpFiS6YkBMkex7UsUrKP3jH6j0rPknVVAT/DIpr3IzwBj+6aQ29DTkmBGI8jPQ1GJiEwQMDn/ACazGu8/xcdxTJbobAvGaLk3NN7hAhY/mT3qt5vzF859jWcsgVu/50xrjcA28Zz93PIo1YXNSS4yuM4phuBv5IH41lPcDP3iage4XnB59z1pk3ZrvcBOnQ/rUMt5hhgkj8hWVJe5J3vnA+XtVWS86AsMZ6Uegrmu92+4kEYPUUjXDYyCMj171iSXiqSCeRUb3A8gzBwFB2k7u9PlY+ZG011gM3APU81C16GQYYhgelYD6gACMgiq0t+c9S340+Qh1EdKZXMTSlgIwcFu3Paqouh13k965s3bZ61G1w7Y5qlAn2qR0jaiBkMck9OeKhl1IbcE9OgFc+0zsACelMLN6mq9mS6ptPqRH8QzSW95FNdxRz3DW8DH55SpfYPXaOtYmT3qW1t57u5jtrWN5p5W2pGg5Y+1PkRHtGdQ8WiFCB4lAJBBP2B8/wA6z/Fuo211qUBsLhriGK0hgMpQpvZFweDzTP8AhE/EH/QGvf8AviszULG6065NvfwSW9wAGMcgwQD0NNRSE5NjknyFBY/XPSrcV2R1askHj3p6SY69KLApNG5HeEEnCkdwasx3YbJBxx09K54TcnaTipUuGGD1FTyGiqG/9pGQHPHqKsCcFQCc1gR3Wc4GKsRXPIAb8zUuJaqI3IpCmOeD+tWxKrAEDn0PesGO5xwWBz6VZSQMDsYke/apsXzXNczbRu6+tS+YnRjuXH8JrJiuQu5XJLcbSBx+JpxmCkDPyn0osNM1kkAVR128A1Os2R04rFW6wAGPFWBOMfIwPPrSsO5qpOejA04zAA1kfaGVslsj0FSJdc/Ifm9zSsVc0jJhgV5FOErBjzyPXpWbFclxtz8uc4J4zU6ygAdx3pWDmNFJicJHjOBzUkUhx85z/WsxJtpAJ5PTPpUizgMcZ/z3p2E5XNPzmyQDjHNBl3N8xA96zfNAH3+B70wXCl8bvl9aCbmlGxBPz5BPTFWfMPHzAY9KxftIA44I75pqXbBGy2V74HSklYd7m0Z8nnnFI0qgAZ+U9gKxjeNt4HP8qf8AbgUXcpBx82TnJpgX3kKs20A57+lRLcSEnJVQOeetZr3uHIdG244x61EJX8zO45NMdzX+2EEqrAg8UhmLN83SskzD73f0z0pguSXVc8k8c4osK5rvKoYlTn61C0vzD5j+VZUl2zsQGx9Kjeck8tk9zSsF7G39o24+aonuN5OWwe1YrXeBgkE9gTUD3hA+9RYm5tyTgKSze3AqKW6AUbSGHrWHLe8cuMelQveRiLfvXrjG7nP0p8ouc3WvBs4JDHg8dqhS6BZlkcLhcj39q599QOzbuyOoFVmvScjpxxV8hLqI6Jrxhyenoe1QteKAxLAEelc99tbDdeRjrUDTOScnPFPkJdU3pNQXBAbkVVk1JmGCQQOlY5ZiaDn1qlAj2jL735PeoZLt26mqtLTUUS5NkvnvkE8gdj3qNmLMW4HtSUU7IV2GTTT1pTRTsIKKKKACiikoAWhdwYFNwYHIK9QfaipLa5ms7mK5tZWiniYMjr1UigCzqeoXeo3X2m4EgmKqrsgYeYQMbj/tHvVFixb95uz/ALWc/rXb3+qeMb2QXdlbazbwuisyJGSm7HJQYyFPXHbNchqV5d39282ozSzXIARml+8McYP0oAq0UnbFFIBaXNJRQA9GG4BiQO5AzT1kxUPelzTAsxynsalS6kjbKsQfQ1RBxgg80pYnqeaVkNNmsL92xvxT1vdud2cdiKx9x9aeHOPSlylKbNlLxexGCPWpob7a4YqGToRnBNYIkxSicjvS5SvatHRpfnBz27Y5p73McjZH61zqXR9cEdDTvtR6E9felyj9qdGs5AJzlfUHpUsdyCCD19c1zS3RXgcg077S69eDS5SvaXOpFwx6E8epo87OM53DuD2rmBfyhcH8DQL6XnMhwe1LlD2iOkNwVYEn73qaBdqeTww965v7YePX1zTvtuSC7Zz1wKOUPaHR/awwIyBxxzUX2lVAJJGea59rwk8Hj9aZ9qJGCaOQPaHRyXseAVfd2wKT7eG6Z3d65s3R2nnimNcscdvpT5Be0OkF6ckdc9O5ofUP3ZV25HYDr+NcybluxOfUGmtM394mjlF7Q6Jr5vK5dME8EfeNQNegK24Zz0yawvMOaGldgAWJA6A9qfKL2hrvfkAbW+tMXUSvBAZQc+lZDMT16UZ460+VE87L7XpY53Y/Gomumz97PNVc0U+VC5mTSTFmPNRtIWbJ5NMop2FccGIIPB55B70mTnJpM0Zp2ELRSZooAM0ZoooAM0ZoooAM0ZoooAQ9KM0GigBaTNHakFACmkoooAXNX9Au4bDXLG7uozJBDKHdQATj1APUjr+FZ9aPhxbRtf08ajs+xmZfM8w4X23e2cZ9qANea1ee4a5HjK0cM27zZJplk+pXGQfas3xXfQajq/nW0jThYY4nuGTaZ3VcGQjtn35rXu7r+0Ly40fxTFa2l4CRb3kMaoIG6hW28NGcjnt1qn47hNtrFrA6orx2Fur7CCCwQZII6/WkBzHmH0FG8+gplFAh4kPtS+Yfao6KBknmH2o3n2plFAEgY+1LuPtUdLQA/cfal3VHS0XAfuNGabmikMfuNG44xmm5paAshc0u4nqT9abRmgLEm8nHzHgYo3H1OKZSigY7J9aM+9NooDQcCaAT/Sm0ooCyFx70D60lAPNAWQ6kI96N1KDmgLIQD3ox70tFAWQY96THvS0UBZBt96NvvRQaAsg2+9G33oooCyDFGKKKNQsgxTdvvTqKA0Exx1pNvvTqTNAaCYpPxp2aKBDaKdRQAmPekI96U+1JQAdqQ/WlozS1ATn1ooop6iDn1pOScDJzxxQa0/DDIuv2RkKL852M/wB0SYOwn2DbaAJB4evvljd7SO6OMWslyizHPQbSeD7HmsmVHikaOVWSRDtZXGCpHYg9K6/7PEus21xM9glpHEIrqCfHnFsYlVkPzNIW3YYe2DxWN4ryNTiWY5uktoluCTlvMC8hj/eAwD7g0AYNFFFMQUUUUDCloooAKWiigBRS0UUAApaKKQBTqKKACiiigaFooooAKWiigYUUUUAFFFFABS0UUAOooooAKKKKACiiigAooooAKKKKACiiigApF6GiigAFFFFAgpKKKAEooooAKSiigGFIaKKBBSEZoooA1E8Q6qiIouyWVdqysimRR6ByNw/OstmLMWYksTkknJJoooA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Keratosis pilaris. Multiple mildly erythematous follicularly-based papules are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratosis pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCiM3MCjnAbDP0AB9P8aCkYTC79qZx8ucGphG21kjYpMvykcde/WnKYkfdOGU43DnIY9hmvJPoCiwC3cTox8xlwRkjr6jua0Vil3FUK5Bz1GB/hSSIssoMkaecWyWAwPQYNSMwGFidgCcsOD+lD20BISVJJIt32ggN1cgE+5x1qpY4mYSIQUB27h/hVmSNdoI++Vycg9+Mqf0pYNscR+8jAcjbgEjscUhkVxGhcOM8AnG0enrUFtO4jWKcMWD5Ta3K+mcdf/r1PK0vm4VSByVJxx7Z9MVBEmVefcFYDCliOPdu/SnewFhgH3biTzk5HX059KltLNBMM+W4wcJ8uCD3OaZBcJJA+4huv7zO0/j656UolVbyGNTtkZflO3k+oPb3oAuOiBd8YLOBhsnO3H+earFZHcl4yiA4HGSffmm+Zsyv3zzsVWG7djnAPfmkivhOhGFRxkHI7g8jHamC7CXKCJUZlwABxu9fXI/lVaBYm3eUzgryu4DaPp/8AWp9+gwfMQzRgltiyBXY9hnnGP5CqulBEz8rZLFWDNyfXn3/Siwr62LDhWYNMgG1ePl4I9Tj+dCMi5ySIlxzuGOT1/Diq2p3LWjOQVJQFCOxHoP8AHFVbO+F1H/qgCD93Aw/1GP8ACkP0NUkMgLEMwPByCCc9QfSsUxzy6rHvmCpKTtSTBGQfXp64PWr93frbptVBjJ+WNcqM9gB04PSpbaKOW3R0Xp9zaRuH/wBemmS9S246qGkfHKliCo+uPeood8UTozqqF96sePbp1xT45UWQ/dkKjzBuHDY68e3PSsu91AQy7HQsx+YMMbcA+o69ae+oN2Ll3Cfsm2NYHO4blJxk59eoz7UsFstsgUJIuWyFABwT2wKLecSQKrRGQdzjkn0+gp91cxxIzTEooBYDP6U229AUUtURyRiGKZjGsjEFURgemeOR0PuPpUWm2rk71kxJuwcjhj7dvrnrTLDVYLgYXepJOQ4IJz6fh2rY2pgfOOhb7v8A+rmlzaWDlV7laWMkmMDLxn+LgAY54PWqktu0kkG1VWJM/IihR07gd89zVi5uTuXf5hBOT8u5cAevanCYzRpJGpGAcArkNx39qE7DaTIwuzcVVd2QP7u4f1yazpprmPUIxMR84IRc7jj1yOo7ZrXYiTJYMrAAFSN3bgg/57VBDaA3CqdyvHkDJ6r3X/61Ct1E02VkVZR8rFWLbztOQCD1x2B9+1acQBfcnTquDjjqeD/KicqyuSGdTySQAMcYHqAPSs2eZw4WG3aRxhvkG5Rk4/nSd5ArIvTt8hxtRWPOScD16du9U4ifM2pOj/xOVyML0696tQM0kLJhFcALleTkdv5ipH2tKojEechdxXbn29xRYZFev9nB+ZVBILFz8v5+ntWUlzNFK4uZIScgCNTk89Djp71uTqZlcsgYk7n3ZO7/AHl7/wCFUNNso4WZ5UCfKcKwzgsenFNJdRS5hTMUXd95zwdoPT+varNnK5RZJOCeFwc4zxzT5YmkYrlZI05XBIx7Clsbfy8IsrfKeY3IIJx+mKjbYojuJJo9zbB5Y+dmHCgcgHk8k/SrMDmRRu2k47c8jOc+maY1uJnA2hfmBBPPA96sAx5CqxVR97BwG9gP6U3YSuQXD5Uxwuc5yEZgDnpjHfr+lJuG1AUXjk7Tnn0Hv1zUkkZmUAxqWB3c44OeB71VvVZo5dx2BsqxU8k+2elJbjJPOBU+WyMAx2r0PT+VMuIpZI1KGPlguCxztzyBk1S0+FllYoAsOMbGO4j6/wCIq9OzeUJJGCoVzkjoo7+xqmrCWupDdxQgFBIyxoc5jYq+7HY+vtWdDbxRXEqWQlMa5xJM3MgIGNw/hPX/ABrUjnhniWXBdRwgPB9B/wDrqnc3cVtI0ZDM83AwM5/+tTUtCXG7vcvEILYPECj7QOByWzwR6jnioreMFSWQB3ByMdMeh/pTRdJcRIwYbPugcfdHU/0Bpqyo8pQv5jg4yqj+X8qRQy4VQolf7nAwB8z+/T2qOzliuctHgOWznOMc9xjpnirF2WLq7Ksr8gJIx+XPv1H4e9QWcJk8tiYVYjhI02gnP8XrgZppEN62K01nIbk7FAjfkgjLbh6k+mavWny7VRi2DkbuMY6ceven3RVCh3cbtoyvI44Az75pkr7XbdiQn7xL4XOPu+5pN3KUUgufmYbwCpbBBXcCPT1FYM2m+dcHyEis0aX5VwWwCOuT1/HpmtCC+aS4MXlNuB2iMHJyD29vWtZFRIfMWPdjnJB4PpVRfLoZySmVPKkaXzGCtKCPMcjgADAyD1+tQ3tk3lMrrGznBUNk/N7emK1HzLGQ5WNhyxAwAT/PnJzUD3B80lRkdBgbip+v9aOYrlsrDwcKhKJuPXnqB15/LGKjl+WeF3lXazkFWI4P096mSctE0XzhS3yqQCFb39sdqfcIjy9UXaMYOCNx6Yx0qS2P2usTosgLPnKqeAAPyqhNIYUzFJgZADBfuZ6n/GtFIcnYHwcZLOvDH0/pTTGrx5ZCgZTuxjBA9u3pSsG5EgMgxGWkif8A1RZMZ98enWppN8ihNgUgkEj7wHf296rxuyxrtZDGeMluAO/5VdBjCDEIYFcqDnt/T370DKUBWZP3gCbSyAM2HB7MR2B9+tQ326KEiMQyXGBtYgEH1/CrNziJmdFIdvlCAZ5PTI57VQ8+NplSbaDn7xBChvcD0/wp31uJrQu2TloWBWKGQtlgi5C+uPrU0US7mkVhuzljuU8f3QPWoYcMgI/ebT8w+7n2/rUNzMIIciIEKQScA4GOuPWjdhokXQisCytETswM8ZPcfWorPEIeF40lRSWHGGAPfP15p9nIrW/mknyZuE2fMSBj8j3qRXRTGcSbOc5PAI9PX6UPTQfmVrqNVIeJFcOo3r7A9fbtxVMamk8kcCID5YC5Py9MnjgE/jWq5WN9wZJWBBw7cHufYCqdxuuLvz5Ybe2j8oKGhAwCueG9Sc9faqSViG2mNW4I8sybbiOLO1LjDxscZPXkfQ1HbrbmZ8wPG3yncx4IPoAP6066u7a0eONZYklkyoRhjevXkelOimUo5G5YFywRGwB9Px6d6dwtqPaA/ZpY3k2ggYCZBxnPFVmmhszl2REI2ISMFTjr9amsb2C7aTB3RKcYZsM5A9euc066iRTFMIIJyuWEcgOCSD94D05OfpSSuO/VFaC4W5VQZAN3y7lJG38B0x6d6w7/AEmeO8CCd3iZzmSIcAdCDn8q3NIjE0UklwwEjcOOATj+72yferMdmIps42Bl+c8AkL/T6VXMoqxnKLnqV9Pj8i0WNynyLyVbOcjr9KnYoRkSJKIyJPLZjjjpn1Hr9aJX8vcyjaVbarjjdnpjjGB6VX8lvtcJ8sBQhLSLxuJ559f/ANVTfW5fSwyNWlv53lUpEzFkCcCIFs7QO+K03KGVUBYlgSgJHHrj3NQzSbEHyFyF8wqvU+gA/Oq1pczOZre5jkgcyZEMnDD0IB6Y6YNJtvUcVyqxLqPmNFsQ7S2QGJyOOo9z+NGfIUnGdi85yAD3Ppx6Vb275UDZyTlsJgHHp/hUNynzKC2HPO1juwOv+fwpJ33G1bYxmvLpS1wbZ0g5/fE4jPOM89v61p2rsyjaGbrnccn2780mozXGoy24ud0kdmQkaFMELnkAdPbpVuK3jjACuwyDuDHkZ7f59KqSSWhEOZ7k4jLR7Nhyfk3KuOv88VQnEkavC3ntA8g3oD97APJHqM1YaV98Ig5nJPG7GcjlttN1FtsSSsTI+3gkE7j/AHe/PfNTG99C3Zi2+IwFYZOcAnKkk9zj0pJ0V5VBcEKQxOcr6du31qGCYzBAFfcowVdSvynqwz3+tRzW7NIp+YliVDrknoeCO/pn60A2aNwwCqCVaQqMbhkHPbj/ADzWXJqCQTRxmCRvNIY/Kce5wevTrV8q6pjnBzllOPovbn6VSvLa4ZDaxm4lQSK5jjfG71IP0P504pPcUm1saFvOZxuj3cjkN/M+o7fWmWDsxldREN8hUdBnsRg9KbGW2HI4BALAZGfTHtzzU8TBFP7pWbJbaMZPGf8A69SOzJbhypRY1z8wHIOOPp6+lKOSrbGKk5A7575Pp6fSmzCKbyVDNklTlGxn8P61PGUmmDBt2484wMEe1IZSkmiikDBCV6bmGWI/z1NQXNysNoW2HzJMBVIyST/eH6/pVqWKV3lVXJjb5hHu6nocn6dqdEXglMsDBztIzJgMVxyAf600tdxXdjOguRMqRiN4WbIBdNpJ6dPw/CrcsYkQzcMo6iTIVh6cfj14qvAJXgLSs7SMP3hycqP7o9O1J9sjgnK78gkoSAcMo9vrVdRLXcfbW7qyCPAeRjhV4wfbHoCRVG7ilIiW0WONgc+YU3HaD27H39cVqXEoWLEY4IwF/hHoOfzrJe6l80o425BX5jjdj0/z1oTe6E0upahhcF920PjO4D9cDj3xUIt3E4VFxjr7kf19quoyyAfJuY4EZHGG/LnipH2tIR8zuVwmzJIB/r3pajsrIjW3cBHLEYDFSVznHH19RVHUJVgaEQryfuhsD8PeppZwsyKZHyx6Afex0NRXca3IAdtoVuPlzlvX6f40eoMsxSNNDGZ1BwN+xuqY/majnAIdUzIe4xk56k59ulV7C1MYj8+HyXds8HORnOevFW9jiZ5Q7MvzAHjp6n1H09KbEr2KcNlBbyMwxuJAXzDkg9wSOgPX8KvhuI2Cs+xsvsOCVzz9fX9KyZYD9qtXQnJyHzyqnHDMfr29qusSkKgKDuyFL8gDOSfr3+lFmJMvcDCR4CljyRn5fr9O1QzRMZNwLIi4+UPnj0qpFfD5FleAu33U2n7vcn26e/Sp5p9kYLBThSwROSR/9fjrRYFJDLCSGe0+0IZF6pIHJBQj3/lVuJWiHyDYOdiq27HuD+NQWarGVkWUDflwJF+82ckY6Grs3lYjbMazNyFRT07bf6ih3bHFWRXkc790e/cBhgozv9T9P1qRiPKV2RFLfMQcnv39T/Kobi3MpRSqRrGd/mY5Ddjkdu1Txyyqoiy7BDyN/DN19OPWgoPMwX3N5attwGUg9emaWSbyI08zfvDH/lrjnHHzH6ikiKTTom5hJuO9mOVPGce9R3tv9rXIAKYVF6Zx6H15NFgZDgeckgZ1LcgMDlR3OfXrzVO9DPJbpsV1BAZ1UBwB0zzjP1571dVwySCQgnhVVz949+nfPelnZmBKxvLtG4kkZUddxP4ULTYTSe41ZlDGTG5yQsgbJ59c1Sliaa5cQy4jIyRwR/nimnUIlkW4kl2qwwr/AHQQc/N+fBFT20qYWSRBy3DLjKt3yPbrRsK6Zo2sJktBvCMWG7EJwFx/LPp6UEytOREE4OXz824+nPAAHenpcxAcPErHhQynIz3HoaE+ZQANy5Djd8pIx1//AF0mUUZr427qgYEAngjktnPB6EfyqS2n+1xrMq7CDuOF5QEnsfvAmo7xs2txHHHEJMfKzZdlGegA4BJ/i5pbEKtlkx7gGYl2AJycZB6Egc8etW4pRujNSd7C31tBJDIEhjW4dwfOKsWUAfc54UHk+opyRvDPGyQq+wKyq6fKcZ5Pt16VDqFzNG0j2bINgILSP90d15HUjtzU9jITHEWX53XcQG4w3UH/AApybdmEUtUUbSP/AEi4liUq8x3YjGFUZ6AdOorQaaFd25gWxgYPP0Hb8DSXZxE5IErYLbc7VTjnp1IArGBe7tvPN5CkaSgsi58yRSTjjGBjHJpKLlqJtQ0N2LEKBCg2FTuJySPT8c08K+xz8pCr8sikkHn9fxqnYvM9jG8iKzuPlC5BCqOR7cd6uTyRW+0kM0aoOD6dvoMfjUSRonoUdQt2+zyt9s8iSNsFeolGOgxnnB4B7VHpYkeyAmJSHO5WxzgDoRnr7fSrroLh0dXUsVDKxG0v7H6D1qOVo7KNElOY16bWwAeef5021YOVpk7qpRXORLFhg6t/Idv8ar20LLNcNM5ke4cSF5vmcsOdxY85pba8juUIhkQxr/DjgY469c+9TOFCmQxn7+4L+gz6nOfwpJuwWRHLOI0jMrIX5BX0X0HpzU6hTArhlO8HGMD5hgkH044B7npWXqCxBJpbgyEKuYQmSH5xz6fxc9eBRY7YbZGbkugYndnC9ufXinytCU7uxqQrG67fM5HPA7dx/wDXoLJGoclspwpIwQMcZNENwkgLNuAJDLwOB7fz+lMvjtDOR5hZC2Gwo9geelSkXfTQfuSZ1kCu5U5Geoz15HfPp2p9tdSxTSPaOhkljdTnk7WHOAfbPPtVSCHbbxLGz5GBu29T/e9uaqOsaGGNb15TIpcqItuwdwx9vaqSa1RLtsybypIYYRIzyyhcebIOcY4z74yBUNzq9vazeWeZMZUAEqPQHnrV1DJIh+T5lH3cbs5HX8sfnWffQi3lgms4Db3NuyGSRm8wsT3Udl9QaErsTdtjTspI5cKzByGOFJ4z3JOeKsbshypPH3cptO7v07VTtYPKTcBh5MsWHcE5JH58VJceWsDSsVxlVGRjv3z0+tFtbIpOyuynqBkjaJt8VtBuMbhvvZxnGBnP14zVq2L+XhlKyBQxwPlU/j2P6VQjMn2uRbi3CSJ/qvL2/MvZh3x9fwrSjUqsahWGMYJP3v8A9VElYS11G6auxbhndV3DLY4GPT6n1q6MLb7RlWUcqecD3+g/PFQW6gvhXeUHLE+oHY57HAqy6/u0+6Rjl8YyvOM4qGUMd3eHcuQmCFIAI9uf1xmomkKx4LMcDaVPPGf0NOgwEBiUB8Z+Y9PTnj/IqO4UzIUDlVI4cpzkdR/n1pgMm3PG8u8EgbyV4OOmOn8utZ0aPNJtWIIyrtZgmS+DnJPqBmtiMqgjAL4AACKNwznjHr+NDwra7Cu0HkEKpBUj1PfvTUmiWrldlLMwJDKhHBAO7tgnPPGP1qm2mx+cr5BC/KpbnJHp+FaglRmVkDlW5CuB9Mkj8agZtjgFAjD7oL498++RSTHYj8rEeFLbN20HOQPXHft+FVp7tY03PsG9t3B5VSMAgfh+NX3BkjDgqodeSo5H1/AVliKxupLm2vxJEJV/cSIBujk4A3DgbRzxn3zVxjfQicraluN7eT96pDsqhcMTlT0JPX8hTnO4jpgYK84A+vGc96yrJRGwjMUqbcBzKOMk/eA7g1ausFjkM/JDYAB29Djtu64FDXQL6XJmYTEiNgcn5wUORxz9B3pTIgiUj5SoCjHX/Pr9KqaddbWKsJFQKQBIcbgDyT+XQ1ddAU3MTlPmcKcfTH0pNDT0uSbklcbQFKnPXOAe2f8APWop0EisXfO4gHavKtzgfX3p2nQmJNsh3KwwCp429elF2cGKNAwZmx83YHOScdaBFGOzVGZSgfLDa2c7B3Pvz6+lLfowiLCbyECjzCB0x0/H3q4xCuAemOTngt6/QU2QJtMZUFerZB9OPqMU9eorLYzGnuDeqjRtHvbKNOMcZ659P8K1I5nE6eYYwEba56AIBzjHXn+dNubA6pqEM7C4Vo3+XKfKE9wDjAOMVfvtPmhmiB+W4Ls7+i88DnI5xWjglsJSfUgt5kSfcImSMc5zu3dTz64pt2D5iu0hWPH3hGSTu7gd+eKybuC/i8u6mikht5wZIW35JXO3dtHbIPNatmMQWqzTEqcYmxuCY6pjoRz2pWa3GpX2Ksdu8epFUvI71AgMgG5DFyQVCkA8etT3CypHxlV3hQ5PGAeeR9RSxWyy3uVkVDjhXJB2ddufX/Co7iJdqKijc8hQBW5Hpx+f1pPV6ArpaskIeULE+QoKl8MPmIP8j3+lRGJTOv2qIvbRqyuExGzDrg888D8qpxW7vd7CER3QM0fIYYH5D1962RAgt3R48lxvVpTjgcgemB1+tNLleon7y0Kmk6TY3V9emKImGUqsKuBGMFdxz24yP0pllFFbwqJUHnB338btijjn15P41NFCnkosjIsgB3SHhcgcAY4PYdM1Mqpt/fgtKrYLxMCWwOQw789KJST0SCMWnqV7wSvHPGIhI7n5JG+Vlw2cjHr+lWbmeKOJpVjb5jkxiQksTwFH1/WmKyLFGHK7OwdeoHYZ6VNGcTpJEWIBA8sNgtxzz/I1HqVbsVtLvPNlmiuopoTE5LBwMKwPygjrgZq6W2nKhsNkYChduR1x6dTUKQ7DPLcF1JcyEr13k5yT/OlW4SSINjk8siHgN0G4fr+ND8hq/UZe2ThEiRQnysgfOcg84yevf+VW7WLCKZ8OAvPqG45x9MCq4ITqgBXrvXI9+PXr/SpIrlZVjdmBRRuC53BgeM+x6/lRdsaS6DJ827JcBUYq2WRh8pPoV7ccd6zds/8Aal5dmQpNcybZGAA+U44C9BjBxitGeWJZG+ZEAyMHJBJ/XFPYZAJAZc7m78gd+fSmpuKsiJU1J3K7QqHOxflwABnJ5IP45NOnjnYTMHV0EgllVx8jjqQR9an05o75vkykx3F4ypUADvjr3471M4Do20DcDn5yNpx39c9Klt3uXZPQrS5wViYbJFIJccoBgn9aqGYxNultxdcYWKQ/IQeQDjsalVomt2bCbSPunnaRxx/n1rP1C6FpL5ZCOWIYMpPz884+n6inG97oU3pZsW2iVFeRxtO7cAcYIzwOOnv60jX+J0jMbDa3MkYPbuPcVZi/0i3jLRuJMHeQMsB2wDwRnFMv31G+gsrYSBVhLsQuF3FsZ5A46U9HuStNiwI3l/dAbjIRweMjrgnvmqj2olmWITm1jOMyOu8IMcE4545/DFXJDHwp28ALvAJ6DH6k1HdLGIgWVDtJzt6DjI4z6fypLRlOLaKVlDNHKvlliA7xBsZVmXg7R0yOvOOtakTbwDJG5kI2jaOT7+9R6OFiUTozHzY+MuVABOSMH8zTZo5Y0lMIZ5mbaBwC+T9eCTj2oavohRuldk/mCVlXKnC8qOoHHHPvTXtY2nW4IEboG5Ht1P8ATFU3jks9VltbuadrhcGVWiI8kHrn/wCt+dXFKR5SUDJI3EDngcAn19qTjbQcZcxJCpMchDY2hicjJx65/HpVXUrmOCMMySbsnkeg9R7nr9atFyIySrFeh2jAxn8xmqovOJUMsUhm3bmmiDlf7uCQMEeoI96UY66jcrE9ncrKQqACRsg8jHHJOe30pbyGR4tsLlJAp6Ag89/Y89qqWFosMarIwMzOXdupJ7Y7f5FXzceWUUnoQw3Hrz+lN7gtUV9Osra0lm6oWQDjkvjnOfbirrgBCSx5wFBwMerD29ajgkL7mcAjcSVDYA56D3zj60vmRIxVG3d/nPTvkj8KTdxpW0KF2+24TakiuAEQKQAPUn1OMjFXp7s7VVHGxVLbu3XAHvnr+VQTQLDL5oZQyqCctlfw9D2/GoZLwRzBWTzZGJJxnqemT34/CjcNi1HcIIsuzFWPDsDke/fninJN5qs8bAxluBnp6E+/es2SRlb58TDbllVim33PoM/jVmyEiRI0ibWJLlM/dzzTaSQlK7sJcyFAskVwrSyZCwrknOOgGMdOSauh3khjKgsTxgtgqPr2GKSRDG6SxhgiN5nPXGP61E8nlmQucZx2HPpkUrpjSED5Z5pA52f3mHXAwfyGKbInmvHKzRssTh1JJwVHXr7npVW6uPs2GIP3SdvXjsPfsRj0p9vcF9nnYkBHlqxUYI7Y/XimkK6L00jLvMh2KfmIzjHHy8dqqyxJOjPIFYOcMjjA/A+2ar3UUgjATeCHEaNjuTyzc9RVt8QqE2gJGMYHIY+vuO1GwbihDtSRZC0nIG5hx2BIPTjvUcJSRgBJl4hnG8As5OQQPUZ6e+arJIDJtJUkZVck7TxnB/z3p9lDIYzI+0o5yinBwcYJo9RJ9EFyqlPJQEjO856uepGe1LLKUSX5giNhQRnjinSMY48hzEXUh2XJIX+ueB7VCFPljhC4UkcnB45+uOv6UJAxj6m4vygjk8xkA2Rr9wevHt3rQgbzDGN2AQRGSwP1Ix9D+FZaLdrNbol1LCoL5aIbMMRhTkc7T0x0qwoKRk5VXYYYKNowPp0OOffNU0rEJu5ZvI2IaSMMZOGzjA+p9M9MVXhgdYvPfhpeCuOQo7H1zSvMba4C3EmYmXKsvUkgYyOvpU9w5ZSBGxTHBJzyOQPTP9KVh77C288m1RHI6GNdwWU7QwznAx79R6VIZnu5t80oXORhMk4AwAGJyeTg+1Eas+UVow3UkKAQc5wM9OP6U/YpLZdIpIyWKiM5UZ/I+4/wq02gaK+rL9ttEthaxCeExhJoS6grk5Uqeo7DHSlMLRXZkjlUqo3J3RCRkAZ68nH4VYuWd3kYlHkVQpAbJPHBB/X2qMDzHTc0ci5CoMkYOM8j05+vFOU3LcUYcupnzNNBd28bPsnlPCLlyAAOT6Hngdql2xjcXl+7jckeC3PHA9sD6Zp93JBbq1xGSU2su5iC/I7/AFOefSs+2uJHmCztLAqHZkx/cJHGfY9M0JXFe2jZowqouXklk3SDEO3ZgEDjGO2PY1qhmEMk1tCyqgDOsg3KD0AGee4+tZbGW3jKyMiSD5HAKkMxA5BHYDrVhGXeqsBIiuVCqSqEgEfQZP8AKobbZaSS0M/UL0W8nldHYHML8sRnPGOc88cdqsW8xlQF2VC4BVME8HjGPzOafPa2kmm6hIm6fUHA+yo7HAwMmQsD8p4IVTxg5NQ2vkx6fG4QPGzH7xILMB0I7cndWkoJIzjNydijqkAj3zSTug3rFBAIy/mjB3Nn9K2rQLcWschfPHzHYcqMfKcjgnP44FQ2rB5InILMjEFWODnBAz+ZH41ftUZVgSPzVVB8uCDzjkknjjnjrUNqxavcz9aEgsGQMWLOFLLnLdOPoTzmsy3s3h1dbVUnf5woEp2ncB3B5H41vkAI4kg3CNBjcDxzgEjv1qK0s7WNtQluBNNdSFf3hfeVweR757dKFawNNsSdDdiQWqukTrkFmJwM9cj0ycVNOcswbyuB0IwSo6jtgnr704Dyt+wLtRjl14X6kdgDgYOfWnPHMBIjvznaqqB8oPJz+IB/KpLsjH1SJJ7i3EK+XeSS4ldWJRFAyCCR0/OtLylaTbEcvygOcB+eo+uDSu3mK/lykucsNvy9ew/IU+OLeXUFGGAjMvIDf7I7jrQ5XEo2G20bQzlgY3d2yzEFiM//AF+D+vSpnCSIvKs24bV28cZ4z2PH61GYd0RyrCR/lVi/QkdNoHXqaFLGafYqsoOxGPPl44O7Hr0pPuUuxTS1ENqY13YUlmyQAeckk/WqmoJd3Sw2jPJDbGRZpAg2gntn12rnpjrzWzI4BU7AoxtA77cZ69M9fXOKr/I7bkQq4YkZbHb9Dj9acZtEygpbkENvEsDeVIojYBg7ZDd/0Hf8KcqfMFIPmL8sfGWI689O2TUykSTP5zGNFHl7wPTp0/LPrmqsgEsoui8jjYFLZ3bTzwffilvqx7aCSXHkRIzksqBmBBwMnrz7cVUju45pp448AH7xKAkfj796v2MFnOZDqbGKzjUCWOMMp3ZyCW6Y5HrWQtl+8861ijgiFysbIW5B9MHnb/U1ooaXIc9bGtAF3DeyBNjMSPmAOehHv2z2qJVhNvGFI8wg9jx3yT+ftx7VXGUS4MDEJvKIrYG4ZKj6HJNFpI0yzEM3/PIc9SB09QAOM+tT5jvrYnS2SK5ErEcR7Wb+8M8ZPrngfSmneTJI8gBj+d/MY4c9lHHX2pfMi2kucLIhwmTuVR0P0z+dSmFJreTcR85G7sSR6Hoe/X3pXvuPlsrIreZutztzG7EJGFGWXp82B1z6dc1Tvzaw6uIrW7muh3laLarYHI9yDxnvW3I+ZyzYALBjIBjBH3cds4Hb1NULW134uC+5RncjqCCxB9ffP5VSatYhxd9GWlRiixsmCE8zyyQQCOgOOn/1qiv7a2msbyW5uHjljQy/dBMhyFwvPXmopp4rZMls7m2ggY3e2PzNLAwkjb5kAUEMG6MPT6jP8qStcrW1rhpJQW8kqwyRx7hshbOcdgR2454qaGAm9YOQkYyAynJc9uOmKdGTHCFjA5wBnGV/HrU8UuJljj3g43HBBGSP5VDZaVgkJkTb520Bicq2BkdD06VXuoZRBHHbscvIJHm24fJ6qD2XgZ4q0BteOIOyqVbccYXC8/0P500S7xHIDiP+EHJJz/Kmpcq0E0pbkVuFt4XBVSwAJXGd/uPqasWi4LDCDA24U4GBzn9KjYhNzEOWzw6nlsdxn0FPU7tp6FckYHPH9e34Ukm9R7Dv3QyeCoOXVTzk/wD1sVnlmuJriMEI6cg4ypzzgeuPSpbZv9GjYy7n3ElgMjGc7fwNSLEgk8o8BfvZBy3vge5+uKewjGu7OS4doLWJY4jOFVi7MenJA/HHFX7a3e3IWVUAClNxUHJz1z6dPxq+UKyIQ+Dzt4IJYgZznoBxUciEKNgAZgBhOhH59eTx60OVyYwSK82FUH92kjHa28kYHX/PqaYk5VIfn2GNvlKtwxA49h3pk6Wj21y2oecyrGdsUZwWk5CDPcd271kWM8hj8pMKRjKRkscevPXHJPpjFWo6XJlJXsaNvEYd0ly2/eSyIeQzcenQ/wBKiuriRGREbJKgH59v0HuahmVX1CCOLzZZWQMqoMKCPvE+h6HAqxPZrdxxyXBYIudpC8Yz19/Si3VivpoWGn/0UMfM37iwZBks2OM9j2rNtzHDcz2zag9zMNr/ALpD5aZGSMnGD+nBrVtoeIo22pGAUOPlBx3z9Dx9akazhiMyuioTzKQ2cj0I7fhSukOzdivFcneXjiUBgcBeQAfr2xzVi1mQSMqD5BwAejY6ke/b8qpzxuUM3yZY5KA7c5/hOOg5H6VFaWkyMS6s8ceSATuLE9x6A89KXS4Xd7WLkdskUrShGmlKFPmDcZxj8eM/hT1mWCYNEUZiBkuCBnqT/T8amJCDzDhFXAXnq3f/AArP1BcEAl4+gXpgdSKFuN6I3ZZIpnEXmBlYCQHysBs4BY+wzmlkcRvcNHMVVQI9ip8rqDkEimaVZSrpY8woHU4bCgKBj5sk9qivrmEWx/ebi6bSCoG3v8x7d/0q3dAmmrjb6YCOctGTKq8lPm+XPTHYfT2qgs19b6jbrPaLBDfIZbd5cYMYOQcdTnH1IqzbuLpQ0YAZSG3RocEck5HcY9PSorqwhe7tb2acyBCIw0jsxUDkDnpnPT8qdlYmTd1YsSAz25jcxyY3so3fI2T93HUA4/lVFLK5e8+1OXlkjkDkkElIwoVTzngHsfatKORcqty4VymR8uVzjgn3/wDrVOxUFZH2RsQFz5hTO4cj3AxQpaWG4Ju4y3t2SbyW2uilCQ0XJ5z+Ge9NLtcKTPFsKSDZJyNykZ5UcFgafbvFJFMrHekSseAONxwOfrjI646Uj3YSMRxfaABtHltgDjnqfcNzSG0hZbXYsgwQ0IG7DYHOAAc9gTn1PShWitbyOUMXEIUrwVPsRjIA4PHeoZLlrksPMWT5ckSAFufp949PeqctwY73Tlmc/v8AdvLriONRgc/3hjFCuyW0jQmmjjeWQum64G5pCnOS2crj6AZ69aqXd5KkpMVr5lrGyq7quUycE9Dzk+tTxiJLhmcw4IV/lU7Dg8HB5IOBgdcmq+rw3d3aRRRyLCjO7cdATjcSR68cDIoXvbhtsaVs+HVkUSJvyQGJDkc7Tz9KhikP2cNcFUIJkdcFdvGPr7k+oqeKILKkSMzCNBGrkbQD1yCOvGTz60HMcjLE5jwQVEhUgHrgjksMVPkX5kDSJNAkZaLJIVsDjvyR9P6VZjZfsrKjfOCVTco+Vfr+H1rNuPLn1gpCuHywdwuFcbc5UHp1x7A1pRFgEVyilmCgEc9Bz7CnKNmEZqRU1BC0cexZDK0g3SI2AqdDwO+eBxU0boIQTwcZKu3p0GO3H9amRUDgmNHKoUjY5wwPXnuKqySpHI7ksZCv+sJBXHc5I65/zzU3KW5JIn71JRkeWwbdnOWzyM9CBTLONYw7K7jLtJI6t8oXtx3y1FvcbpVMReRy2FG4EfUZ47npTZXjkYQq7Eqq7iwwuOScH8uvvSHezLG1pDtKIzFiPl5+vTsB6elUo52e9njmPmMjKpYNk4PPb04q2YTK8pmG5RxvRskDqf5gUkdnHbzM8cYjMsWz5Dt4zn8Dx360ITv0M6+iAX99ujhkUqspH3+Pm4HPXPPpVW2RgyskizQpkF1JZTgZAGR1rZeOOWCVGEbCWLaBnLAYAJHcfz4qolskUbREvtzg4wMHI7+gHrWl1bUjlk3csW6I6bGbcpUE4+bK9Spz1I4GPrVbyo7e4mmBjPyMG4zk8E8noT0/A1Ykm2l33AdQuV6AEjtxz1pElWVANrqWy2SoyBnjkdOvWpuVZECwrLBuLBUYM0jSY2g9z+ox9KHieOzhVWG85X5RhySRn6j61I42QGRvkChEwpzuGTz/AD5xUct2rxsqKzOrYbAGBgdvbPP4Ur3HoiGbASdCWGxAVwM9OAuM8nP+JpYVeO2RJFkcvIyh+MMo9e3H65pk0v71QNuVA8sg/KPbOOQe9TQXUW5EbDgcIsbkbQBg9elDaaFs7krgsqgsQJFDEMCMZ4zj2FCJ5gEag4J2n5QSBjgn1/8A1VEqx3E4S9uPJgdT5kwQ5Qc8++BnjvVbR2hETtbify1BAafBaQFgF4HQY7c80+TS5LnrYl1B1+wXSiyR5mX900gJKkHG0fXNUo3NpEhuGGScs20YGDwAO3IziugbapjEkhYKB1Xbs56L7dDmqQQNJmUwm2CNlpSQqkg56HIJwcn047092kKS5U2Vo5luFDwOCcbmPQgt09yNvOKimaC0v54bJpLuRI0Mkq8oGJH5jtmnabaTpby3HlxpHv8AJSfBUbhjnnleB16VohcKzlTsVdxJbG/GCP55odkNJsQRi4tvLY4KAA7umc57VdnYR7pGcuEYnbuwS394eg6frVPzAsWPM3IwL4xtAP8A9fPFSspTY00hXYd6rgfeIOPp3/Cs7GiIrq2gGl3E89+8UsJBjES79xPJU/QVDaGQwBZMruUMBt5Uds+1S3MaTDdOW+zPnK78A5HOPzqVoo3mjYEDdhQvK4Udh+NU2raE2d9SQYjkjb92iBtzxnoMeoPB5qG6YfbLeMyEyv8AMDu7kdAfTufao03rczSl2WFgvl9SdvOcmrcVqZ2TeRmJso2cEEjklqkdhJH3zfMN5AEgbJYN7/XPOKQR/uyzKMNyN2BnPen+UU3eZGF2IDkjufTHSqeoGRxJHCiEMoQR54K5/Qj1oGRvtnsuST8pKANnDZ4z68dPrUYtPss52xt5jZyi8Ebvr/n1q2ojigf7wjBwoIzx37444qOZ40VucNyxkXk8c4HcHHFVdsmyIpIAJDIXUYBjG0kEYPT9OaRUaJSfLLbmHlRjuPUZ7YHWq87paSRo1yjMEVlWM5Kk8898jOKmZRGITKWLjrnI2knIAx3yRTtbcnfYZ9plt7pzIDBEsoO11AJOM49+c/pUly5CKHk8t3PLkY2+5Hp/+uqljpskmoR3NzPJc3SEA7iWwR9emOPWr3lbwqs2ACTgEk49T+GQPxodr6CSb3K1hMm0gP58sZKSSghUDDlQPUYPX6Vcj2hw5Dc/KAOCSOg9qZEkQhdyUWKVmcj146dOnA4pAQyhhHgsVyegHfB96l67FpdxJ40fcJneOARMWZACyDk9+mTimQBpoR5sTJ+74D8hgR8pX0z2Huat4Vo2ZVDpL93eTyMjBNRS8Y242qCu0ZIAH3SfU/T0prawmtbm2sZ+y+aJCEQNjJyxA64XocsevbFY0kduL57i7lTy4baSWSKR8h3UgHcv93nIHftUk000BcB3Dqdsio21zz8wJ5H14qrcW6XkMe4vIEkLCFz9wDHLHHPStoyS1ZnOLeiKejF5Yo7lFktoJJCsQXlcZJYjPT+lbqymYBHnIVgWAaPGx25wAOhOAB9aYYFtkk+yxuASXbcPmwF+c46Yzke4qC7n1E6mDqe15XCzBnwcptGCQOQduOKW60BaaMzryUWzQme9CyysQ0QQkxYPC565AzxzjvWmmAVDksMo0uSQQvJyAe9QW8FqbkvHE7MzfIFIPOQceoJI7VpA/a0MmImnIYsMFnGTjA985ABovfUFpoYUkvnarerp8bx2I2yQwlwzNnhckd8UagyeXPNfNNuhiVgIzuYvyOo5x7+/PNaDhlnke3ZlZAJAwO3aAoxnjI/xqRlhuI5I9oDOoXdlvm5B6ex4oTs7g43jZFSxSWWwhLyKrooclELEOxHyk4yTjPt1qfZGgjICyMgdWUMWOfvZIPbp35Iq08hjiP2dRveVpC3QjIAwPXnnPaobyGR0QPIEiIKlSBvKDGMkDJyeARmk3djS5VqVZb9bW68uQpu2l2BX1449COM/Sr0QYRh3Kp5idY1++AegwcHPvWVfxmPQj5VjvuZJnc3nmbT5YwuAucrj1xzmrmm4jtYYC7y790kjYwMkER7T6Y/EdacoWJjUbZPcMWAeFg0Zy56DbjknHXAOAalimlmj2IcxFArTAACRQD+Ocg8ikaBpflQiWSRQpAl68556bsEfpT9PtEtLKONAi2/CqdxDN+XfqfxqNLGmt9diB44wPMCs/ljsegA5x3yfWqc99FA0oJiBP30VslmI6DP61pS8M0ToASwyqnLKBkEdR/PvWJd2Rub+GCysS0is5FwoLySFRlnHqB9MDFOMb7inPlehcutTjtfLieRzLtO1WGASTyAPyqZLq2Ri97CZImIdhDJsZkUD5RkYGT6+tVLyaaTQZYLeKJ52kGHP3mYgjOeoAxu+pxV22tVtjsfO6ONeFYHJABY8e+BjtTsou6Fdy0Zn2IkMMlzLGY/MYiAK2WQEd8d/WtGK5VZFG87HOSUj3Dbn0PfOKkk3AyGTYrElSxUnnHzNkemRVeSJZHkEIEYPdSTk+/58cVFrst6IitdUikfarFo0B27W2sfm5P6AVe3tK0x8zaski8EZDfXH92sqa3ngubmV2yJJo1JI4VQD0A7c1ohCnyxoFXDBQWzx03Zz3yetDsgi2xYnzELgRHYJD5ZKZD8cfUcHn3qG4cCOTCQ+SpAJQkgLgZ59P608GK2RIegRVCnJyiZ7A+pIHHpTJpI55HeDaIlK/MF5UgYGBn17c0rLcrVGTqUkC28k8nmiWNl2JEQQQe+Pfjk9TkVoWRmSBF37BMVJz1C9wR7cc/Wk122uNQv1luJg0xKsr4CKw+9z25Pf2q8+XEUgZR5Z2qwH3iBzgHnqSeOOciqk09jOKd7sZcxRpeRS3KEQjeT5TDOf4VHbA56VmLCrX121lE8dsOI1mO4njHH065NbIAfzQwimkVljYquVLN82Me+B+FQSQE+bjmJnIYlc7VByenrS5uhXKtzPlQSb0tl2bACgUk7FHXOPX1/lVSH93cyTW0JgQJkDO7OV55IzjjArQVJWlDgLtCNMVU7di4JyfbGOKzmu7cBIsqg8oMu8YL8+vQDPGe9VG60IlvckUGS3WJvIEgC71YggY6e5461ftE2QYc5Malhlf73Qf59aqQxq0Ek8kg2zgIEJwQNwznjjOCRj096tySSQRvJOCODyRnI6ED3HHHrUu5cbWJMMbp3IXceYkTIIbPzFSemPQ1LcRg3Dox3E8Z45J+YqM984OKymvbmOULNaSxRL8+SCDsYjafoT0/GtNsPGY22ybcFuehyOPwB60crWolJSApEkDpEXY78tnH3yc5x296hnEiSKISzGT5I2OB85x82Owx+VS28bxrMJTg+YdiDJ4+p/M1HcK8kUpjfbtBKl+oXABx7npilu7sbVlZGWLySG5kSZUUq23nAHHYE9hj9RWq8/2mcO0m6BDv5HDkjAGOfTAIqlNp0bXErTkNLJIMs3LKAMcnHTJxj39qnmmCou4mPcQSox8pxgjPanK19BRTtqSwPFCm8qHkUhjnjnOTgfhiprmQNPLhiqqWO9xjPHQEfXtUdlL++yfkjRRj5RnZ34x14/rTLPM0MKoQrbCSu77rAkhc+pAFTa5dyW3kQyj5nOG5XG3IXuR7ngfSrcMwQrxlGbO7I4GOfyxWFeSrLIzWUZdVlAJDYByR3PPPP59q1JpBFDkqS+xv3TA5Rd3p69ck+tNpEqRckkwTkELuDZJxkkcde3eqCyI0kYC5ZuQTkAj/8AVzUdwWWxiVsjzFZj85yVxkcfXjFUmEct7b28KyJLtHm/3AuAchu4zxTUbilOxqLN58LnnYTtjB7evTv9fSo0j/cwwqHLLklsjPXOD9KS0OViySkTMzKDyBjgHPrnPGKekweBVAG9yWxjkL1OD+Q+tSylqQwaegnluSgV5FAAKbsqWzgf59KsXCLsYBcKoA2qxyCB/F9PapY1ViEjj2ySNgcdDjj8ev51EqBpPNO5EUsFBB5wMEE555/Sh3Gkh1rPseLyhgjqcAn36dzVO7cRzO0fyjI2heSTjA+i8/h1q1hYISu8I24OSoxjPYfTFQzQRT25DRHpj5jxknGfpj9aEJ+RFA6yoI5HMuGHCZxwMhQfX+lRTpLMGVy/lyYBIb7uTzkDvjirKtHHAEj3AKxLByWx2GPcDv6UqzhpSY8qAcBV5HTt9eKq/Ym3QFtzDFmLarSBo8ZwSPUe/tQ7rMTtwC3BxwoIxjj0okHmIqZJmL7cEAggeh7Csy4BadIYopHZx8/zABVHLcdc+1K1xt6F/V9zWpMjQskSMqIVIJbPcjn8TSxMDZ2KSRIl0sYDqBxJ6ZPrwc+1bEcBnjjUNJgAMFYArx6E4JH3ePeoXA+0ZaVkSVd77cIGYgEnHYDjj8a1u7EJK5DcReYri3U4lBJXGQ6k5/Afz4psdokd1aXstuoeGMMImywlI4UNg8c89Klln8oSNMiZbaS69+eCvOCAfT0p0sa27vvy3yY81gGKkjcPunv7++aavEGlIoBR5UE0btNeEnzAvGcIcgjjklifwqGKZkuxb3X+jyzRoUGQBjqdxXOFxz65IrSeKJnZ3RTAMOAcCQKOAP8AebI654FUIrL7PqP2iOPy50QKAy7t2chuOgGccDjinFq2pEr30JyTGzhGQq0W0s7dQVyc+nUD8Kzru58m7sZLaaZ7lnbzFCkJDgcYPqQc46Vf+ykxTMBujjIaSUOBJgHg4zjr19KfZpGGilKSlZmXCtgswJwGGOQCwP4Co5rFWv1JUbY+10iZUXBToHABJzjnnjoc1Zt7ZZHRfMxM0DbsMAsPIUZ3H73J6d8VXZYhJI8qhmKkylRxuZgMqO56DtzioJ451lXcS0bS7HjuAG+UDLc9MZIPHehdyn5ErIBcy+csssqZRiFKHYowpAHTHJNRYVfKCnz2XDrsxjGMAkdepPB9/Wn3cpeN90u8O4LSBSwZBnaF98np3rMupnhihmkhungkJKvJEAjtnAXI74H4U7XJukzahd4pGS4UmEKXchsbtwzhjyD2PHrTreS3nmDxSsrQgliFPzcZyM8f3Vz7VXs0E10xZfLDyYYbc7VCknHr6fiKtoFgiKRxOMsq5JwCCcY9/wDINT01K6lidD5RlZUWPZuIwAePvfjk59/wqqEiiKFXYCJyUdVzgEZI4PQ+ntRLOkVrLI0sEaQAtjK7jgYX8c5quJChBEcqMVEgizjyywOM/kPrS1KumKyxpAyQCPfGmweb1yepwe/v/wDWqC2mSZJIISzxhMuwTPTnJPb5jj06VJaKl5ctBLM0MbnygCN4UkZLHpwACM9qyri+tJPEt1b6UAYIBlWXOzgjBBPOM881SheNzN1LSsbMIhuWgS4w0ZkPmBWw2AR1J7Y7iqOn3Mcs19LAsyQRS/uxNyWBOQOOmOO/NWGic5AkCA7nWLfjZvIxyeuTz7gVKkeGZRIoVssSydSOMn3znFT0sWtXcJo42NwcsNzAJ1JJ4Gc/qPrUYlDK4iQByu0jPzEH9PWnSM0TAks4VWZ0YY3DjJ9wf5VHZQv5fmeW6zeXn5OdiluAD3+vvilZbju72J2Wy+0OuoteGzVhlbRR5gxk9SPXOc4xisjTky8xto5RAmNity2eDn1xgj8xWxHCjJL844RxtU7TJkYOPXI60xLdA/mjG9yFGwDayqeoH/AcflQmuWwNPmuTIgbTVuGYlfN8uPAHbliOf5ioGeEeUfkTeNy7znyx74HJOQM054A32fYg/dPuBXtgkg59v6Uye0nubKWe1lhiNsfLLSyAg7f4V9z12+9NK+wnK25JbP5VzLIu3lt8rBs7iPlDLjrjnHrTSpNv8jDKIoTB55zx2zyfwrN0q7Eksqb0KgFFOOg6cenH9anu/OltZrwXFvbwwHbIkkgVnZuVCjudpzx6UWuDmkiGSM3M8ycIkqBAsTZYbQMk57cn6c1Q1QWN/c2dtp0EkNpdTKgkuDlQARyMds8VuysVtLdZtiBYwikZIIKks5IHB5zt9cVStbi1SWAyyERwjYrBBlzknGOg78+1XeysZtXdxbSNIrktBIojjhwN6/8ALRl54OOmP1p13bKxEJCHytvyYPz9yfoe/NTraPNbtCqkeYil938OWycZ6nAHNTxAQxhAu52bneTkA54/Hj+VZ36mqjdWKWpTXXiPxO1/fRC18pFgjSOQlUMZC8dlGAeO3vT5m8r58eYWzIFHOIxjBx06VdkWW1tGlgG2JSElmB4LkkqD+XH0qvNI7rJJbXDxyORC7Rrg7ACTzjjJIz+tOUrvUhRUdhtlIl0vyM6xgs7DJOCf55wKglvwzTMWbAwFcDOQDkAjoScUsdnLBZJHtdpCDllbkgkAZI/Hp0FUtcMdzfW39j6e9uFxC8hIKvjGWIzxyeB9aEk9RuVrJmnGQphlkiOzzACC3APU4HoCenpVO4Wyh0R7u7vRFcRzqPLChmmjGQxXnjv14461PjyYTtZpCsn3yozIcHk+nb8azbzT/PmiU2wjaFTG4CbhKfUtnrwenHSqhbqTNvQdps4liLJykjkQlvlZh1DEc9htrXjMdtcRhnEijDHAAAzk9T0OOntURsxD9mKgrHCgyAPvP0wPwxUcaSTSAfMWZmLOBuOc7R6ZwKlpX0KjpuXYZFkh8pTt3PvGRknAwOPcdxS3mZ3juGDuHJC88r8o4+v6c1m3j2NhqdzBo/8AaFwFMaNczDaIztO9Bj17fSr8zhJ3bMoRk+QFccgdAOnHFKSsOMr6g6LNIQ0rYIKFkIA6evXg4yetVrW2S2hLfvMkNFnOQd2MgH15J579Kbfw29rZB5Lto5DP5SwkNlxtB3KR09PfmmRTgRSZbaPlQFcqNw4bA9jzz6U9ULRmgzRu5RSu92XHUcLxn9CSfelhiCqPnDEpsAUAnAHA/XP41Xt7uGTzAjyhnbbyn3VzjkfTJ49auD54dwJQSN91R/Dt6EdiOpqGn1LTT2KN+6iKRFDebuRgWIA3HjJ/p+FWFjWO0gUuA0ilioBxxxnPck/yq3Hbq6oXXjzudzAqFHTH86YWSSRlLN5L7lLDoAD/AC6c0N6WHbW5WRwIpMAlihG5sjHGSf5/nUYaQwbY9y5Yp14IODj6Yz+IpLWKQj/SCpdiMgHDDJ6ewpJVeKTO3a0hcklc9OuPwA/GgLEVwVkac26EA5wW5I98+vv3zUMFo4d7maQBUYKNvTHf8Mdc8+lWCQEX0BwqnjLf155/Cmq8cZi3xq+5gm1QSxH9PUe2aEJk0FsxYIYnUOwTIyQSTnaPXH9akkiiiv0l2yHYowJBtZXwdw4/H+tXXuLTVIbZU1SKFoUZHR2ZcHOS6kA5PT3zUGtXSXN6rwMbhliRWlxgyuMDcR7nH5ZpvQhO5l6FqO++nWGSSRYiWAmX5Sh4/BuwHT8q2I5RLZBT8wjB8v8Ad8biABk+uBx24qCx0+G0ljnhGyeJHRnzkL2BPpwTgdzRNPFbpIN5SFiqgrkAbD8vHc8Drj1rZt7ExVlqVdTbUJ7extYikUVopmZZF3mVySeSPbn2q2heKdLuby7sNH0m6OQON3TOCSfUkCk/tFZLaQw3R2EsSJFz85AXJ9yB9MCmiWTZM8MSTLAEeVkX7qkgAntjj8qTbbGklcmtY5TDGty+JO7JgrH6n1xjH64qVzv4DynBWMhWyBnHJHB5yTj1pySQyrIvzGGJgGeHoE65U+uc4yax7q5ktoraeaHFvIXERVxmbnJVvQgY/GpUW9RuSRN4ijdLGHfJ5bN/rRtCmMLwq5/vfoc+1Z3h2dXsjn/WSyGMFgfmQg5BP4e3etOd5J43kYKpEOVDHcztwM+x5PX0zUMESLuSDecJ5pUjaMHgjJ9t3PvT9CfMtRXAYW6uZXib955Stt2LlenbLY/OrEuw3mxJFQeblgj7wFAOSoP1PcCs6a4lgt/NtoNrLmQkc7VDEYC9wV4x6mtCZw92Z/ISOKIeYsJiJEUYbAyO+7gYOfQdadrIL3IYzKZvNkRmVkMkUnJfrjcgHAI2t1rEv7fUJ7aKwW9uBaqzOYAMRksckHHJyc59617lRa3ixrDEQkIUtE5YlySNxHY5HT3xUmjKs2BJHLD9odSrqWxHg4YnHc9qpXWiIdnqRx3Do7xsruiAARtJuK8BRwOuNvI9x6VYumj8pUUF5VR9zkbvqFP45we9ZrZeKTzEKIytHk5LIFYdB/Fnjr3aq+qzSx3S2enx+dfef87xtg4J+QAZwQ3BB6jGKlQ01G6iWiNdrRZ7ecSQHEeY0hZhkAsFAwOo469sVHdFFTaHKSBh5YRj8x3AZPbjBAqNDcw21ud5EwjD7wMHzAWADH0OS1VNR+xxWUguI5WYokMO0gnzQAx3D0OSc+3OKXKky+a5b2vdSyJGruV2orBvkCgZJYd88YA6mobfTobEs0kXlvjcRGMDnqPXnn86borOdIEkzmRSgfahwPmOQD9MZz64rRlfyhJPN5s5LgEs2Q5AAw2PQf0pXdgSTd2RtviLSyKxIVV+7uAU4yR/dwMD6Un2preSJLlGjjlA2K6kEhSWUgdwTz6GoAFmkWBgsoJ8sSM2OSPmJHPGT+lKsFxf6vbSOz3LLAkMaEkhADnAz0+UdPrTsrBJtMu3KSBHLgbI1CqMHIduTz2bp+dULid0jmmZyUQL8zrtKqMnofoasRj91G7bXSFgTuc/vOTjnvu5yfaqmrQapq5PmXMNvbogjCrBnOMkIzdyMYz7mnBK12TNyvZF+GUSoq5LKzN5W4gAAgEN7DB/HFTJOZlJLD5VDBSc8A4wOMZzz+FV7WzEK2izYHzbmOCMEDG0D064/Goi0tvBGE+c3DEIG+6uDt3e+Rn6Vm0r6GibtqbK7QJWhJICsuwAgBACe/JBHP41l6zYedHDDOsSIsm8qc7SxweR6Ebj68itNWi4aPesalvncBd2FGT7jsPrULs293i5dwuNy7tgPHHp1x7/AIUXsO19zLsbZYLONY4hEu5hvQ4ypHzDB75PX6Clmto5WQyFSGYMSSDna2VyD6nBx7Crx6yFEbJO9nUfdA5xjtk9+tJIQjMynBVVRAwByhzwfQ0XY+VIqSqu1I4CqINq4LEBDn37E8n2FVBaSX14zFWeJEWOKMAEdWJbIxngA5Oepq6E3ywoZWJ2ts64Azgndg8celQ6VJNPczQyIhCbFkDckk9Dx0GADj3xVK9rmcuW5afDK4kVRgpGu0kL83P45z09KijvoZ5VAYuxbBDNgODkc49+c0qyefIjHy5kYO4jIwu4KBnk9AM8Vn6RayT2xnmhjjtppsmGHJCAAEnnnndjBpWVh3d7Go1sk9xbvPvaJHZwuSAcrgE5+v6VZgja3jCxl8EthsDBGOfzOPyqu8118yliCpb5SOFJCqfocAVWuLlYLxEcfJ5ZULu5IGegB55498VO6L0Rp7A0Lcof+Wi7QcEgAcZ568fWqwgjQbkhQ7WyWcZPTnp3HYetTxuzwwuwMRVRtweMDuPxpl3KIYl3gZKAMzN/EW7ew6HvzSG7biO6MshkEJH3eR0wclvc4B69c1A848qLdKMcAnAIz6AevFFzL5lxJFKzvFJIhlI6MM8+/wDCAKy9avre7mXT9O06MXcju0l00vBTOAoUYGVxgMMetXGN1e5lOdnZIu3K7oZGjDFlUFVBJJbOMAe3Jqhq80NvfxRx3sTCZECQKxaRGAHU45HJzj+ladu4YAHcdudvJDLheMH35qFbLbcpKyMWiQsDkDyyy579eeMe9NNLRjkm2mhmVRt0YYsXJBwNpP3M/XrimlppLRpfLAigPlhuACdxyzZ646cVZa3LyZgWNWUKVJx/AAdw/n7VQ+wPd301xd7nibezkHhdxyDg8dm/OkrdQlfoXJFiu1hkeMIfLDAFcjdkdfbqakuY0aV9xGwqWJx90Z9O2Tj8KSQRxzSEbWjYkKdxOTgcgenYfQ1IGZm24CDbtwV+6McqfqMc+9S9Cuhl29s018JZd5jjKgYQ5ZB3J9DgZFatucqi5A3LuMnTKnqT9c011zF5allGFZUPXnPf6A0K7rMnlRxtMTnJORgnA/Pjj2ob5gSUSdyf7QjjbJhQPycYHQAjH3uRUQbhAH++xDEd+OmPoP1p9nKSC0TBy0yxiVT7H5s9qrzxuGVgxUK4RUwBjgY/Gk0McYybhwwOTy2QM89B7dhUwDiNX2tztAZCSQuDuI9+OtVZjcT3E11PMTN5jByAF3ADGfr159qlmby034bzfujsDxnr2AOB+BpBuVAj3N3NkMI0GFAP3hjkc/lSzszo/AWRVROBgZI7enHSpYZStu4fLttP7sj7zdDjFMs3ijlhlMYuDuLMrD5WAGOfwp2J9DotKgvYNNsWsJbW3iZS8i74w7NuOWOfUY9OlY2ux3P9oP8AbZka8RFXMbKRg5OSRxwMVY/tu1WVA2kacWzvfCsQoHPPPris3Vrje08/2eG1U/M8UTYB6c4/GrexMVrqaFnJvilWNmG8qSoUtnHQk9M1U1SGXzDcaZLBDNGx2hnJLKBgqR3PUjnirsDP9lCo6AYJ2KvzYB68UjtCFaJ2Uk8K6ZCAk89ev1HpTV0rlSs9DG0K1u4LS6+1MFmkbzlQdC3oPfBHFS3elR3cZZ5JUTGG2PtUgdVJzyCa05o5I7XzNjSPIHbco3BecEN3yR+X4022iguLSd7u6jgEK5Tcm3zVXGVGRyf1pxi2xSslqQ2Y+ypE0UaEZz8wDbhyOh4+n0rOm0uKTUYZmnl3CTzG/wCeW45yQOg9qkuLqPyEaIIYnAKfxfN1PP4Y4pi3VqNRtILK7FyJ4d0yMpXynx90/wBDTsS2nbQ07a2XkSSrBEWCmU5Ij7gbeuOevtUIumuoTNcTCVyzAsUBA5+Xpzk8kGpbZFuYFMwQnoQxzuJyOPyH6UIArLF5Ixl2dMYG0cAZ7Dj+neoL8yaMCI7mQLKkX7vcdu/sT6gY59etWjZRrGY/NEUcfllSN5YAYyqnuF6n8Kp3CxRSRurBpiMyp5ZwpwS6gnqRwM1aN/5GmuIsPDOxbzVx1APOeuB3A74q0ncltWMy41C2sL601C/TzYF8yaVVxlmyCjMOoVRg7hzz0qjYavHqC6jdW0X2e1+YBBzvYngHPp1BxxV+4t7dzb70AkLgEqnG0DgY6Ek9cewpL9Va0EbRRlFneRAwCu/U5IHXG7r/AIVdzOzuV5gY0BiK4TYuUk3YcA5wT1z1z7UllplujOLdYwnnId7cF8DP1xy3H0qjf6jBDI0jS+WWdUMAHO3bgbTjHPc1s213NC6tOVknQNky4Khvw7jLVDuUrMfP8k8zLEFDkuE3btisMgbupwv5ZpklpBN86xMA27YG+U4IA2nJ9Mnr6ZqKGeG5kKIqgHeGY8bum0KexwPyJoklRdsrrtaQeauB/rMjuCfbH4CpaZVy75qRBdsAiRQpCklnVA+Q2fTAHHoOKim8t4bM9XFwwuJEBG7PzEk/jjpxjmqc0rFzO7ZjKiPe0m7AbgDNWGdfMaMSnBLqzbSwwxwxGP8AZGePWnZoSaexVtZ0uLqZLSyEVqhJTc4D/ODtLH0HJ9xVyN/KWXbypwyAk4DDC4x374+tH2biR44AGd8iU+ir/F2G1VJ/KljtljaGNFdXRPOYSEDBC8Yb9R7+9Lca0EjmZpPtGU+Rgv3QdxU9Bnp2HvzVjyw+5QjgOzOMYGOCOPXkHtmqv2ctcwl48MU3EbQep3dRwe/HtUNj5rDKb3mMYZFi5IJB4J7HGPXFHLd2Qc/LqzWiDEqAXjlYAg5A2MeOPXuajaKOWVgigcnaCOSTjJB9qoabe+eShKgRkKQvJycDcPpzz6mrsgZpcSEo64AVjwp5OD+dQ00aJj5j5iqGy3BAOc4GQM4/3elReZFPfvHZNcyW+5YopZEx0HzMQenfgdBmlVxGS67QzKdrMOUxjlR0B7CobOKK2dxEvyMcleqnb1I5/wCA5FO/QT3uWbzMUhESGTY/II4LbgOB1JxjiobK6aWfcAGkjclkAG7d6AewFNtbiUmOeCZoLncZY5w/MDFj8316/hUGkxTCG6MrGSVHcJKEA3tIQOc8jHPIFOysTd38i06vbo8sLqXCLGSFO0kjOMHrwee3es/StMWw+1lmR/MuVlWNAVU/Lg8exY4Hsa1JEjLIsRWQ4YlexPCrjt+dF5GAsmXRfLWRS33trbeTgfjg9s0X6D5UtSO1eORVSJcruwGDhgqZ4IHbgHiraxhGZflAnyAQOndQfTHXPoKzAj3Gtm3jDRxQskQ/diMsD/EVHAO3Pfqa0ZZkKBowY3CEFhzkE4z6cKB+dJqzHF3QuwiKISbVRyWU8YYBuTnknnAqk2no/wBpeBBDJcKsW5l5wG3EAnvgDP5VPdywRanPBbLFPGsghibht5ILYwOp5HPsarySXEGmperbmW2WXIlU4K7sDOOpXjA7ZzTSewOStc1gIhJOQSVT5YzwrOueTjkA9ePas24aR2hKvhYl2jHH8OPm7e+fen2901wjqhCSRKZPLZSWdiAMYHThs4p03nCG7jt1e4NqGY4XG8cZY9gRj8qXK2HMlqQyQK0RYAYyNhPG4kY5I6ck9T2pq20SxrtiOIITGpCjIycg579/wAxSW9+1xOXkUknczFCGGQpPI6E5IzSG58mIMSglZkgAVsgjBOfXg9/pQtNAdpajwEjBgQsygAsQCOckYHt8o6d/pT4JQrISR5hLMzEgjdjc3J/D8qjkkYqpMaqCVUgnGB97+eM1nXV1DBfRRPPHI0672CNk7T13ehwB19RQkDl3LyvHvWBZCsgj8xyV+Yh2wSD3FPjdoGmMeVjblY2yCScKAeo6AH8agd8TsQojl+UP83AOMgY/Hp7VDcRSJbrOzjbMxG9emRxyfU4J+mKEr7CbtuWJTwTuJTesZ6dTyAP++cVU1Y3en/Z5rhNouYhKvzDLIxICg/3uKSG4jMKMj5Xzd0cgXIxggk9z9DxVKLTWklFxLNuj8vzQh5+bdxkdO1NLQltt6Gtc3IRyrKW2pn5flJJzgHPXAFOlVpElaB0EibQZFP8AFg8+vc8+tUbiWOGymea3M042lGDlVQDJbIPBGMAd+9TaG8i2BeVlEs/7xYzwVO7GBn6k4+lEl2Gm2y3bwx2yxopXEQK/KemQSxz7n+VSllMhTKglt5U/MRlfyx2qtJcr5wgjO5fnmKIoLAZxtJ/4D07GoPOmLbo0JILIOMjgHP16n8qnlbHzpbltUCTKrsYzubecgE7uRgHtxVa+Kwwp52HjjXdKp+UOuD/XrTPtkcnmR27rIFZRyeHyeMD0xkmo76Qb8uxMUjheVznPU5/ED8aaTTE3daGO1wLW6TyBdTXkhZXiaMqseOSQ2eQFwSPetB3lW2Yq373C7X25A5+b9f5VMfLjjPyAvyxdiQFY8EH157+woiRIo1wDtA24UYzxn+ePbmqcrkKNhkq2kmoJa6YLu9nlJlDuuCAOXUgfewemD3qbUhEdlusMsM6gLIkvPOME7ePqB3robRrWLTYWtmkS5t7U2Y/dNsiMjfPLkeo/HpWZrU0N5qMTojyIsaRB5Uw8joNgJHUU5PsKK6M04bh2cokUS7k2qSBlic7RnoBzUH2ZISnnMsgjhAMZBLLJu6EDtx29aWGVU2p+82q27r97kcf59aJ5t0UbyTAl18snBGxic8fQcGhSaVjSybuUmZoTJOA5IwgkxhQTnr+eKbe28NzFNbXCRSR7AVaRjhXUZbHb/GqWr3ttawXEUiXZmOWjEXIJzhQfTj9aks52nhOzduID7CMBsgBh7EU7W1Jbu7FqO3hXeq4lUBSEXOFwOAOOgJA96rWsEUBkMav9pkb5ZI/lyvIII+taqSia7U7ULsQoBI2uxPAJ9AP1oHmrbPJDGI2UptBTI3Y7E/y96m5VkRRSLtKsAwYHABPfgEY7cVHqSrbyXaSEuDhRH0L7cZUZ6jP481Tj1CGK8t4IWLSMMT7k2gcnOD6Ec47VfEP+plkTeCEkG9OrZOME/hRewfErFW1EsNzJgsXaQbCn8AI+f2HofpUOp6ykGmfYUiZJw4yuwZ2cDHGc9B7nvWr5WJU8zOw5H7xxgk9s9uTx61TeEGRShRtwJ+cBht/vH0IwPzqlMhxuRmWBLgCdN7NKRJFjaDjkH2bJ5AOMAUrMUk8thCW3E7ivIOAeRzx/9eoNR8z7EDCc3Lpu5feMhv4ie+0Y4qt/bMV3rbpp1m8ML7VCyEs6OBhlz3XkN+AFUkmtRNtGhd6bDOryTB2VWGMHG1hyeOwwKoay6wQhnZogskZYKC2RnJ+bPpx71syyK05BSIhGJO1+JPlOB9Bg4+uKqpFH5cQDbgEy4Ycburc9zgYA9/aoWjuU1dWMjQb15726ulto7aOeQm3IztRASCApPBPvWl9qXTroXDWpvkt4SfJB2gEgYOfUE4x7CgRNEhUBQo4C9lwemT/CCcZpl7C/kyFk3ADChiCGQk84HOMjHFNSdyeXSxmaQt1PFFFOzxJHiaNVIbnnAYfxYGK3bSaQSJEXIjWRHGMHYEyAFPpweP50Ry24RPJyiZ2jehIVcdAfUt71BEyrBZx3RaG0YSNJNH87RvuHLdwFUdPfNF+Zh8CLMs8jxXOFYssbSgKRyXYZLevUDHv6UzxRdwabaKm5DPuVg8UmSPl4GRgAZyecHpVG21GC/nDIsc+LonPJEgBLYI7qeOfwpl1oiX0jSbSJJYSxDsQN5bBOSec9B9Kd7KwrX1JYry6m022COqF23tngISQo+uEP4bq1bDV7rRoryfS7SEtcRG3O7Lsig4ypxnI3DB9qz7RYo57WKVJ/IhjWIooy3XJI6cnA2/nU+kzJcWIVGdHl+6rMANoLFs/UrntSvZjS5itpFk1paj7Yjfap233BcZYAEYwe3HOPf1rSZZZ5/KtVLyysFVUBJBz09h3P0qKd9zuANzFh5nzHleuce/H5Uya+ntmF5ZmWCWINLG8TEFT0Ujnk4470la+pbvy6FWO8uGMtyZAlussaSgJtBxzgj1BC5Heke4EyBlR8+eYkZMAhVJyfqfTpxVCy069vLtrjVjI1xIrMATwGzyfY8Z5roYbdYo1ydswRcsD2PQewOM5+lNvYmKfUy7DUori6MdrE5tjMArsgUqq9R7denQ1qCc7HkhmC5XJ3jnJYge/PftxUYgigSWOKMDILIPu7sHAz+p/Ko2aCO5t3miV7aOQmRS5G9OMjpgHjr61L1ZS0QLdJLdMkKsEVAVVU4bsMeozk/hVxGNwAcFlcM4TGN3THTsT2NYWralNrnihbyK2+z2csjC3QptEaAYC9uB/PNbVuGt7ZWSVTJGuQRkbmLHgEdMdcfSk7dBxbe4D928rhM7iFZymdrHK5x6n5uKn5ufLQMmGK+ZxkqrEnAHUjg5xS6PDby6jI97fRW0SBzH5hBEjhOE6g+v4kVzmk6l9ru2aJJo7QTZAxlht7Z7k8cVXIkk2Lnd2jVigQTebFE4MspkDnGWVl+6PfB/KquoWaMEDu6soUAbvulBu5I6YPb8auzSJkBJBuZyx3HAIPIHHtgcetQ3cQVnDoxEZ2gE5QucEr6Z6fSpV+g32HW9tLBIdrq877Nz93bGSfzPP0FIyT+VKVnniWZAjbGwHTdkru7Dgn1JOKdJcJGsspb5dyu0g/u5IVfbJp04ksL6fTLzLTLGHfHKhSQQRjgjnGfWhXvcHa1iPStMa2s4o4kCt5Lu0eRkOW25bPUkHGDjGKuzRNG7gAh4yIshM455579xmmNcEsu5E2SvulJXsSAFz65xx1qf5j5xVdrBjtJ7c/NgdevygVL1KWhXktkaPywjtEoxsDfeB6gd+uKrx2FqLpriRAWJ3M5HUZz+XTH0q7GzSx3MihcxyvGrgnkr9O+ST+VQHy4LeB2LSOxG0AZLbV6DsOTj8KSv0G7PcSSJvtZuPMPmffkYjBBbIPH0AAPvWHqmny3sSQpvUxKhEW4hQGbBAA744/DNb0r7xMm0CRWG4q3VueM9DyR0pE34xBmVMryoxh+eM9yM002hSSZTgtxaqsUO/yo1ESPt++EOc49N2B7d6naFkthGQVYEAqRnHfJPc5JP51Bcbo/JZVVLSWXy0kz8yqDk5HUZx+NS2rvdzRxW53SvG0oOMbQTjPv2FPlbZPMkLMibZSWTMh+XJIA6Y/ClllECM5IaMqAu75duG4Oe2ev5etVnuGS9ntpFKzRpkIeCxPy8/gSelV9UF4ulzfYZGDXLLE7/eDInAH657dBinZLcTd9Yj2khlgWd/nMsZVMEgqw53cdcHd171l69dXF++l6Vp92zSBDELYR5MSkk5B7nH41q2VmLeHy4nZ9gcrzkgkBe/vlvx4qxHa263atCqhowcMFBPHGOfc8fTNNStoS4uWpmabBHYW8b5aOEMzh9xLEKAuAPXk0392DGJCH2EZYZxuAzg9+OPyrSubeNYljXeqqhkbdwQOv+HPqRWdNZXDMscM2YZEd2Hv0XnsOSfeknfVg4tLQnuGxCIQWycFmByNoyWOPUsT+FRXU9naRCe6mZX3bY40GVMY5w2DkMMjB56461JJZOkIiiG5QiqQBjk+nrj0qjdaTDOQZS2AxHyYAwcAYHr1J/8ArU4tK9xyi3ZI7DRtQOqaQFsrqGKL7CYzbyzBCsm4Hfk9RtHX2xUOuyR3GorLHL5skaxxSzxdZJQuNw7kZ71a+yy2enWMWm6Pa3SiLYZRbiQ5/uN3HRevXNO1n7PLHe/6JbQR2ZgAmhG3Ejj5oTj72Op7im9SYuxjW1tO9/JLcSO0jkkKV6qOnA6EDOTWl5MscSbkQI6qC4btn/CoZ7aSDa0cy+VL8u3OCDgZyfTt+dSBN8jHzUVEXOzdjjJ4x24GPypatmqSitCvsimjQSgYyEzjJOST+gPb1p1wkayAlC0ZYnGcFV3dB71DeXjQXEsETxXQUfNxnb93J4/LP1ovrqAW0V1K8cUcoIWM8nO4jJx0z6U1Fv5EuSRU1W+tbZJJrxxbuQNkarksARn8evHrVggMQso2OrAqm8k4K8c9CRkc1BJpkV7tLZGzapkHI3d19+B+tXIbWGK3WGJjmPGFkbds9R/n0obuthRTvuIwQPECqmTywQT0j56k/QdD3NTSTGVGVk3MApADnO0cDHbpk1BdmOFCGRIw33wGBzjIH4+3rU9ymyURSqwEyAoV/iIGMEY4IJA/A0crY+ZIjEyMCrOYWnYlZph8oIBG3d9ep6A4qhb3kM9vFcIBuwSMMSpCnGWH15x6U/UrNLu3ihldQ7g/ODtBzyRj6giiDTbO0iKWKMnBVfN7DHPHqf6UX0tYVnctQtEYi+7585IZfujGcgj8hRbRhBm2jGV3OHAAIyMMc/jVZ7mYeU4810XbklcMe/TuT6H0q3EhvJUgW5s4pBsJMhKb9wwUA9uc0opt2G5JK4zzfOmUfui65GAuQSAAoBHcc8nuKpT+bbhBNktKqNAigZlJ+6V55BAJJ7Yoma3k+0R2zKTGfLUqMjh+qn6nHocVlXFvqctzHO0vmw26tHAFHzMuMA46457elXotGiG3LVG9c3Ul2+9d0pEawjgZQbS2cdumabpyRahdrG9xb2lq8CM0jyAFVLZAz/wHp7iqv2RzA8coRQW8py7lWJ4/i6ZHNQS2KzFvMiO6XaVKtk5PPQ9Rjr71KeoNaWL8dw10yoHBjILSKxz5SIvBPOD1JAHOTUL22IvLlyVSIZAGc8nOcdOmOahisxY2sLSeZuMvnEA8LnoAOn8PJ7VZxieK0RFTfKq+Wx6svzE7vT7x9fmAqviYrtIswRQQQyquFfLSfcA3HGPyGOAO9SyyRzLEXKtGqoAM/KMDgfhz09cVWklkCzPcbA8hG1V4wu4gjPbrj3JFSPPGZYRcu0MDOZCwJPl9yAPp+dJxaeo4zTVx8o8zIklkVyOqAfMcdz2OMKBxSK0HlPgeQY1ZGULgsSQPmx19MCs1NRhuLmRbWUNHE6IZGTnack/L3xjPPTirU7D53kjc7TuJIyRxu5x3xg80nHXQpSXUdPeafa6VfJPBcDVlmDW8q5MfH3lYDkHjvxRpAeS2VpF273STawyQoGSM+gz+tB/eyxxM8aO+AOe7YAJI9cE1NcTgowjkRYXXbIEOBjIGB7jODjuaTbegRsne5Ozb4wfLIDKxVRk5Geg9uSD9akuZZVjEcZCuzAqXwMHO3afbis27k1G7uLWOeeEW0CNCiIu2Qxnkh8dhxVmL/S2QxbVkIOAeRgDH5DOM+tJrqi4tvRlK91DdqFja2MLxW0qqJpCCy7AcBsdssMj/APXWnFBuLpOCUAIw5HIBOM/1qW3tgZjIoQAKoy/BkJ3YwOmB0x24qULDtAjODu2kCTsOPwz3P1olJNBGLRW8lorlAVxJERtXnaN3zEgdBheMU5wu5RK4VMhFBf7ueh6YzgdfpU0q/IxJV4ycriTOTxnj64/KqX2yKzuJZr60mvIk8wSQI2GGRgfN2wTnFJavUb92OhXv7WG7inR28w/NuUDG7OT19+tTwQwQKohVlRV3kKoBJYDOfTgAccmsrQbh50meeOSOB5NgDAKUxwxHtjAwa14oZJ4zuvIrbBXc8z7QTg5TPcj5RVO7dkRfS7IgiLHEybF2YUqOOeDgnsvSqWoXmouk+nQR2ZggSScyqMEk5JKnIyT0+gFXba6W7Qy/I0roS+4AZO7n29APoakkhBiuo3dFaRApAG5jgDAz26CknyuxTjdXKloZpLYBjD5hZWjcY7IFB/3ev0PNSWemQw3bSQLlrkh1j3bwVXPf0OGPvU95GxukSWCCDzAixJHwgT29ScHmmwA6lcR26SBVCxs4JIPlA52g+pxjHvTSbdhNqKuMbyplbfKykFXeQ9Vxzj8yTn2FX7F2NxE+5/MKYjyOjZxznsM/ma5TWtUjmu7mKx3i5aQqxhAxkHnI6LjOPw966C0dmkQiFmjjRQUI5C7ct0/E5olFIUJNlq2ARTDZqR5jtjsS3zEs34d6r3H+kNE6sVYFlO0ADbtyMdu9K0jgK7PGWXCZGOm05P485z6VRlbzYJVXYEcKflHI+bjjHPHWoXdmjH6s7Wk3kz/uoJJI1RUcNs3YwPyyfxxVm2YSxFgEDeYZjuO0YxtHT6Gsm1si2oR6hNMZ7kygIhzlTtOTntjgf/qq9GVhyvzOowmFbGFAwe3IJP5U2+xMb9Ss9iJrpXJcK+Yx83GW5yAPbjPvSzWaRK9vlFLAJ5m4rgD7xAPHt+FXYthKH5BIEJGVxtJbktjqcfzqldXIhuLdY9hZiUVe+0PyfbGaaYpRSILC1FpA8gfzmuDvmY7mKDI2qCeeQOtXh5WJxsO4uOVOWHOTx06nGPao7dHku7eIIRHI4Zt3ynaoJy57LWHNfxQ6gbeN2lKOxUopBc4wp5/hJJP0xTUepLlZ2OnmkSG2Ycn5yBkkEnHGR+Z//XTA6hmAXiRQ2xsZxjoPQ96armd1Miq8QYMSo4zjk4/AD8apz5jtpZZUdQke/J4JJJPP4fpjFQld2ZbdlcsXMcMytECfnKJkclQQOp6npT7aFXgkCnK/eLSNtyBxjHYcH8qybG4MmJVjmRnIb5+gPO3+fX2rQs3W4hkLxl2wEBdfvHBC/QdW96bVgTuDSKJlV/vOSxPOQOME/iTT4jHFEGIZTjfnP3WOMf1JpUiRFYuxeRwqAgjG0dTnv0/U0pYCRU3KPLIjLlsgt6foT+VTa49jetYbSG0Be1uZJJbVrlmW5eJWwT8gA7Ac1kaxBbW9+v2JPJtpo45442Y87lJJOf4vf2FWIpbextNKkubjUTNjz4zBt8uPJwwy3fAy3rmszXLs3dwbkC5lik4AlA8xmBGV4GMAnAA7CtLGNyaIxyRFZpB8hYjHVc9Mc/jTlizG7XBWJ2AbdkknI6f/AF6lEFxPB9ohgR0t2IlZRjDdi3p7fSmwzR7VfezSjK5HLcKc8fX+VNxaSZpGSbsU5IPLeSRUiCuwzjjcQM59qzLrR5ZZUV55hbM3mNADnDZHJH51sSyxwyRxb9zTOSY24Awo+Yn654qXkbAmXBUMGPDZ+vtUvsOyZKxe3WR41KRFsgqeRzgbh2NNdXntbiaJ2eOJj5vADdMgk/nT5JEEbuXGXyyoBk5H8fPcVj6nHqV287afMsf2hBEy4O0hRx8vXPU042vqKV7XiacTxlori7YYCB5SRkKSfT8+BTb3xdHqmpjZaG1hjCgFF3BW2kDJ6jPb3PNVUspS/kmXzZkQguTjccfeFRR2lvGA5QxgrkcdT05/nmq9o0rIjkvqxYI1ntArP5c+VkX5SSeMccYwMfjnNT3qzCESyJGI3+UFGB2s3yjPPt+GRTYjdWC/adP3N5bqYmkGQdoztZe4qBbKUQuLqZHn3H93GDj5jkAHv1zj2qU11Kaexb8VvLZahpWkLKqzGPzSyNmNVJGASOSxxyOxqjcWzToY3SdRIQCuQxyM4yB3z/WoNO09be8N00qzSpIVRWOR0OQB/drRjALorbs/N90YIJ9/bP61U58zuTCnbco6fpFvYwkSSljH8xbn5icHGR9T19a1TBLaRsS4wwAUklGBxuGARn/9RqnqZzZyBXKKCSV6thfl2nue1Z4S4uNSa5u72e5dUEaM3AGOBk9+M4pO3Vaj16GlcSrJdR4do5JHyzH5lTvlSevGCSfWpNTgl0y+ihuwjzi2S45bBPmcADnsvORwKo3EcZR4XQ/ukaNwCSwOD8xA6HtVPTdLP2uR2ncskYjUyt2I4X9BzTja2pMr3ujWmaOJZmiePbsZEz1Vc7R1GM+/U81WXzC32mxjk+1RhyWHJHvk9Mnk0G6it/KN4shto2T7Rs/jQZzj1OScHtUlpewXmoXMVs7ztu82N2IUlDgZP8JPRcf71C2uEtdDOsbnVrvVlluQIi5Mm9V3MzZOPxNb1pbSsyhgzsVwd3I3MQAPp/hTLSMgMFkETNGAN/O0kY3A9Rx/Or9u2+QIjguh8tT/ABH06VEpNsuEEinZ6bBBFlZBJJnzHdY+cAnrnqcjrVO8N9Ann2E0W8BlYsD+8DghySep2kgH34rSdwR5Z/1eDnLAcenXr3/GpXjFvK2WWQOQVY8gHA+UA+pOD9DRFvcJRjsc7osFyjXC3UkaiNg0QCkbm9T9FGB6ZrUS0uZGtUgnLW0S+f5Sr8u/kgD16g1pXpKqEdYXQ8Rqow2CSWckdTwfwpm17lkjtgxQAgKoxtypIPucKc0czk9B8qS1ItPW3FwZL5reJArJEk7YV32ggMwGecdTwSaxdAu57i4aUgqit3baFOSSAc8ncTV1IYLu3EjRoxES8tyAeo4x6YP5VbsoY44FwqrvZgiCMABs8n3wMCm5acolG7vcuwysWt9oy0khUq52hB0GSehA7j0pEmjm857dcgMwC7O6sAOT16k0yV4/LVd2SQyBWz8gxxj1zyfzpsEqeaBFkZUAgrj5QNx+n1+lRYtMtZRiZHdI5Fd2ZiAmQFJYYP5D3I71AojkEFxuU7WGEBym8/Ng+o4GfpVPU4UuUnjLSM/lfNn+F2b17nk/5FT29t9msYy7bMRE85POcFj9f6UX00Gt9RqRMzGRpV3KhK8+rZ3cd+/4VVubRLjzYmJEQAGV5JGc9ew6/mKuXN0q20m1kjBUlflwTxj06dqrLex2X2cmYSifcVhRsvExH3W59P500nIltRLa2sOmbYrVEJY7QudxweAMHOD1OR602V9rIMByTuBAzuz0H0pySrMguGK7s/KAB3J4/pVLUppRgQL8xlBCIeQT7/QVOhXQjurK4M/nS3ctxsJ8vd/AOpP45Bz/ACpj2CyBkKfM5WNpUYqVI9+ozj8s1fu7hkhtkcqpWPDkDIGcZP5Y4NVTObW7torgIGl2zRNnIHHT64q1d6kOy0IbDTLexLqY03ORvbGckZOQT16jj1NSyiexsbe4jKoLg7Q5f7hyMZ/D8KnELSszKrec75K9SP8AZx2zn9Ky5dG+0alDc3bh7eNxkhuiqPlU54xnmmmuopRfQvTTGCNsw+azR7sdZCG46HjJHPPc1VtppJ8PcokaBzcE78AjkZUjsM9B/dNWzAjZMxLcAAM+SSSQvvjqfxxVi4SKFf3ClUBULgjMYAIxj16fTNLm0G49St5xtLZnOQ8RVAVPAJ5J9/5imPOYY1aNCyhgV2EYbjj8zzmqGpnUprB7S3uRFbvKXnbbkyMTng9QQOPerNjpzXFobV3ChQkalhjGAAcHrxk/iarQm8tRthdvdSSSAN5USMI2YEeYc9B6jJPP+z71e+zhrlZNzmWFSY933gc9QPc5PPpmkjtI7GPESqyyorIJF3FcseR6DjvU8kqi3keRiNoVgrMcEeue2Af1xUN3ZSVkVHt/NQxzDiQBC+QAoxk59Scj86p2mlW2mXCyJkzFFG0fNzjPJPPvWnIU8j5f3bNtUgngHPp6ZI/KomUTqbltzFidrbcE7eBjPsCOPWi7BpXInjli063vcERTN5auWBwccE+lOa1tr1Y5nB2ZdyGOSyjgdevAxn8qo6jpT3QbdNIITIEYK+M5HzDaPwFXightZUQ5QDC543LgDBA6DP6ChsSXcfGixQqYyhG3GSeCcYIB45yRSMqIqRqchV2GPqB7jHsMVW1WURJO6yqzBhGAOm8jAA9cDPTpSfaP9ER4InBClgMk9woB7c+vtSY7l8zKI2k2yN8vAGB82OPpycY68VXCsiSKCu/bsU4+8c4POeOM8/WpYQ8FmTIwBDhxgAfdTOPrknPrxUPnfZrmOOaFZ2QDfHLnDZzuzj/PShJ30Bs1luNTnsLH+zNSsLONg7Sxzlc784DDIJ5GBj0HvWbqsF5cX7G+u4bh9qB5IDlOMHAxgA/e7etaC6tYnc40ezGG2gFmOwDt169BiqV3Kt3dK0MKWxKKNiuQqOSeTnrwfzq5SZnGHczLiO/lM8MFxILaUESYPDleQas6Za+XYWqh5Ayt2PI9gfx5+tJbNnKs52nHyIMjB461YFvukRVeNGZTt9gPftU3ua2sOlSJyytEwkGPutlj7VKbZcy4jdFJA3HOVHGT9ahVhAxed2WUkbcoVxgdfw/rUqOVtpZd5BljCgO2QxPp703Gz1He6uRXFixuBKWdYymwL1wCcbqPOlgkDQucxE7ZF5yDxg5p1tKY1UTO8sPzDLdzgcnH/wCqmz3ISDbD824hSgBwxzkc0kw2QrzSS5VFAcYQNjoAuSMj2pJLgk/vQ6GRRkE8jgE4rDvdauktzYrbLkzmXzk6lSACufTitWykn3hrhWaQFsLkHkkYwD+VVJq2hEW29RUnliS5uGkhjghX5izjcu4lQee2c9KWCT7YkEyK6kYMgZfmyeBjsR6dOpqHU9LjuvJa6Qs0LDgnHIPIJ789qu3FrBCgQAhC5BwMk8ZAX2z1+tJtW0Gk76kLWxMDmSHyZI8gFztIUYyR26HGDTb6aOzbdy0QiZgW5OG6KeRjpn8Kq3FjNqDgXU0q5k+cquSCev16VMijy1UK00ZHQnI6cEd+B2p8yWwuVvRjL/xPorJZ/wBk2MrTRhVeKZt2/APGQOfmOTnngUkcscccb/dM5UEoOODk8enapn0+xiHmYQOfmWQD+I+g9KQ26xkrsO1Rgdw2PU+mf5UOo29RKCQ69n0+0a0jtbj7TczjzGEIwFYdV5GeAvPqTUJnM7RnZyAN64465JJxz361TFja/aVkSJzKGL8HBHHPJ6dvzNacalG2KFAGCQP4jj+XOBRKXMOMbDrsxupDBnO7cDkYUHPUVXs7e2iM3kAJKNqJvbBXIOVB756/jUtt9lnvyJpmt4ipDDGSCFwWHrg5ziorjWLS/dltpyCXfcCAD5agBO3LYXnHrT5HbmuS5rmtY0LfcjkRod2QoLqCvXgEn/PFF/N9n06aZXix5ojBRctnpnj1GeabDPI+8AHYzAhGOfmAxj9TTZLeGabzWidnAKqxGCxHOfwHrWZoIJSrGNiykENlQMD0z37iqttbqtyrxXHmuAVxj5cc8AnvU9larqF2LT7RFbS3BLRtM2xGw3KH0Y5BGarXut20niBbPTLZRCsjKzS/Mc5CgZ7gAAAD1q1D3btkOpaVrGvCo8gsH8qRV8zKjBIAJz+J4xVVruaxjBju5rRcbZHVPMxkYJ29D34PPPFPgk+4hUyMxxjdk8cY6dMg/XAp6vDIgAaRySWYkd88f04qU+U0aUtDO0D7Q9tvuh5u8/Lzhcbj8xHfIHfpxVyC8dPL+Ty8yfKTwQefwznn8KdcYYyLbKwiywJU7enQZ+mf1rH1bV7u9WGxt7GNNrFQ8a/M6dMn/axkVV09WRZx0RdkvI7OWVr1fLG3fGrLyz7Tx7D5gffAHSoNAv2vIz5jM6x4QMoxk4xj0oay+17FvfLI8zGXOfu9j+NaH2dUVmt1MSEDaq8HJzyR3x6/lS5rofLZ3LqFXbcfliDAODwAR04+gz+NR3jyCzjWEbZHfd8wyQM5P51XhmSFy7BhGhKqACckAsc+vb86iUvErK5KyNGoZc7icgHAPftn3pcj3G5rYt3EkLlWlBVFXLBBjKL2zye/61kx2arqon1CzYzMpO5mxhyeM+oxxVq5uYlbzW+UFCfl5JOc/Xt0+lWppzLk7tzyEbmI6MMZcE+hJ4pJjauTRIyqTFEuwbUYnnJHJHtn+lPheRMIWQSDJLZwBxjr6DkfhVBBKkkTH5rdVZxHIx5BP3jjHpTPtWIA0l1GI/K8z58ZIAOcenJAx3zntTjHmFKfLuXQoNqiKBJF5PzF+C7ZBzk++M/lWHHpUZnmZJt3XCFuFPbHoCAavWN7HdWqPFGxAdVGeh6evOMA/WrscBaEH7jHLANjpnIz+AAFJtodlLUJJGh2TtvaMjo2SWC8Z9eSetEtwVgLzIwDRox2r90Fsr+ZAxn0FULq5t7MvJcxz3CbvLKR9QNpAYdjg9u/WsuCO8vlhfUHYRTyFArMVygHBIH1OM1aUUrszlKV7I6CW4SJZEBQZPmLg/e445+pJP0+lQvOqzhgqmKJfMBA3ZwMADHbJ71Vkjb944bdGxAzgYYdSAO3/wCukuGkSG6+zI8l4SoRlBKbF5OfXk4GfQ9alb6lyvbQswyjY6kyN5K/Mo6BiMAH2znP1q1BO8UjDdGCOVwBkuTgAevXP5Vi6ZaXDRb7ncskgMjBRwz5AAwOSP8ACn3d6tlbXMsqlWVW2GM9WDDa30AGfyAqnZslOy1Ni4KyHyVBXazDnBy3QZ9MAZI6c1XdF8vyjhxwMg9O/wCp/kKyrK4m+wI1wFd93T7pJ6tgenIH4VoR3BYKG2sYlzIFwD/tH9APxqOVtjUlYkkkInimkhzEqF9rknLKAB05PJrNsbm5vLr/AFJitICXk3noRxgeuf8APStiLymmhbIcrjzOM4fGSP0/M0skURQiMJ5YYqoBxnJz+FAyO3RooC6RHC538FsEtxz9T+YqOSRIGcAAH5A69RgnI6dSTkmljc+W/loDFk/NnrgnAx7fN+JqOC0aSeRpoz5hYTFgcbRj5V/L+dAmLcwxTqJfvssbSM3Xbzzgd+CBTmXAkYBlUR7EYjjeT0Pr9amMakYyIw7+WMYAPqM+nX8qrXr5hJDELgHIGOGI7fTpSuPQLo5jd4wAcMPMUg9CBg57cZzxWY97NNfwCXTknjhIDlHMZkGDz7Hjk98VbtpVlQlUWNUBZf8AaBbC/wCfrUpth52W5GcAjoAPl49fbPpTUnsJxTWpq6Tp/wBrsIriHw4xiuGLbzfEEgZyeefvYH4VV1eaLTtQkSeyeGNVjaaCKTzSBjlc+p447Vq29zE8FmZ47ny3iksmKRErtPKMnqcnkVl+IpIv7RaJIXaaBFgEk8eDI4xliO341ba3M0nsU4LUGWaUykZJbay+nripA5isnNvvjkEbBiDyR1yfSq0jyBXZZGZVZcYXHXuamlRZGBJZ4tvrkCk7p7GiaaMm51fUtTvY0aHy4Qm2Rh/GfUHsT3rY3TmQq5CYIAUfw4x0qS1RBIdkKrH8vKnqB6mpLx0KhRg4OVA5I7de5qW3JXkEY8uwx2jKF1UIoHzAdWGeM+tU5pYVg8zzGIC7gqck5PP44qQwmdZIVcrkGNn4+Ue/tUEenCG3AL5PXOM7vQ01oNtjJrjTjeNFaTyTMyjBWP5Tn27dK0DMYo9sYA3ALvOBgHnk1kWtlsaafyl4HBTsc9/SrqsHRQWYRM5CgDJzjgfShu7FGNluPiufPZY9ys2QQTGRk5yf/r96muQN+4sHdTu3Z5bJGOOwHSqcOmvbmTfcMFZvmUHOOfTsf8KtH/j2YJ80jYHTjOScfh1zSdhpvqWLCxu9RjH2OOWXB2xop5L5+YZ/qaoyeVE8sit5ZGQwzlkwBjgd8frmsy4uNQtbKVLC5uE84Ym2DHIORyO/vTdNt7i3tUkvGDZdmkJOcn/HJq24uNkQuZPU19ytCi7EKO/krnhlz6+g56+1EtwzxQosirIGIkCuAvHXA+lZVxbtOwwQiqFbBJAOe38qakwtJ906wO8atuWUjDDA+UAdamOrsVJ2VzRu7gxplJmYdyR0yC21s8k/y4pvmPPdKixSSykBSFbcSx6YHQnp+VZOueKzqN2k1jZRWpRRHJs5LA92z3wOtTtc3KXZvbJFleLDES5GVHB6euTzWjjG5lzysMubRrhY2LsGCjEiryAeCPf+fWrlhZxQC3ZFSJREP+Ak7uB6++elQWkmoSXEslyqKjPkCPCg8cHHcjNaaGRrgpFDG8j58sKODyBn+f5Gol2iVHa8iFLpYvIjGYogdzTckoe3Hc5wcVPp15YzaibczyBhGZJJJGKbmb+Afr9azrpU1CHYqbkkUkFRxkDt9aW20xY2mbzJrh5FT5pem0YAz9OlEZJKzQ3Ft3TJdatBegzK5EhVEHGDyOme+OKZoNglmrGcrK3VySQ0nzZXnnBHXitiMrHwwQoFYqQoyD0B/T2xQ8cYKs3+rK8bUyVwvH59aV2ikk2VvIk8nEcjFVXy2LDGCeS2fXr+VLDLFaXHky3JTJ+eTIACkjue+OPx5qeFissqsUUNhgRkhQRxn8B+tVtUsxcxMHdWkYZGOmWxj8gP1qU7FNXWg7VJ7a2uoo4JIW81hvk37o1z92Pd6gHJPqKd50ZLld8cR3AY68YGTnkjr+YrCt9GdLkiWUm33bhGxOCcEbsetbUrLDDHumYqY9qnGMHPJ57cVcpcz0JhFx3HoBNlcyyHptTqvTPTnA9ac7+e77W2yF1j4U888nA7cY/Osu11K5Mkp0adkZt0W/OMpzkk+mCM0acksNnHJM4y2ZMpxtJHIP4cfjRZILtsbPc3UQjuLMKZIGeQjO3yznAPPAyefwqtplzf308l3elITNyqpwN47gdV45PuKv8Akw3ChLkxfOpCsFwPxI54HHPWr01rPDbhpmbYy5IcY5PTryAADgdeDVJtrQzcdblGe8ghAe7lVFJyvBwAFJGW9dxH51Ztb9ZYYWWM+WFyS3XBBck9s5xVeeMBJElRWRmO4bSQFBx+IJxx7VJeyrDE0SopjdTHGETAILYyPfsPyqb6WKaady7LIGJLMis6ITsPJ54x9efris7Ure5lgltsRSJKys+RhgR7/wCznHvWpd2lrpdvHJdn53YgpFIN45+VSDyqgYHPck9qoWVy07sqshRMKjPwWxncQfr0pyi4hGSmWxAiqgVZfJiwQo+Xgj0/vHA4Hapo2VIsSphtpK4PDDoAe4GBSS5eAlpHaQ8hjzlj1/DnFVrmWRlEcCKFIUbjwVUZwQe2azZrsXJY2MS+YEkLMTj0AHb8T1pqokUXzkCUgkJj5unr24xTGkEMKxKzZVUTLdFHBJ46ZFZ+o6qI7d1jhZpDmRHVd2BnoR1+vpTiiZOxoLGiQbvkCHIC46ZyAc9+AfxpyOY4Q6kqcFwRj6bRz7d6qQTSjy0jYGUlQOO4UZPHbt9T3pwuIo2EKgsQuQQvYj5frxzQ0CZcdvLnAZo1YKAQeCeCc+vp+FRR2tuzjfiRsBcYxtUHkDPriq/2KOWQSTFvMVduFbO7pxz1J9auM8SyOXk3E5yFXr/CPwx0PtQg9StfoZIpJFXEmQpUYwScsQPYADpWPq97HPc2UGjhJiIsOAu13kBBLycnI9PQCtryFEhXJkMjhtu4j5iOnt2/WoTBbxXUUoAXkhnx8z5Pr9P0pqVtCXG+o7TLeWKKP7RIoUSYDIcjG3nGfTnn6VYu7QTQkKOWDEru5Az2PUcAfnUKOiR5IJkHzgnkYznJ9BwBiqF1qMaSW6rIzPM6xvs5ZCOW/M4H0p77Bfl3NNYjAozhiFDsSMEDOPw59e1OaaNWwuFdmBwTwR6+p7GqBnDRqsxaR5IwcHjknjJ+n9Kpzpe3N0hMkTiGTf5keQ5HuB1A6e/apVuo3fobt0DMP3xJjZc7SMkAcZHp1NMkgIDBxvYt87Ft2eMAZ9OaSVTIC6kxswzuPHfPHtnP5UNKNyK/3H3bBu4A6c+vb9akqwwxmKZ1jQRqScIOV2qM8Hvgj9ap3FxmCIRSj5gUVMHO498/TJp150nKS7WKFd+DuGfQduKxd97Ff28lpGY1t2V1l3kFSVwQM9c9z71cEnuRO60R3E0lrqdlp6SX/wBlktYyhikicrgP99SOhPHXnisXXNSF3qoW2EspihjRp5lw8pAI3HPrnj8K2rC7lsNHsWu9bvrYTIJPJjgVliXJIGc/j60zWLKGZmvXv31CWOKEyPJEF3RP9x0xkEfrVPyIT1sc7e3BTSrQpJHbpMyiY4DluOfwFLJdW8bptkYW42gL2K/xN7Z9KxJtHc3P+seSMHgNxjFbH9nIykHeUwB680pVObWxUaVtmXtUvtLheBLe6WdnJJEa7Qvtj6U2MvKgK46dSNpYVgwaQIr0FssVyEzwAfXNdDHsjYeY6uo4OGz+ApTnzu5UIcqCzm2tJGFwrAZY8gn29vai9l8m0dssSCQ4HQjH9KUtHF5bLk7um0jP1xVnakq7N+8umGyvIqU2tTTRqxjX+uafLfpbabDIYpApd3bnIHcD35q6jokaup/eKSAw4bnp+marQ2ECzNJHCsZOcMwxwPWrFjbtd6gtt+6Rpi2DwGIUckZNVfnZnbkGyXypZGeO8iDKxDqWG4DkDPrSJcQSIfLZH3ADk5PTPGen+RVA2Nndl98sck5YcfrgnsafKHtrcNbNH56EMCvOMdAfz/SiTS0aCLb1RfkmtvJGA6hiWKk8KO59jT23sMAYjL8D2+nuKxpNVvb/AFQlrMQqF6R8DOOc+xJzWvabNjEb2IAJOD1x0+nWlKyfuji2/iEeAqrIZNkitvcgb9vXBxVO4smlQxyxoSUzwcE8dfpxReXb2ju8kLsjkrlWOUJx19fTFJayvJDGXLxNj584PQk4HoOlHS4dbEFppMFpcSlHQSbOD6HIIB9qvxhYmaPf5ZbA3bie/wDLvVPUdQht3dZmcO8ZYPt6vjpkfwj1pLO88yOJ4zuc5P8As46/oM0yV2RcWWF92xUIBxy3J75xUaw3GFm0m7eCQAvuB4APrnoeaxZnaBZGngMkIcNnbgZxx9efSrmj3U8qu6usaScFWHDD6d+RQ7LUSu9GXdLs5rFRHJIsnmBkXDDPJyQfQdTVjLQRltw8vcQcoTgZ4I/z39qRZXK/NnaVO5sdRgZOKmWaJ48OHXI6H5gBng8ngk1N7mltLGPJrDr5NqLfyyZCXbzC2UA+VSDyBk5PrWoZ5YIlnhCl0Trt3BhnDbu3en/Z7fzGuOMY25cckk4/n60gSNvmTeQV2BexHf605TbFGCijJj1v7ZfJHZ2xjPlBHMh+9J/ER7Y6e3FbkbqcgTHzQGKFV6nHBA9Dnn0JFQQ2dosiBQWkfks2CGYnBx/d9PwqK4gaa3ZY/NZQMYX9Mnr6dKTld3YKNlZMuiRjeTWiXQkaJ/nhIx5Zzgnnr26VKwDL5hbIwSD6gHAH59PWsax0qazYyT7hK4LZznYBjj3BNWjPNBaPcXDBCjqq8/dBOBx6nNU0nqgTaXvE89usVuwEPksRvJzyR6Y98ciorh1QbN7xk5BRRyDjt+OM/WpzMXmbymBAGCxXcfcn9axtS1F7SV3hWNp5yFTAAMWTzwepI79jSXmDdtiSSCV3hkiGzy12qSSSV/lk8/lTZby8vL9rnUZThScKjZZ2bj6An9Ktm5KqEaHKqCqOFzgnhePUc8/jVS1aDzYpLpS9tG/MQOGZD159T0z2ov0uK1ugguXd1VmZI5MkkN3BycZ6jryakkQSMsnlCQbnZkkYgHH3enpycj0qG/1K3udTvmsYS6XEeI2kAzCgPGMdMAAUmn+cAFuCMqi43Oc5Ycf1yDQ/IFq9TNuhf6rfxxXKFCigbmJxtxkZJ9v51sxRFIViiUoVQxxjG7jt075JPP1rRaRAqtHsPIc71DbmyB36jA6UuyFmeSQqV2D5O+SO2Pwov3GkQPqUL38cGnq0e5SZVZNgRhwSDzkEfzq+skksLblDxjcwRuOccYA9vwqKyig3SqGeSYlg+Dg444B6nA7fWplYGMZITqy7OMgnnn6Y/Cibe4QQwSmOQs5iw74wiYDHrmjYnmLOrK2xichQTnpg/j/Ksm/c2m64VSGjIzlCwBzwevIHHHriobC8u7sW8jqscSttBUdT2JHUDHA/GhJWFzO9jXReX2qPnDffHIz3P07e9Q2FilrvKM6tIB8pPKjOevbgDp1zRcXDIQm5RyERv4eRj6nAyabPexxXscdtdrOk67YmjO45AwFPv1/SnHXqEmk9S66NkbVbbkYyBycZP1GT+lYV/qe7ybSyt5Fvx8shJ3eYwbOV9Pp359a2kbz1jVSMBQpOCcHqeaalnE2+ZlUyKS2SSCWJ5bPf8KSk1sOSTFknlZ2YI4uMKjHdk7uRg/Rc5qtPdh7n7OjqFwBHj5tw4HX0ABxVqW2iCyRhVUSNuY5Jyefm/KohbRs0Xk7WkPzZXjbkHAJ7cZ/D60J3BkgjUkRuxjVicndliBgD8OnHvVYaTYtdNcGPdKM7WC7QvOTyeuAMD6mi3MrpLLuXAdtzDJCjIAyfzOPp9Kct19oiRdxeRicY4V/UD86bi1qyVJS0Q07cpv8AujBwoACqMnH8ufelgvI/MBlZY32b2EfBwfXHt/Sq155wHmCISOVbg8EL/FnnA/8ArVnabZz3d4budSkXmAeYflBDdFx2GB+lCta4NtOx0uDNta3DIWB2Fj07ZH0H8qjtUl3uZJQu9sKAMkrwQB6fX60sEmPLJRsEZUngHJPP4jpTrybzCy4PmFCBIpzg9c9sdQBUFiTJvTnHzj7wOBznP19Kgnhkdg7KhU/IqJjAwBnAz+GaCoQ/M75xtLPyQBj5cD3xUdxOFDSS7jIXWNSeoPQ8Dv0pp2E9ToIIY3sLQ63LYPHtJgF4js+3PJOz+AnoD2FR6pcXFtNc21wLU+aEmMsYAQxhf3YXp8g7D1qGLVbKazgOoWcryxLsja2kC/KCQqHIIAGTz6daqa+11c6wrT2yQ26QR+VGjb8R4+UE9+5/Gqb0M0rMzmnR3Ccq5wiqTwc9zSRMLcsiyI7g7SqZ4x3rPvbfzY9jFlwM5Hc9qjsLaS2gdgXIz8xJzUKasaOLvc2kn89wJWKsMFlxkmppWiAkZFLEY7YAB9PesuJoBZSPPdrFOvOwqSSvsaSy1HzxIPvDOAxX+VNqyuNTvoLNqcFpFPDLbyFyMxyddpx0NSaffmWAvtkjG0ZCg8HFJId7RKoDlzg+/vWkqhmOEwpwOnApc7asHLZ3RnNqUIuoVtHaR5VywY8xtnmk1G189Fk3FHJBVw2CPXmpDptvExZEzIx4C8knPWpwoYIokY8EkEc/iO1Jt9h27lKwsFgtmeKVmcfvGDnk+/8A9apJXhjaO4kkjCuxVkzkhh245xzmr8QUo6x5C/dYMOAKxp9KiS/WZvmXI+Rj65/lTUl1E0+ho2hKpJNLGJEJ+Yg4A4/nTWlf5mjaQYJwmcEn+9n9KpRskatbSu4aJt7HIO8dAF+lRx32UeS2dyccFucYOBijlYuZGjJLshZtnmDgM5/hzz39yKmjl3wgKFZ3AZR0wM4//XWdq+sWX9k2qW0HkXcf32LZDNznA/HPNR2F1IsIcKrg4GW+Y4xjANNpR2YKTkWJNoldGid3A257DGOKdbpG0C+X5cgP3Tng9cDFZupR3UglSEowZdrqxyp9x71asLaaKCIMAeDgggH05HrxQrBrcti3xId+DIFwE25OT3x60+IqXjRWUvGdu5h8qAeh/EnmnhvMLGSQlx8udvTjr9aozW09xsjhZSjAqN3y4J7/AMqQ3toSXkwht2+VMjgN94fX37VRuruD7Rbx6YGnZxuJJJZWPABHtyfxq4ivHCEuHaRhnduXgN0J4qO3tjHIZCqgrhEIH3ec4z/Wmp2ViXC7uaUXlx2ql+PLTDYbJJ9Poaz7y7e3mR5nWKXILFSGOG5G0fTArReNQ/lOpyG3H0xjAAFUZNIie+E7AqegBPA57/UUr6lOLtoaEMh+zBneJWfdvBbAyOAPw5OaSG5UtI8hYCNBtYdOeFye4plxApijRIztXJ4X7w9eKyJrxpVhjs3Zp2VjMG4IIySfT6fSmrNiba2OhiJIDBC0ZBAJ+YEk/wBaoTact1OSwZnwVcDgHjO7I7g4qqt0IYQSC0PyoSTtIJ6kfQ0z+0Lb7TNbwyPKIgQwxtyPUn35xTUdLg5LZmmIFtl8o7izgKAx5wvrj37+1CiHzSzIpcLktnvjp7etV5rea5s5bmKDYkaK24thckfIvPPPP4ZpLSwJm+0tcF5ZCAQ4yAu3JPHXJ6UcttRKd9C1cKoXD8oo4BIBJJxn3xycVVuo90TAMFXaUG7BPJJPt0/nRPM8UvmFX/dhm+bkBsjFU4r6G8vjbWIm+zLHhY3IyCfvbvUnH4UJJjlJp2Jre0tTJvYOSqqkOFz0PQio4TJauu2Mzpu3shbAmbOAc4zipbi9tbPzXu1cMu/ySinG4DCqfbvmprKQ3dvHKitk4+Rgcpn1z1AAo6XJaTdiCz1OS61GVPK8kbTEIyvygAYwD6+561PcXQMcYUruYE7wuDt6cd+oqT7JB84kfYACFDAhjxwQB269KhWOG4kFvEqs5O1ifkAPTOaHrqykrKyKFxrbQxLBb2siX3mN5chI2pGeHXGMnnnd7Yrftpla42zAlccoxPy9Pl+vbpxWXLYW9nIrrb5JTaueQ4z7enJJFW1uCTICXljjYPLImfnzzjOMn0+gpyblsRFKG5euY1lXEzmPIwcHO/n5vYAkgfhU6xQ2674SC5AAJ5BUdgPQY4qm19lhI4B643HOD1wF744qO5mKeaqlt7BQo6c4yB9AASahX2NNLXCeIebImWHGNynv657d6pR2Frbnz9kcfLMgj5JBwMjP061atpfMH70ZLENjhhjuSB9f1qG91NLSeK7Fn56L96MsRgdcdelXFWdmS2mrosLc7EKuqeWGUkEke5Huee9Je6nFAkQZ9xZAwRAc4xn5c8ZyQKyNP+03MEst2m2B5i3lsct14B9cVJHZJHMZTv8ANIwF3EhSf4h+Hp607JOxN20aLTxuzQuz4jBJGSFGFGc+oHP1prTq8TJvIyVyW7AjOCO+P6Vl3cdyS5hQTQH5SrcbOPlwR6ZPFXNOt/Kg81XZnZwBuXJ29CWJ/lUu1tB3d9SncJqiyGFJCiSxg5bnaCcrkjr1zT9Ls3jgSIB5Z3fy9xOMMW5z+GK2UkYzfupgxcgfd5BzkfzFVLu0Ezknd+9zlgp9TwMdP65xSbb3HZLUk81UklgUFtpC8j+HsB+v51IEgkZZGLup/eELwPYY6+lZ1hYtDvmaR5i42Bm528Y4+mcfnV8XDhnYDEjHaFUZXIwBz6D+dDGht3JNFmWLDK0gTjgZxj8P/r0MwNupdFByuWycFj0z6YwSasPsRxIzRAq6jg5OTyT7/wBKgmIkXZC7jBBHo3U59RxSBq5RmuxZxRfaGDOy7mABJ3Fu/YA9a0rOeBnhW9LLZRltwjOWHbK5785rLk0yFrgTGRzsPEbZ2uevP0/rV+OHeVt7fy0MhES+Y4VdxOST6c/0qtybNbmqJfD6+WPM1UJk7F2R4H+0fT8ah1y+hvbuE2YnZVhSJRI2CcDbz29c461EuhX8U5R5LESglXQ3cfyjjqM5zVTVreWKT7LPIhxGjEQyKydOOR1/+vQ7kqz6lJ/KEIuGnjcSNzGG5zUqSJs2pIoAzyTx9KyksWaRjHJ8u7n3NXWiaNCYwGYEnHQUrqXSxolKO5UngjutjcZH8QrS061aKNIw4bptB6fT61RtnllLeeo3Z4UDgU77f5F1At1A0qDORux9KUUr7g3ZXsbCRxtIr5wwOAp6VHJc5JSMgFjgnGF69qy9Iv2uS4Zcbcgd88+tWb22+1bljxg9x/nrRomF7okhvTFeLFcHZKOiqOFOeKZqctxHO8kKea5JGRwG9/pWbZ6fO14JZpnLoMLv7CtxHWNcsTnbglxxn2pNq+g7O1mVdMluWiL3gOc5YgVZup1Kl8b1zg/MM89aWAt5Yw7bOQo6A/Ws2+01pXaRJjCr8SFe4pp9wd0tBl9bW975bRT7nHHpx6fWlt7cwRxoyhF4VlHt3NPtrU2sEZLZCtk9u3rVktJuWTZtiYgPuGBz0+tFnLYV1HcqfYbZ5ftDwF4ycAE5wCaf9h8rc8asyRnJ44z2BFaEaxNFmBVL8knBGTVYbsyOFeNwMZJ4Y1N7aMdr6oLeQzKUjgEjffck9AB0PtT4GMkm4oUDnnB4YYrMcXCSG4s2wCSpRuc8c5HfmrumWr21sVkYtuxkHjPXvVXVhK97DnuhbzpLLHlFcFgvp2wOtV7PVC1/J9nj/wBEY5UdNwzzmrrpFKhChWcA/e6/QVDFsijXeiruXcmOpwehp62FopDprgLuR2dQw3KDjLKPWnWd2HiTy2LEjK8AnNUdQs5LwGVJTGQpG9eOPQ+tPtLKKFFCSBXC4I7A0rqwLmv5GqbwLgSF40bjzByffjofSn/aUkw8ZeRcqgQjIbrj6c1nXVozRqpYr8xA64A6cetTJFGsh8tZFL5j45ANJeZRaEv2oO5IVMqrtJIFUE8Dn8DT7eKAEyxgBmUhXx93tn6Vh3WmrLOQQSSecnG30wPU1cZXtovvOpX5Sc/e/wAmm5LoJJ9S3qlqs8RjYR+UwBwDkjisuCwSCCRIWV94PVcjjAH6mnSa7DHaIylnvWlxKpXEaxjgBR159TVmwnNzGhmKq0YP055P4037uzEnzboxLq5uI4JLPLsztn1A4x+GKvWUksFqjXG4JjqpOOO5q88aq4KNnA+VW/hPUilMSG3QZXp5ZIHTJ7f/AFqXNcahbYZfGGOSzQzLN56F2VTwCTyPr3NJZ6dFbky4cttOGJz9FH41Wt7CCC8d/mQ4O1mGcevHp71cWeRGfynEaAEZkyVOQcH+tP4noLb4iR7aFRGrRGSRTwC2ABjn+oqdrKeLTfMktZYoc7S0pAJY4wB6jkY/Cs66medY5I9obYCRjHbj/PvVW41DV9Wngju7hmjiK4KjptGAfr0B+lVHls77ik5X90vS3X2e3IkUhHcbRg52gdQeoHbr9Ky7u6WAp5QEjSERgqTwWOdxHfGSBmrs5R/9YAxA5AG0YHQD9eaowabErzsN4QYP3SBnP9M5pXQmnc2Lq5Yy8AA+X5YBHBPTIrG1C4uJlW3jim82JRl2cgNjjcT7DjHpWsE4cPIxK8IpcfMR7/Q1WjuLaRJWQq/RAmfnOew9eM/SpjJplOKa1J7JJY4t8jOzBVjWQJlcDqf161Wu42lUPbmQyxncpLdRjt+g/Gkub5VkkSElkJyxZj8zdAoH6VLFIY4gEbEhAyAeVYnAHsetDbuNWasRCK4tkZ5Jlmup5SSDxtGO4HTpV6CKC6tS7sIl8wR5I+Zhxz6//rqBsyK0cgwpwAFXjPQfkOalto7a1x5LlwSWJJz8vTnvnpVX5tyeXl0LqRxgQjcpRcsrBuvHTH1/lTN2MgSKGiPyybCBz1P58D3qFixAYMqybN3yjcWHYH0wO1M8qbbIsy4jEfztkjAPQ+pOeRSbK32LV80VhbWslxMGV2JeGNw4VsfIH9ye1Q3Uhkt/3CAKx4A7545H51ljR2kuYy0ija4bDEDj6/561qlUj2qVky4yVJHGORz2pt32FG/UyppZX1GKOCAwsGxvzlTgDOT24xzV6aYQRlcyiQlhy2CfQ+/HFWoXVI9uAh3hXGPmbPX29qpapBNdANCYQ5IQH+6Ogwf60rhYsWk6gRLsHll8swJxjGc1Tvbh41RkjUkjAQZ6+w9uPxzUmn2xtbMoSzjkCQ84/D3wfypkk+SiGNv3jfLhThQOhz68n8TSCxPYs/2U7Q21QVIzyAeSQetWi7GdVwXBBLYP3TwOPUVTmR4owYl3QFxvAHIPUDirqKYirnClsEyDJwOmcfnQGosheOEJcFDgYYsMEjqRx68CoUtftINpFEZpuQEUEsx7AAd+eaSJYZWEsgUqDkFPXrjB744p6O8JVbZmD7gFCctuJzwf04oAY2g6xLd/aryyu5LjYI2lER3OOgzxzgd+vTNMuTPY3X2WSJ4pEVX8uVSAD/Dxj8a6K/s9dvpxK1vHDOyjev2pQxfoSVLcE+lc/dxSW90y3DSGRQFdJTl0x1ye/emyUZL3UEl239nxmO2yMKWzjjn9a0IHVVO8Hd79hVVYYVdnVTg8nAoFwrlwHEw4PHY+lTe7uXsrE+/ZuFuN2B8+O1I0KXSshBMuehPasO8aaOdiCyxt97b1xVjT3lluHZSzKBgbuwqrRsQnK+ptafDGEI4Ur/CBU0dyqlEK7GHQjtVaCfruOB0yD1pWg+QtvY88L/jWZqI8vkIZ2O7LeWQCDt9zTL6dEEShiIzkMx/hNVpNPjmuEZ2wnUqD3q5cIgjaJ9jKcN83UVV1uhWezKVhdie7kUAi3HKkH7xx1NaVy6BF80Ku7g4HOKSxhiQEAgL14HX2qLUJ1UGOUBtxwARnj2ob5ncSXKrC3JWNY7f7Qj+bHvXByBn1+nesi8t5nkaGOSQ72GAp+UYpdN0+A3RcOzYBAHpWrdNGuNyruH8SZ605O3wiin9oLdmjiVN+5ovmyWwG9eKbJMVtVuTImEbDhuMMeR+FRTA3EJKAGTpyeB2rFv7S7vJ44H8vy0XBKn7+PX1qoNdSZqS2OmWZJYQFJyRu2kc59/apnuGeLYCXOck7chfXFULS0dI9j53AADtgCopI50uIvImAkznPYDHSoVrlu9hLhlnjElqdkh+Q4OQR6EVStheXF81zNsRVAUqq4Gf/ANQqfS7KeEySttJ3EkY4zT7qVo9qAlXwWG7oT6Gqvf3URy/aZfuLtdj4SM4HbjtVOe5gS4VZjGilBKpGcZ9PY1nRStdpsiHzoSWfHGR6fjUlnp8s03mz7YyoIyoyOfWmtNGDu3oaEl4Yo/NEirGuBjOMHtgVYaVUZZIgVbZ85VuG78Ht3rHuNNkuJlDSMICcMB1PPX86ufZt6CJSGDcqSeDjip0K1QG/VGhZ8KjDcrH1JJ698e1X1vBPII8qScZZh94+me2KwYtPlWdC8haFCQgPIUHuM1oyRxurIVGV+UEdcD0pu19BK9tSW2W2lldwUkZZNo4yOOpIP4VowIgiYsvzng44Oc9P5Vmwxw28KKi42nnvn2NS2uoKWWJ0XJOTuOM5OOPepfkWmV72eOO6ZLl2QbCdzDOT6fTtSaVcTy2pwhG9+MdCMnoO1aNzaxMdrqFH8W4gkev4URhYbcMrKQoHJ7A5o6WC2tyrcSMiOrIHJUhWHU89/wAKy9WZNxjsrpZo7qPMylcBeemOxrZLR5xhsKMZxwM/1pqWkMczOIQGB4JOSfr6VUZcpMo8wljErjy8MqkKAH5c+matJAqjnAbknB/zmoZriOESbiqxqOME5P5dTUE93NCYTcrJGkjBVY8qp6gDHsRS5W9UHMo6MdNexRXcRvCxtEJHyj5iMdvw4zS6bepNaq24Bmyee3PUZ656UX8cTxyyBJDHCo3EEkICcDJ9zzVS8JS2UxbW2jYuADwBk/lTb6MXmjQkVp/MjZYwWb7xOMDvt/kaqtbpYxMIVxIDjP8AECOrZ9egrOe6Vruzis9oLR75N6EBCOCc9ycdfetiMeaGeUhgxyd/pj/P1olGw4yTOeW6ktZz5kcknzEplvuv/e/OrumxTtIRNuE0xLMep9c1oJAnzktGxQYY9/Xp+P6VZkjMZR3+6F25UZ49B7560rthy9UCtAqiLaSqAAZXt0znvVO9aRUKwAmNWIkAXDNnqM/pUxuSHMcAQEMNw6Fgeck9sf0qGS8MhDxOShDFdpzx06+vWqV1qgbT0YkMhjt18wgTY2vtbcrZ5C9v85p8t+sk3ysplbJKjo5HH5ZOKy5NTfzYbeGJt4JWReoPvn34FQXC32+XyjshlIPPYjkHHqOearRPUzu7WRux3kpiuoyAZYyBIMk7Sfr9RWbc6kRJ9+ON8hVVeAB0LfX/ABqW3szbA5KzCZvMaTfkn2P6cVYWxt7k7m8r5BkkjofTNTdJ6FatFfR7hpLjey5iiGFU9TycZ+nXmtoSr5ZUyZdhxnjJPp/T61BHAgi2qqo4XD5bB254Oe4qNooFkYjd5iYK5PJ7D86T1HHRFySf7PCzSMA2No4PykfzNVmvDJNGEUt5Y/gx0649OpGap6m8pjLtHnH7sunBPqSPXnFUrPzJrnr5QwQvq/q39akovI7Ro0n3EIIAB9Rzn+VLE/nlzukRGwOASu0VL5OFCjzApj2HAHGep/L+dR3KybS0SARMAAD7f1oFuSCZYY2VUcA4Bzg/XA+lVLLXY9K1W3vI4vMjilA2qcbgScn2PIxUdrDdyu4mChASAiHkZ6n3rS8O2Nra65a3l5tKxSByCm7aOxPrjAP4Va0IeqLl5ZaJE7yT6jfJ3HmWR8zHXrnB69aNYvv7SuY2jikggjhSGMTjDuirwze56+lXLmWWe6m0vxFcC+s5n+WcSb2gc8h0b+7zyvp9Kh8T+UNTtxDJBcJFaQRLJG+4EgY470boS31MG3JYYPyoBghuakQJEWCqBnvVW0vVlcoQN2eh4p11IdjbSMegrOxtfQkWRJt/UkDAFBYJHkcAcketZXn+ZOPKjMZUDNW4rm3CSC6371GUHZvY1ShrZMhz0IGaMmMqziYtls9APars9y0UJ2nK5yfeorQpINxj69Pb2qa4AZQhHUdB7UN3BKxXi1DZfRiN1kV15xzsPoat6nI4UNCu/HUr1rM0+0UXayICB245Fa7KFYYyR2HrRJpbDSdtSvpRufIOQ2DnOe1Qai8kZDyR7l9uuPatNrgi328c9fSl3RXKDp1xntj0pKTvcbSehi6M1x9p851Cqy8BTx7fjV43QS5WW4Vmt/usO9SK0ccuG2qAe3apSEkT5vmDDOfenzW1Fypqxm6deyNNL5AKwhuOO2ehq4d0kyxrtU/3iccetSxiJIuy89KpahbzbhJE+w9qV03dj5WlZFqG/wBxZC37wA5z1FTtcYjOCC/HIFZMVu8EvnySeYBxkgenQ0iXIlkQS7QWycgYxQ1fYSdtzQe+EEKq4UI5zuPY0lzbR3iqAAQACR3JqvJZw/Ju9Qw561M7eUm5CwU8Z7Un5DV1qya0tIbeIKCqgA9OuacrqjKd2Aep6nH9Kzrm7NvfSWpIdwAUaM+ozVdWlaZVUsIypLgnkGny9w5jUlmjWRyCzIpxu9B70qz27KdrZTgtnjn0FZ0ZEIkaYALJ8oIPPSoogqxOsaqFXkZPf1pKwa9S5ezkwsUQhgowMZ79KzRdSzvZ7FKAMwLK3BwOeKswzt9qWFtpKjIYnp9asWUsNwwVEQuDy3AwO9aaxRDakyYxylAc/Nt24P8AdxxUFpFcC5Mk0oUYOFUdcdBVvz3JaOMFjkkLu5OKZY3aSyAAqQSd2ByD6VGqK0egr6ssFtcw3S4uCAUlUE4IPI+hqC5vJHsrYqriZlyygdD/AIVbuBC21mCDjJ4xVmNoZLcICAWPIK5C0+cOU5+EyvcJhZFiJyCxzlsVqTTKqgRlC4Uk8nAOaupsSBgOAcF2x+g/Cs6bT2kUyxTYweD7dqL6isNmxL5sB+baFwFOR7n3FVP7Nu5WiE0rvbpzGM8Zq7bWltaruJCAqQQScj3/ADoF3tRJGB8rdtDA9T3+h6U9fshp9oZcWd6scwtropHIgjb5eGA7fhVmytSlusEznKrgK/8AF7cVJK4YHYzSFemM4PHp61kG8me5tyhzkkNjgg+h9qWshOy1Ny3tI4CZYIeuVUkZAP8AntVe8uWtoQGJBH8R9c80o86SPbbsfMkGMHkjnP51YnhjlgYXJLBsEcY9s4ppjaMx9SFxqElsiD5VDISMYGBx/X3zV2QSOgkgbaoO4qc8nv8A41HbW9tbOTDCwzjILde+aSSd5GbcX3AZ+UcAep/Km/eYk1HcoXSX0ZkktlVllRkkyM4B4INP020nheU3ZO5sN8p+UkdOK0RexGPBWPBIAK5yDnn2NOlmjLSqAcxpj72SD2596HorBo9SBTGCoijRpN2GyMNuxzTrqNMPJACxHAUcE+o/pWdffbyrRxplX+627BXjmr9s00cY84b5NozIefc0Bci0+5mntX81XSMsHUbccZwQPcdKsSJIQm3aVZ+RzhB/WnT3gywcxkAjjaMk4x0p0dziILG+4rhThhkf59aljRK8/kxxogdsjYAq8lj1OaxJr4QpIZsGNW3DYOp6YHr/ADqxO8cqsUbaDkBvUd8VQg0w7gZpNyIcqo6A/wB/HrjjNXG1tSJXvobVtO7Wy7H4b1GcZ4H41O6oItrcsMqvPOPp6n+VZ6SpHIUt4+FwoJboTzn3NTF1hdk8xWbjJTkZx0+vapa6lJ9CWKVXMixgSCMnkDr/AJJ61Fd3ASNt5WQg5BOe3TigRR5BDMrA5yBzTLkLvzK5CjaThcd+KljLFnOzwMG3JIpzgdx3z+NPhWZ3VdvmPuCooTGWJ6DFQ3BhaVnt1IUE4Unr2GccVZ0G5S31C2adti7zmQj/AFeQRu/AkU0tSWy0bG2WZ4ptWto7jkFQrMqt3BcDaMdPQVlXshtL5obqMx3it8yrxtA7jH6Hv1ro/JaPVLSbfIkkUSQGyS3ZmcBcFUIG1lfruz0PNc/rrxJqKlZI/MtraK3LIchnUHIB9BkLnviraJ5jBseZWz1z1rWwBbYxxmiis5GyGqirhtoJPrRLCjl9yg4oopIJFWQ7Nm3ip7tisSupIYY5oooEh+lksVyTluprRkAG9eoxRRSNFsYl9O9rIskWNwBPzDIqPSJGeMFjn5iaKK1XwmP2xJJ3hmk2kESKVIYZq1ZkraREMc4ooqZbIcSjdXUoDuG+bNaVpK80AMhyRRRSmtEOHxEd9w4QfdJBIrLu1xq8NuCREvzge/8AhRRVU9iam5pXDHYy/wANODlby7tusSFcA/7tFFStmV9pEljZwsvmFPnwfmHWrOxR0A5WiilLcIlO4wJCAoABx0qtPEixzkKPlXvRRSQ3sZF2zB15J3Bs/gK1tJiURwYH+sX5qKK2lsYw3Y3UkxNvVmRwcblODV6zt47cKYwcnBJJyTnrRRUv4S4/EFwN90iOSVYZINU9NlkNzIm9gBnGDyOvAoooXwg/iL08jiVF3HaH4HbpUFtdSK1zCNuzehHHK5yTiiinHYH8RX1GZkmjxjkHIPeqT5a7uodzCFWRwgPGTRRVQ2IqbnQWwAtl/P6ZNWbaJCCdgHIPHrzRRWa3NOhC8rhlIYgkgZHbinXF5MbUAtxzx+maKKaEZt25jurKNeA8Yye+STk1SleQSzskjo6qcMpwTng5oorRbkS2Lel2yDSIJVZwzAt16HNWreFBkqNpL8kd+aKKzluVHYs2zFmznBLlSR1NS3xw0qH5gGwCe3OKKKFsNmDLJJCs7RSOux8rg9KfYuRKcdN2wD0BHaiim/hIj8SHi2SS4RGZ9inIUHAzWlJAgghOW/e8tzRRSZXQ53WJns7+RYTwCCM1qaVAkkcW7J3kg89iaKKqWyJW5fUAShOoxnJ61JIMgkknb0z9KKKjuWiPrIV7HA/+vVO6laPOzA2uo+vWiihAy+1xcDT1iW6uVhMefLWVgvPsDWV5Sx2yhRw3JoopsR//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Keratosis pilaris. Multiple follicularly-based hyperpigmented papules are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34152=[""].join("\n");
var outline_f33_22_34152=null;
var title_f33_22_34153="Clinical manifestations and diagnosis of hepatic encephalopathy";
var content_f33_22_34153=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of hepatic encephalopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/22/34153/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/22/34153/contributors\">",
"     Peter Ferenci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/22/34153/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/22/34153/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/22/34153/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/22/34153/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/22/34153/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic encephalopathy describes the spectrum of potentially reversible neuropsychiatric abnormalities seen in patients with liver dysfunction after exclusion of unrelated neurologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    metabolic abnormalities. The term implies that altered brain function is due to metabolic abnormalities, which occur as a consequence of liver failure. The full reversibility of symptoms after improvement of liver function is considered to be direct proof of this causal relation.",
"   </p>",
"   <p>",
"    This definition is easy to apply in previously healthy patients presenting with acute liver disease and overt neuropsychiatric symptoms. It is more difficult to apply to patients with chronic liver diseases who have only mild to minimal signs of altered brain function, particularly in settings in which the underlying cause of the liver disease may be associated with neurologic manifestations (such as alcoholic liver disease or Wilson's disease). The problem in defining hepatic encephalopathy precisely is not just a matter of semantics, but has major implications in the design and evaluation of clinical studies on diagnosis and treatment of this syndrome.",
"   </p>",
"   <p>",
"    A generally accepted nomenclature could provide a solution to this debate and provide a standard for clinical studies. To achieve this goal, the World Organization of Gastroenterology (OMGE) commissioned a Working Party to reach a consensus in this area. A group of experts proposed a consensus statement at the 11th World Congress of Gastroenterology in Vienna in 1998 (",
"    <a class=\"graphic graphic_table graphicRef61352 \" href=\"mobipreview.htm?7/37/7772\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/1\">",
"     1",
"    </a>",
"    ]. A classification of hepatic encephalopathy has also been proposed (",
"    <a class=\"graphic graphic_table graphicRef82325 \" href=\"mobipreview.htm?2/6/2156\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with hepatic encephalopathy (HE) usually have advanced chronic liver disease and thus have many of the physical and laboratory stigmata associated with severe hepatic dysfunction. Physical findings may include muscle wasting, jaundice, ascites, palmar erythema, edema, spider telangiectasias, and fetor hepaticus. Some of these findings (such as muscle wasting, spider telangiectasias, and palmar erythema) are usually absent in previously healthy patients with fulminant hepatic failure since their development requires a relatively longer period of hepatic dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/17/2330?source=see_link\">",
"     \"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The history may reveal a precipitating cause. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypovolemia",
"     </li>",
"     <li>",
"      Gastrointestinal bleeding",
"     </li>",
"     <li>",
"      Hypokalemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      metabolic alkalosis",
"     </li>",
"     <li>",
"      Hypoxia",
"     </li>",
"     <li>",
"      Sedatives or tranquilizers",
"     </li>",
"     <li>",
"      Hypoglycemia",
"     </li>",
"     <li>",
"      Infection (including SBP)",
"     </li>",
"     <li>",
"      Rarely, hepatoma",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vascular occlusion (hepatic vein or portal vein thrombosis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Disturbance in the diurnal sleep pattern (insomnia and hypersomnia) is common, and typically precedes overt neurologic signs (",
"    <a class=\"graphic graphic_figure graphicRef58163 \" href=\"mobipreview.htm?37/16/38158\">",
"     figure 1",
"    </a>",
"    ). More advanced neurologic features include bradykinesia, asterixis (flapping motions of outstretched, dorsiflexed hands), hyperactive deep tendon reflexes, and, less commonly, transient decerebrate posturing.",
"   </p>",
"   <p>",
"    Focal neurologic deficits may also be present in some patients. In one report, for example, a focal neurologic sign was detected in 17 percent of 38 hepatic encephalopathy episodes in 24 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/2\">",
"     2",
"    </a>",
"    ]. The most common was hemiplegia. None of the patients had abnormal findings on CT or CSF examination. Five of the eight patients also had a normal MRI and Doppler examination of the neck and vessels. The deficits resolved completely in seven of eight surviving patients after six months of follow-up.",
"   </p>",
"   <p>",
"    Subtle changes of HE may be detectable by a number of specialized measures, particularly psychometric testing. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Psychometric tests'",
"    </a>",
"    below.) Such patients have sometimes been referred to as having subclinical hepatic encephalopathy (SHE), although \"minimal\" hepatic encephalopathy is preferred (",
"    <a class=\"graphic graphic_table graphicRef61352 \" href=\"mobipreview.htm?7/37/7772\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LABORATORY TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory abnormalities typically include evidence of hepatic biochemical and synthetic dysfunction, and electrolyte disturbances (such as hyponatremia and hypokalemia) that occur as a result of portal hypertension and use of diuretics. In addition, ammonia is the best characterized neurotoxin that precipitates HE. All other routine laboratory tests are only useful to exclude other causes of brain dysfunction (eg, hypoglycemia, uremia, electrolyte disturbances, and intoxication). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14506?source=see_link\">",
"     \"Hepatic encephalopathy: Pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Ammonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gastrointestinal tract is the primary source of ammonia, which enters the circulation via the portal vein. Ammonia is produced by enterocytes from glutamine and by colonic bacterial catabolism of nitrogenous sources such as ingested protein and secreted urea. The intact liver clears almost all of the portal vein ammonia, converting it into urea or glutamine and preventing entry into the systemic circulation.",
"   </p>",
"   <p>",
"    The increase in blood ammonia in advanced liver disease is a consequence of impaired liver function and of shunting of blood around the liver. Muscle wasting, a common occurrence in these patients, also may contribute since muscle is an important site for extrahepatic ammonia removal.",
"   </p>",
"   <p>",
"    For clinical practice determination of ammonia concentration remains controversial. It may be useful under certain conditions (eg, monitoring efficacy of ammonia lowering therapy), but is not required to make the diagnosis of hepatic encephalopathy or in the long-term follow-up of patients with advanced liver disease. The accuracy of ammonia determination is influenced by many factors (such as fist clenching, use of a tourniquet, and whether the sample was placed on ice). These factors should be considered when interpreting results. Furthermore, ammonia levels can be elevated in a variety of nonhepatic conditions (",
"    <a class=\"graphic graphic_table graphicRef57620 \" href=\"mobipreview.htm?34/26/35243\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Venous",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous blood ammonia is not a useful screening test for HE since levels are inconsistently elevated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/3\">",
"     3",
"    </a>",
"    ]. Furthermore, HE is only directly related to ammonia levels up to about a twofold increase above normal. Any further increase of ammonia concentration does not contribute to the further evolution of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/4\">",
"     4",
"    </a>",
"    ]. However, ammonia can be measured in patients with clinically overt HE since it may assist in selecting the appropriate therapy and monitoring its efficacy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/15/4346?source=see_link\">",
"     \"Hepatic encephalopathy in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Arterial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared to the venous blood ammonia concentration, the arterial ammonia concentration provides a more accurate assessment of the amount of ammonia at the blood-brain barrier. However, for the same reasons as discussed above, it is not more useful than the venous ammonia concentration. Furthermore, the grade of HE is more closely related to the partial pressure of gaseous ammonia (pNH3) than the total arterial ammonia concentration, since gaseous ammonia readily enters the brain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/4\">",
"     4",
"    </a>",
"    ]. The pNH3 can be calculated from the total ammonia and pH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/5\">",
"     5",
"    </a>",
"    ]. Determination of the pNH3 is mostly used for clinical studies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14506?source=see_link\">",
"     \"Hepatic encephalopathy: Pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postprandial ammonia levels may be more closely related to minimal HE than fasting levels. Thus, in clinical trials, ammonia is often measured after a standard meal (or glutamine load) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/6\">",
"     6",
"    </a>",
"    ]. Induced hyperammonemia led to a significant increase in daytime subjective sleepiness and changes in the EEG architecture of a subsequent sleep episode in patients with cirrhosis, pointing to a reduced ability to produce restorative sleep [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H83448261\">",
"    <span class=\"h2\">",
"     Other potential markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum levels of 3-nitrotyrosine may be elevated in patients with minimal hepatic encephalopathy (mild cognitive impairment). One study found that using a cutoff of 14 nM, 3-nitrotyrosine was 93 percent sensitive and 89 percent specific for detecting minimal hepatic encephalopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Minimal hepatic encephalopathy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of specialized tests are available for the diagnosis and characterization of HE. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Psychometric tests'",
"    </a>",
"    below.) However, in clinical practice, the diagnosis is usually established based upon the clinical and laboratory features discussed above and the exclusion of other causes of mental status changes. A CT scan of the brain is indicated in patients with overt HE if clinical findings suggest that another cause may be implicated (such as a subdural hematoma from trauma). Furthermore, the CT scan can demonstrate the presence of generalized or localized cerebral edema. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/1/36889?source=see_link\">",
"     \"Acute toxic-metabolic encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the diagnosis has been made, it is useful to grade the severity of HE. The simplest assessment is a grading of the mental status based upon clinical findings. The most commonly used system grades HE into stages I to IV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/9\">",
"     9",
"    </a>",
"    ]. The grading is based upon changes in consciousness, intellectual function, and behavior, but does not include neurologic changes or asterixis. The Glasgow Coma Scale may also be useful for further stratifying the severity of neurologic impairment in patients with stages III and IV HE (",
"    <a class=\"graphic graphic_figure graphicRef70740 \" href=\"mobipreview.htm?12/37/12883\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many other grading systems have been proposed that include an assessment of specific cognitive deficits or laboratory derangements. As an example, a portal systemic encephalopathy index includes a quantitative assessment of asterixis, EEG findings, performance on connection tests, and fasting arterial ammonia concentration in addition to changes in mental state [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PSYCHOMETRIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Grading of HE into four stages is insufficiently sensitive to permit the detection of subtle changes in mental function. Similarly, commonly performed bedside tests used for the assessment of mental status changes (such as writing and drawing, recall of current events, and subtraction of serial 7's) lack precision and cannot be easily quantified. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As a result, several psychometric tests have been evaluated that quantify the impairment of mental function in patients with mild stages of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/12-16\">",
"     12-16",
"    </a>",
"    ]. These tests are more sensitive for the detection of minor deficits of mental function than conventional clinical assessment or the electroencephalogram (EEG) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/13\">",
"     13",
"    </a>",
"    ]. However, they are cumbersome, time consuming (up to two hours per session), and their reliability is decreased by the learning effect when they are applied repeatedly.",
"   </p>",
"   <p>",
"    Furthermore, a general problem with psychometric tests is that they are nonspecific (ie, any alteration of brain function will result in abnormal test results). This is a particular problem in patients with alcoholic liver disease or Wilson's disease, which are both associated with central nervous system abnormalities. Thus, only a few tests have proven to be useful for routine clinical use. Despite this limitation, the severity of cognitive impairment for patients with alcoholic and non-alcoholic causes of cirrhosis is similar after adjusting for the severity of liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most frequently applied test is the number connection test (NCT or Reitan-Test), which is easily administered and permits the results to be quantitated quickly (",
"    <a class=\"graphic graphic_figure graphicRef83108 \" href=\"mobipreview.htm?0/32/527\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83109 \" href=\"mobipreview.htm?36/49/37662\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/14,15,17\">",
"     14,15,17",
"    </a>",
"    ]. Approximately 5 to 15 percent of patients with cirrhosis have an abnormal result if the NCT is done properly using age-adjusted normal ranges (",
"    <a class=\"graphic graphic_table graphicRef77556 \" href=\"mobipreview.htm?18/53/19292\">",
"     table 4",
"    </a>",
"    ). Another useful test is the measurement of reaction times to auditory and visual stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The equipment is inexpensive, and the time to perform it is reasonably short. It can be applied repeatedly since it is not affected by learning effects.",
"   </p>",
"   <p>",
"    In an attempt to improve the performance of testing for minimal HE, a battery of five paper-pencil tests were combined into a new instrument, the Psychometric Hepatic Encephalopathy Score (PHES) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/20\">",
"     20",
"    </a>",
"    ]. The PHES includes the line tracing test, digit symbol test, serial dotting test, and the NCT A and B. It examines visual perception, visuo-spatial orientation, visual construction, motor speed and accuracy, concentration, attention, and memory. The test can be performed within 10 to 20 minutes at the bedside. The whole battery and each of its components has been standardized in a large group of healthy controls. The individual test results were scored as 0 points for subjects scoring in the &plusmn;1 SD range from the mean for controls, +1 point in subjects scoring more than 1 SD higher than controls, and &ndash;1, -2, or &ndash;3 points in subjects scoring lower than 1, 2, or 3 SD from controls. Thus, subjects could achieve between +6 and &ndash;18 points. When the cutoff between normal and pathological results was set at &ndash;4 points, the test had a high specificity and sensitivity to detect mild HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/20\">",
"     20",
"    </a>",
"    ]. A pathological composite score was observed in 25 percent of patients without clinical evidence of HE. The PHES test was recommended by a panel of international experts (members of the Working party initiated at the 11th World Congress of Gastroenterology 1998) for the neuropsychological assessment of early HE. A simplified version consisting only of the digit symbol, serial dotting, and line tracing tests was found to be equally accurate as the full PHES test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More complex tests continue to be used for clinical studies, which often include multiple tests that measure different brain functions (such as memory, motor performance, attention, etc). The interpretation of the tests requires a trained psychologist and sophisticated statistical methods.",
"   </p>",
"   <p>",
"    Based on the difficulties in differentiating mild (grade 1) HE from minimal HE, for clinical purposes, it has been suggested to use the term \"covert HE\" for both conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Minimal hepatic encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;One important consequence of the application of psychometric tests in patients with cirrhosis was the finding that even patients with apparently normal mental status have some form of a measurable deficit in their intellectual performance, long-term memory, and learning capability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/12,23,24\">",
"     12,23,24",
"    </a>",
"    ]. Up to 15 percent of patients with cirrhosis have minimal HE when defined by the presence of a prolonged NCT or an abnormal EEG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/25\">",
"     25",
"    </a>",
"    ]. Impaired memory normalized one year after successful liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several approaches are being studied to evaluate for minimal hepatic encephalopathy. At present, none is used routinely in clinical practice.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study comparing the Psychometric Hepatic Encephalopathy Score with an EEG in 100 patients with cirrhosis found agreement in detection of MHE in only 73 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/26\">",
"       26",
"      </a>",
"      ]. The poor correlation may reflect differences in how these tests detect various features of MHE.",
"     </li>",
"     <li>",
"      The Inhibitory Control Test (ICT) is a computerized test of attention and response inhibition that has been used to characterize attention deficit disorder, schizophrenia, and traumatic brain injury. The subject is instructed only to respond to two alternating letters",
"      <span class=\"nowrap\">",
"       (X/Y)",
"      </span>",
"      (called \"targets\") and not to respond when they are not alternating (called \"lures\"). Lower lure responses, higher target responses, and shorter lure and target reaction times indicate good psychometric performance.",
"      <br/>",
"      <br/>",
"      A study comparing ICT to a psychometric battery of tests for MHE diagnosis in 136 patients estimated sensitivity for MHE to be 88 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/27\">",
"       27",
"      </a>",
"      ]. Patients with MHE had significantly higher ICT lures and lower targets compared to patients without MHE. Another study comparing ICD with other diagnostic standards found that ICD was not useful for diagnosis of MHE unless results were adjusted by target accuracy (a measure reflecting the total number of correct responses from a set of presented targets such as specific letters in a string of other letters) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Paper and pencil neuropsychologic tests (PHES) were compared with a comprehensive computerized assessment (Cognitive Drug Research [CDR]) of cognitive function in 89 patients with cirrhosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/29\">",
"       29",
"      </a>",
"      ]. There was a high correlation between the two assessment methods. The MELD score correlated with PHES. In contrast, the CDR domains Continuity of Attention and Quality of Episodic Memory were significantly related to venous blood ammonia levels. There were marked deteriorations in the CDR composite scores representing Accuracy of Working and Episodic Memory after amino acid challenge to increase blood ammonia. Both PHES and CDRS returned to the control range after liver transplantation.",
"     </li>",
"     <li>",
"      The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) measures a wide range of neurocognitive functions relevant to MHE. The test has been used in multiple clinical trials in the United States for a variety of neurologic disorders and in patients with advanced cirrhosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/30\">",
"       30",
"      </a>",
"      ]. The RBANS has not yet been compared directly with the PHES, and its responsiveness to hepatic encephalopathy treatment is unknown.",
"     </li>",
"     <li>",
"      Other emerging diagnostic strategies concentrate on computerized tests and batteries such as the Scan test, a three-level-difficulty computerized reaction time test [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/31\">",
"       31",
"      </a>",
"      ], CNS vital signs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/32\">",
"       32",
"      </a>",
"      ], and ImPACT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One study compared four commonly used psychometric tests in 99 patients listed for liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/34\">",
"     34",
"    </a>",
"    ]. Of the 99 patients, 17 had HE grade 1, 4 HE grade 2, and 78 had no clinical signs of HE. The main finding was that the results of the four tests did not correlate well. Among the 21 patients with symptomatic HE, abnormal results were found in 19 (90 percent) by PHES and ICT, but in only 9 (43 percent) by critical flicker frequency (CFF) and RBANS. The prevalence of MHE was different with the various tests (PHES: 5.1 percent, ICT: 11.5 percent, RBANS: 5.1 percent, CFF: 6.4 percent), and MHE was diagnosed by more than one test in only 3 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The significance of abnormal tests in patients without overt HE is unclear. Such patients have impaired health-related quality of life (HRQOL) compared to patients with cirrhosis without minimal HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/36\">",
"     36",
"    </a>",
"    ]. However, a similar impairment of HRQOL has been described in patients with chronic hepatitis C independent of the severity of liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. A possible explanation is that hepatitis C virus may be associated with cognitive impairment independent of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/39-44\">",
"     39-44",
"    </a>",
"    ]. Furthermore, quality of life is variably impaired in patients with cirrhosis independent of the effects of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact on social functioning is also uncertain. One study focused on 25 of 116 consecutive patients who were diagnosed as having minimal HE based upon a NCT, digit symbol test, and spectral analysis of the electroencephalogram [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/46\">",
"     46",
"    </a>",
"    ]. Patients with minimal HE were more likely to develop episodes of overt HE compared to those without minimal HE at baseline during a median follow-up of 29 months. However, survival was similar to that of patients without minimal HE. Furthermore, the Child-Pugh score was a more accurate predictor of clinical HE than the presence of minimal HE. Thus, the prognostic significance of minimal HE appears to be limited.",
"   </p>",
"   <p>",
"    Whether treatment of patients with minimal hepatic encephalopathy is associated with health benefits has not been well established. However, at least one controlled trial suggested that treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/34/33316?source=see_link\">",
"     lactulose",
"    </a>",
"    was associated with improvement in cognitive function and quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/15/4346?source=see_link\">",
"     \"Hepatic encephalopathy in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Capacity to drive",
"    </span>",
"    &nbsp;&mdash;&nbsp;A concern in patients with minimal hepatic encephalopathy is whether they are at increased risk for driving accidents since declines in cognitive function in other populations (such as those with dementia) have been associated with such a risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies evaluating this question have produced disparate conclusions. At least three reports concluded that 44 to 60 percent of patients with advanced liver disease (but without overt clinical signs of HE) were unfit to drive based upon the results of extensive batteries of neuropsychologic tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/12,49,50\">",
"     12,49,50",
"    </a>",
"    ]. In one study, for example, 40 patients with chronic liver disease and portal hypertension without clinical signs of portasystemic encephalopathy were given the same extensive psychometric tests typically used for expert reports on driving capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/50\">",
"     50",
"    </a>",
"    ]. Sixty percent of patients were considered to be unfit to drive, and 25 percent were considered to be questionable. Another study found that patients with cirrhosis and MHE based on ICT had significantly higher crash and driving violation rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, other reports have evaluated driving ability under real life conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. The two largest reports found significant driving impairment in patients with HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One report included 48 patients with cirrhosis, 14 of whom were diagnosed with minimal hepatic encephalopathy based upon neuropsychiatric tests [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/53\">",
"       53",
"      </a>",
"      ]. The majority of patients had alcoholic cirrhosis. Subjects underwent a 22 mile, 90 minute test drive with an instructor who was unaware of the subjects' diagnosis and test results. Results were compared with a control group of 49 patients in a stable phase of chronic gastroenterologic disease with normal liver findings.",
"      <br/>",
"      <br/>",
"      The total driving score of patients with minimal hepatic encephalopathy was significantly reduced compared with controls or cirrhotic patients without minimal hepatic encephalopathy. The instructor had to intervene to avoid an accident in 5 of the 14 patients (36 percent) with minimal hepatic encephalopathy compared with 6 percent of cirrhotic patients without minimal hepatic encephalopathy and 8 percent of controls. The authors concluded that minimal hepatic encephalopathy impairs driving capacity and that patients with cirrhosis should be tested for it, informed of the abnormal results, and treated with therapy known to improve the results of psychometric tests.",
"     </li>",
"     <li>",
"      A second study included 51 patients with cirrhosis from various causes whose driving skills were compared with 48 age-matched controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/54\">",
"       54",
"      </a>",
"      ]. Patients underwent real driving in a car equipped with multiple sensors and cameras. According to the driving instructor's assessment, 25, 52, and 61 percent of patients without HE, with minimal HE, or overt HE, respectively, were unfit to drive compared with 13 percent of the control group. Driving deficits in patients with overt HE were mainly related to cognitive defects and prolonged reaction times, while they were related to mistakes and attention deficits in patients with minimal HE. However, the authors concluded that the presence of MHE or HE grade I does not necessarily predict inability to drive a car and that computerized tests and especially the paper and pencil tests cannot reliably predict driving performance. For assessment of driving ability, real or simulated driving tests are required.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, in a pilot study, the fitness to drive of stable individuals with cirrhosis and clinical evidence of portal hypertension, portal systemic shunting and no prior history of hepatic encephalopathy was assessed using a film to measure complex visual reaction time and threat recognition (accident avoidance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/52\">",
"     52",
"    </a>",
"    ]. Driving on the road was assessed by a licensed Illinois state driving evaluator. Sixty-six percent of the subjects with cirrhosis had subclinical encephalopathy but did not exhibit a major impairment in their fitness to drive.",
"   </p>",
"   <p>",
"    These results potentially have significant implications for the care of patients with cirrhosis. However, the decision of when and how to evaluate patients with cirrhosis for driving capacity is complex. Psychometric tests alone appear not to be useful to assess driving fitness and several factors have to be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The available data suggest that most patients with cirrhosis do not have minimal hepatic encephalopathy and do not have impaired driving capacity when measured under real life conditions.",
"     </li>",
"     <li>",
"      Optimal means to identify patients at risk for driving remain unclear. Neuropsychiatric testing is not widely available, is expensive, and results have not yet been standardized. Furthermore, the strength of their association with driving capacity remains unclear since few subjects have been studied.",
"     </li>",
"     <li>",
"      Legislation regarding reporting of individuals with impaired driving capacity varies by state in the United States, and by country elsewhere. Thus, it may not be possible to restrict driving based upon the results of specific testing in all regions.",
"     </li>",
"     <li>",
"      How often patients should be reassessed for driving capacity is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The legal ramifications related to driving and hepatic encephalopathy remain poorly defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/55\">",
"     55",
"    </a>",
"    ]. Until further data are available, we use the following approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/56\">",
"     56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It may be reasonable to restrict driving in patients with persistent hepatic encephalopathy associated with cirrhosis, particularly in those in whom their clinical course, physical examination, and reports from relatives suggest that they may be at increased risk from driving.",
"     </li>",
"     <li>",
"      Neuropsychiatric testing to detect minimal hepatic encephalopathy is reasonable in centers where it is available, particularly in patients at increased risk such as those with advanced cirrhosis (Child-Pugh Class B or C), large portal-systemic shunts (eg, TIPS or surgery), alcoholic liver disease, or prior episodes of hepatic encephalopathy. However, the cost-effectiveness of this approach is unknown. Another option would be to have such patients undergo a driving test conducted by a trained examiner, but how such driving tests should be performed has not been standardized.",
"     </li>",
"     <li>",
"      A graded approach (such as restricting driving to short distances and during daytime hours) may be adequate for patients with only mild neuropsychiatric impairment and good driving reports from relatives.",
"     </li>",
"     <li>",
"      Reassessment of patients at risk for progressive liver disease should be made on an individual basis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Electrophysiologic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evolving EEG changes associated with increasingly severe HE consist initially of a bilaterally synchronous decrease in wave frequency and an increase in wave amplitude, associated with the disappearance of readily discernible normal alpha-rhythm (8-13 cps). The simplest EEG assessment of HE is grading the degree of abnormality of the conventional EEG tracing. A more refined assessment can be accomplished with computer assisted spectral analysis of the EEG, which permits variables in the EEG (such as the mean dominant EEG frequency and the power of a particular EEG rhythm) to be quantified. Minor changes in the dominant EEG frequency occur in mild HE. Spectral EEG analysis may improve the assessment of mild hepatic encephalopathy by decreasing inter-operator variability and providing reliable parameters correlated with mental status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The bispectral index (BIS) monitor is a rapid bedside tool to monitor EEG activity. In a prospective study, BIS was useful for grading and monitoring the degree of involvement of the central nervous system in patients with chronic liver disease and to classify the degree and progression of hepatic encephalopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Evoked potentials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evoked potentials are externally recorded electrical signals that reflect synchronous volleys of discharges through neuronal networks in response to various afferent stimuli. They are categorized as visual, somatosensory, or acoustic, depending upon the type of stimulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/59\">",
"     59",
"    </a>",
"    ]. A more sophisticated form of evoked responses is event-related responses, which require some form of intellectual function. A typical event-related response is the P300 peak after auditory stimuli. The P300 is extremely sensitive for detecting subtle changes of brain function and can be therefore used for diagnosis of subclinical HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Critical flicker frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retinal glial cells are involved in ammonia detoxification by glutamine synthesis. In patients with liver failure, they exhibit morphological changes similar to those observed in brain astrocytes, suggesting that retinal gliopathy could serve as a marker of cerebral gliopathy in patients with hepatic encephalopathy. These observations provided the rationale for the development of a visual test (the critical",
"    <span class=\"nowrap\">",
"     flicker/fusion",
"    </span>",
"    frequency) for determining whether hepatic encephalopathy is present. Advantages of the test are that it is objective and it is not affected by the patient's age or",
"    <span class=\"nowrap\">",
"     education/literacy",
"    </span>",
"    level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. However, a meta-analysis suggests that it is only moderately sensitive for detecting minimal hepatic encephalopathy. The meta-analysis included nine studies with 622 patients and found that critical flicker frequency had a sensitivity for minimal hepatic encephalopathy of 61 percent and a specificity of 79 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING OF THE BRAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, a CT scan is indicated in patients with overt HE in whom the diagnosis is uncertain to exclude other diseases associated with coma or confusion, and to detect the presence of generalized or localized cerebral edema.",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) is superior to CT for the diagnosis of brain edema in liver failure, but is not an established method for diagnosis of HE. Typical changes have been observed on T1 weighted pictures with a strong signal in the basal ganglia in patients with HE, possibly due to manganese accumulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/65\">",
"     65",
"    </a>",
"    ]. However, these changes are neither sensitive nor specific indicators of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MAGNETIC RESONANCE SPECTROSCOPY AND POSITRON EMISSION TOMOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In vivo magnetic resonance spectroscopy (MRS) is a noninvasive method that permits serial measurement of various neurometabolites in the brain using a variety of isotopes ((1)H, (32)P, (12)C). Proton (1H) MRS allows for assessment of regional brain concentrations of choline (Cho), creatine (Cr),",
"    <span class=\"nowrap\">",
"     glutamine/glutamate",
"    </span>",
"    (Glx), myoinositol (mI) and N-acetyl aspartate (NAA), depending upon the spectral sequence used.",
"   </p>",
"   <p>",
"    Patients with HE should display an increase in Glx resonance since ammonia (which as discussed above has an important role in HE) is detoxified in astrocytes to glutamine by glutamine synthetase. Several studies have assessed changes in",
"    <span class=\"nowrap\">",
"     Glx/Cr",
"    </span>",
"    in patients with different stages of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/68-71\">",
"     68-71",
"    </a>",
"    ]. Some have shown significant direct correlation between the severity of HE and",
"    <span class=\"nowrap\">",
"     Glx/Cr",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/68,69\">",
"     68,69",
"    </a>",
"    ], whereas others have not identified a relationship [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. In other studies, findings on MRI and MRS correlated with abnormalities in the basal ganglia and presence of Parkinsonian signs in patients with cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another pertinent observation is that the increase in brain glutamine during HE (represented in MRS by increased Glx) increases intracellular osmolality. To maintain osmotic equilibrium, the astrocytes lose osmolytes such as myoinositol (mI). The",
"    <span class=\"nowrap\">",
"     mI/Cr",
"    </span>",
"    ratio is significantly reduced in patients with HE, suggesting that an imbalance in the astrocytic osmotic equilibrium may contribute to the pathogenesis of HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14506?source=see_link\">",
"     \"Hepatic encephalopathy: Pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Microstructural white matter changes in the brain can be detected using voxel-based diffusion tensor imaging analysis during MRS. The test is based upon calculating indices for an apparent diffusion coefficient (ADC) and fractional anisotropy (FA). One study showed widespread brain regions with increased brain mean diffusion values, indicating enhanced water content and decreased FA in patients with HE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/73\">",
"     73",
"    </a>",
"    ]. The brain mean ADC and FA values from selected regions correlated with the neuropsychological scores.",
"   </p>",
"   <p>",
"    The variability among the results of proton MRS studies may be due to differences in the patient populations studied (eg, sample size, severity of HE, age, and cause of liver failure), differences in techniques, and the methods used in the diagnosis of HE. Nevertheless, 1H MRS is an extremely exciting tool, which cannot be recommended for routine clinical use at present, but has tremendous potential for the future, particularly for documenting treatment effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another method, T1 mapping with partial inversion recovery (TAPIR), has been used to obtain a series of T1-weighted images to produce T1 maps. In one report using this technique, imaging of 15 control subjects and 11 patients was performed on a 1.5T MRI scanner [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/75\">",
"     75",
"    </a>",
"    ]. The measurement time per patient with this technique, including adjustments, was approximately five minutes. T1 changes in the brains of HE patients were determined quantitatively with TAPIR in short, clinically relevant measurement times. Significant correlations between the change in T1 and HE severity were shown in the globus pallidus, the caudate nucleus, and the posterior limb of the internal capsule.",
"   </p>",
"   <p>",
"    Cerebral glucose metabolism is considered to be a marker for brain function and thus should correlate with cerebral ammonia metabolism in patients with hepatic encephalopathy. A study evaluated this hypothesis by correlating plasma and cerebral ammonia metabolism with the results of (13)N-ammonia and (18)F-fluorodeoxyglucose positron emission tomography in 21 patients with cirrhosis and grade 0 to 1 hepatic encephalopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/22/34153/abstract/76\">",
"     76",
"    </a>",
"    ]. A correlation between MRS with plasma and cerebral ammonia metabolism could be demonstrated only in white matter. By contrast, MRS alterations correlated with glucose utilization in several brain regions. These data suggest that cerebral ammonia metabolism is important but not the only causal factor related to development of hepatic encephalopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/40/7810?source=see_link\">",
"       \"Patient information: Hepatic encephalopathy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hepatic encephalopathy (HE) describes the spectrum of potentially reversible neuropsychiatric abnormalities seen in patients with liver dysfunction after exclusion of unrelated neurologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      metabolic abnormalities.",
"     </li>",
"     <li>",
"      Patients with hepatic encephalopathy usually have advanced chronic liver disease and thus have many of the physical and laboratory stigmata associated with severe hepatic dysfunction. Physical findings may include muscle wasting, jaundice, ascites, palmar erythema, edema, spider telangiectasias, and fetor hepaticus. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Disturbance in the diurnal sleep pattern (insomnia and hypersomnia) is also common, and typically precedes overt neurologic signs (",
"      <a class=\"graphic graphic_figure graphicRef58163 \" href=\"mobipreview.htm?37/16/38158\">",
"       figure 1",
"      </a>",
"      ). More advanced neurologic features include the presence of asterixis (flapping motions of outstretched, dorsiflexed hands), hyperactive deep tendon reflexes, and less commonly, transient decerebrate posturing. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory abnormalities typically include evidence of hepatic biochemical and synthetic dysfunction, and electrolyte disturbances (such as hyponatremia and hypokalemia) that occur as a result of portal hypertension and use of diuretics. In addition, ammonia is the best characterized neurotoxin that precipitates HE. However, routine determination of venous or arterial ammonia concentrations is not required to establish the diagnosis. All other routine laboratory tests are only useful to exclude other causes of brain dysfunction (eg, hypoglycemia, uremia, electrolyte disturbances, and intoxication). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is usually established based upon the clinical and laboratory features discussed above, and the exclusion of other causes of mental status changes. A computed tomographic scan of the brain should be performed in patients with overt HE if clinical findings suggest that another cause may be implicated (such as a subdural hematoma from trauma). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the diagnosis has been made, it is useful to grade the severity of HE. The simplest assessment is a grading of the mental status based upon clinical findings. The most commonly used system grades HE into stages I to IV (",
"      <a class=\"graphic graphic_figure graphicRef70740 \" href=\"mobipreview.htm?12/37/12883\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/1\">",
"      Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/2\">",
"      Cadranel JF, Lebiez E, Di Martino V, et al. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol 2001; 96:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/3\">",
"      STAHL J. Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance. Ann Intern Med 1963; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/4\">",
"      Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/5\">",
"      MANNING RT. A NOMOGRAM FOR ESTIMATION OF PNH3. J Lab Clin Med 1964; 63:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/6\">",
"      Oppong KN, Al-Mardini H, Thick M, Record CO. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Hepatology 1997; 26:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/7\">",
"      Bersagliere A, Raduazzo ID, Nardi M, et al. Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. Hepatology 2012; 55:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/8\">",
"      Montoliu C, Cauli O, Urios A, et al. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 2011; 106:1629.",
"     </a>",
"    </li>",
"    <li>",
"     Conn HO, Lieberthal MM. The hepatic coma syndromes and lactulose, Williams &amp; Wilkins, Baltimore 1979.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/10\">",
"      Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/11\">",
"      Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/12\">",
"      Schomerus H, Hamster W, Blunck H, et al. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/13\">",
"      Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/14\">",
"      Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/15\">",
"      Amodio P, Del Piccolo F, Marchetti P, et al. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/16\">",
"      Amodio P, Marchetti P, Del Piccolo F, et al. Visual attention in cirrhotic patients: a study on covert visual attention orienting. Hepatology 1998; 27:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/17\">",
"      Weissenborn K, R&uuml;ckert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998; 28:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/18\">",
"      Edwin D, Flynn L, Klein A, Thuluvath PJ. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology 1999; 30:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/19\">",
"      Elsass P, Christensen SE, Mortensen EL, Vilstrup H. Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver 1985; 5:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/20\">",
"      Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/21\">",
"      Riggio O, Ridola L, Pasquale C, et al. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/22\">",
"      Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011; 33:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/23\">",
"      Ortiz M, C&oacute;rdoba J, Jacas C, et al. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 2006; 44:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/24\">",
"      Bajaj JS, Schubert CM, Heuman DM, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138:2332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/25\">",
"      Amodio P, Marchetti P, Del Piccolo F, et al. Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy. Metab Brain Dis 1998; 13:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/26\">",
"      Amodio P, Campagna F, Olianas S, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/27\">",
"      Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008; 135:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/28\">",
"      Amodio P, Ridola L, Schiff S, et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 2010; 139:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/29\">",
"      Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 2008; 135:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/30\">",
"      Mooney S, Hasssanein TI, Hilsabeck RC, et al. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol 2007; 22:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/31\">",
"      Montagnese S, Schiff S, Turco M, et al. Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy. Dig Liver Dis 2012; 44:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/32\">",
"      Prakash RK, Chikkanna R, Anna K, et al. USA validated computerized psychometric testing system for the diagnosis of minimal hepatic encephalopathy - at last. Gastroenterology 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/33\">",
"      Tsushima M, Tsushima W, Tsushima V, et al. A case control study of ImPACT:  a brief and effective web-based neuropsychological assessment battery to  diagnose minimal hepatic encephalopathy (mhe). J Hepatol 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/34\">",
"      Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, et al. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/35\">",
"      Ferenci P. Commentary to: comparison of the most-favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/36\">",
"      Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/37\">",
"      Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/38\">",
"      Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/39\">",
"      Forton DM, Allsop JM, Main J, et al. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/40\">",
"      Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/41\">",
"      Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/42\">",
"      Kramer L, Bauer E, Funk G, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/43\">",
"      Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/44\">",
"      McAndrews MP, Farcnik K, Carlen P, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/45\">",
"      Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/46\">",
"      Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95:2029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/47\">",
"      Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/48\">",
"      Marottoli RA, Cooney LM Jr, Wagner R, et al. Predictors of automobile crashes and moving violations among elderly drivers. Ann Intern Med 1994; 121:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/49\">",
"      Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/50\">",
"      Quero JC, Hartmann IJ, Meulstee J, et al. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/51\">",
"      Bajaj JS, Saeian K, Schubert CM, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009; 50:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/52\">",
"      Srivastava A, Mehta R, Rothke SP, et al. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994; 21:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/53\">",
"      Wein C, Koch H, Popp B, et al. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004; 39:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/54\">",
"      Kircheis G, Knoche A, Hilger N, et al. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009; 137:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/55\">",
"      Cohen SM, Kim A, Metropulos M, Ahn J. Legal ramifications for physicians of patients who drive with hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/56\">",
"      C&oacute;rdoba J, Lucke R. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004; 39:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/57\">",
"      Amodio P, Marchetti P, Del Piccolo F, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/58\">",
"      Dahaba AA, Worm HC, Zhu SM, et al. Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study. Gut 2008; 57:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/59\">",
"      Yang SS, Wu CH, Chiang TR, Chen DS. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology 1998; 27:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/60\">",
"      Kullmann F, Hollerbach S, Holstege A, Sch&ouml;lmerich J. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 1995; 22:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/61\">",
"      Kircheis G, Wettstein M, Timmermann L, et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/62\">",
"      Romero-G&oacute;mez M, C&oacute;rdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/63\">",
"      Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/64\">",
"      Torlot FJ, McPhail MJ, Taylor-Robinson SD. Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther 2013; 37:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/65\">",
"      Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/66\">",
"      Thuluvath PJ, Edwin D, Yue NC, et al. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995; 21:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/67\">",
"      Krieger S, Jauss M, Jansen O, et al. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996; 111:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/68\">",
"      Taylor-Robinson SD, Sargentoni J, Marcus CD, et al. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994; 9:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/69\">",
"      Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/70\">",
"      Laubenberger J, H&auml;ussinger D, Bayer S, et al. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/71\">",
"      Geissler A, Lock G, Fr&uuml;nd R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/72\">",
"      Spahr L, Vingerhoets F, Lazeyras F, et al. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 2000; 119:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/73\">",
"      Kumar R, Gupta RK, Elderkin-Thompson V, et al. Voxel-based diffusion tensor magnetic resonance imaging evaluation of low-grade hepatic encephalopathy. J Magn Reson Imaging 2008; 27:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/74\">",
"      Haseler LJ, Sibbitt WL Jr, Mojtahedzadeh HN, et al. Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy. AJNR Am J Neuroradiol 1998; 19:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/75\">",
"      Shah NJ, Neeb H, Zaitsev M, et al. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 2003; 38:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/22/34153/abstract/76\">",
"      Weissenborn K, Ahl B, Fischer-Wasels D, et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007; 56:1736.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1237 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-298F256B3B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34153=[""].join("\n");
var outline_f33_22_34153=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LABORATORY TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Ammonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Venous",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Arterial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H83448261\">",
"      Other potential markers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PSYCHOMETRIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Minimal hepatic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Capacity to drive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Electrophysiologic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Evoked potentials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Critical flicker frequency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING OF THE BRAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MAGNETIC RESONANCE SPECTROSCOPY AND POSITRON EMISSION TOMOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1237\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1237|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/16/38158\" title=\"figure 1\">",
"      Evolution of hepatic encephal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/37/12883\" title=\"figure 2\">",
"      Clinical features of hepatic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/32/527\" title=\"figure 3\">",
"      Reitan Test - part A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/49/37662\" title=\"figure 4\">",
"      Reitan Test - part B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1237|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/37/7772\" title=\"table 1\">",
"      Definition of hepatic encephal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/6/2156\" title=\"table 2\">",
"      Proposed nomenclature HE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/26/35243\" title=\"table 3\">",
"      Diff dx hyperammonemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/53/19292\" title=\"table 4\">",
"      Neuropsych tests in cirrhosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/17/2330?source=related_link\">",
"      Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/1/36889?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/15/4346?source=related_link\">",
"      Hepatic encephalopathy in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14506?source=related_link\">",
"      Hepatic encephalopathy: Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/40/7810?source=related_link\">",
"      Patient information: Hepatic encephalopathy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_22_34154="Flecainide and exercise-induced ventricular arrhythmias";
var content_f33_22_34154=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50360&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50360&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 628px\">",
"   <div class=\"ttl\">",
"    Flecainide treatment prevents exercise induced ventricular arrhythmia in two subjects with CPVT refractory to conventional drug therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 608px; height: 577px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panels A-D) Effect of flecainide treatment in a 12-year-old boy (subject 1) with a",
"    <em>",
"     CASQ2",
"    </em>",
"    mutation (Panels A and B) and in a 36-year-old female (subject 2) with an",
"    <em>",
"     RYR2",
"    </em>",
"    mutation (Panels C and D). Top of each panel, representative ECGs recorded during maximum stress; bottom of each panel, heart rate and rate of ventricular extrasystoles during an exercise test. Blue area indicates arrhythmia burden. Exercise protocol and ventricular extrasystole analysis are as previously described. Drug therapy during each exercise test: metroprolol 100 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    plus verapamil 120 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    (Panel A), metroprolol 100 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    plus flecainide 150 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    for 7 weeks (Panel B), bisoprolol 5 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    plus verapamil 240 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    (Panel C) or flecainide 150 mg d",
"    <sup>",
"     -1",
"    </sup>",
"    for 8 weeks (Panel D). Experiments involving human subjects were reviewed and approved by the University of Amsterdam Academic Medical Center Institutional Medical Ethical Review Board. Both human subjects (or their parents) provided informed consent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted by permission from: Macmillan Publishers Ltd. Watanabe, H, Chopra, N, Laver, D, et al. Flecainide prevents catecholamineric polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009; 15:380. Copyright &copy;2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34154=[""].join("\n");
var outline_f33_22_34154=null;
var title_f33_22_34155="Instruments for emergency thoracotomy";
var content_f33_22_34155=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F86656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F86656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Instruments for emergency thoracotomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        &nbsp;Sterile drapes and towels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Scalpel holder and #10 or #20 blade",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Mayo scissors (curved)&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Trauma shears",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Rib spreader (Finochietto retractor)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Long Metzenbaum scissors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Gigli saw",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Lebsche knife",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Laparotomy sponges and gauze pads",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Long tissue forceps (smooth and toothed)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Aortic cross clamp (Satinsky or Debakey aortic clamp)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Teflon pledgets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Needle holders (long and short)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Suture scissors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Suture material (prolene, silk)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Assorted hemostats (curved and straight)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Chest tube",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Balloon (Foley) catheter (5 cc balloon)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;Skin stapler",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34155=[""].join("\n");
var outline_f33_22_34155=null;
var title_f33_22_34156="Chemo nail disorder";
var content_f33_22_34156=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemotherapy agents causing nail disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Pigmentary changes",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aminoglutethimide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Bleomycin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Busulfan",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cisplatin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cyclophosphamide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Dacarbazine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Daunorubicin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Docetaxel",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Doxorubicin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Etoposide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fluorouracil",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hydroxyurea",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Idarubicin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Ifosfamide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Melphalan",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Methotrexate",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Mitomycin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Mitoxantrone",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Tegafur",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Onycholysis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Paclitaxel",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Docetaxel",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Gemcitabine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Capecitabine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cyclophosphamide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Doxorubicin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Etoposide",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fluorouracil",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hydroxyruea",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Ixabepilone",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Bleomycin/vinblastine combination",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Inflammatory changes (infectious and non-infectious)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Gefitinib",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cetuximab",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Capecitabine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Docetaxel",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Paclitaxel",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34156=[""].join("\n");
var outline_f33_22_34156=null;
var title_f33_22_34157="Evaluation of obesity";
var content_f33_22_34157=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F69717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F69717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clinical and laboratory data for the evaluation of overweight patients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 318px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34157=[""].join("\n");
var outline_f33_22_34157=null;
var title_f33_22_34158="Outcome of screening II";
var content_f33_22_34158=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56330&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56330&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Chances of breast-cancer - related outcomes among 1000 women who undergo annual mammography for 10 years",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 379px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    All numbers are rounded. The numbers for the incidence of invasive breast cancer and ductal carcinoma in situ, as well as the number of women whose lives are saved by treatment (those surviving at least 20 years after the first diagnosis of breast cancer) regardless of screening, were calculated on the basis of data from the Surveillance, Epidemiology, and End Results program. The numbers of women whose lives are saved because of screening (those surviving at least 15 years after diagnosis) were calculated on the assumption of a reduction of 15 percent in mortality from breast cancer among women 40 to 49 years of age, 14 percent among women 50 to 59 years of age and 32 percent among women 60 to 69 years of age.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data adapted and updated from: Fletcher, SW, Elmore, JG, N Engl J Med 2003; 348:1672.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34158=[""].join("\n");
var outline_f33_22_34158=null;
var title_f33_22_34159="MSAFP level by gestational age";
var content_f33_22_34159=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76646%7EOBGYN%2F68253%7EOBGYN%2F66827%7EOBGYN%2F54546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76646%7EOBGYN%2F68253%7EOBGYN%2F66827%7EOBGYN%2F54546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AFP by gestational age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 313px; height: 301px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    AFP: alpha-fetoprotein.",
"    <br>",
"     Median maternal serum levels in unaffected pregnancies calculated from in-house data at Women and Infants Hospital, Providence, Rhode Island. These data are representative and not intended or appropriate for use in other laboratories",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Estriol by gestational age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 309px; height: 301px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    uE3: unconjugated estriol.",
"    <br>",
"     Median maternal serum levels in unaffected pregnancies calculated from in-house data at Women and Infants Hospital, Providence, Rhode Island. These data are representative and not intended or appropriate for use in other laboratories.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    hCG by gestational age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 326px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    HCG: human chorionic gonadotropin.",
"    <br>",
"     Median maternal serum levels in unaffected pregnancies calculated from in-house data at Women and Infants Hospital, Providence, Rhode Island. These data are representative and not intended or appropriate for use in other laboratories.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inhibin A by gestational age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 322px; background-image: url(data:image/gif;base64,R0lGODlhRgFCAdUAAP///4CAgAAAAEBAQMDAwP+AgHBwcDAwMBAQENDQ0ODg4FBQULCwsJCQkCAgIPDw8KCgoP+goGBgYP8QEP9AQP8wMP/w8P/AwP8AAP/Q0P8gIP9gYP+QkP+wsP/g4P9QUP9wcIBAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABGAUIBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6xUBK+vQwwBDQqytLatupcCvb1CBgIHCAi2wcPFu8qTvbAADwIIAA0CBtDS1AbL24+9AwsEAAQCA+Lk4+XoQgQB7e7h3PGACwES0Qrq6Pnk6+7tAwHkCQQ0QACBBMIAMBCwAOEBhQyRtBtIEQ+BA/WiPQDgQACDBQIgcPQIUuSRiRVTzlFwoNeBBEIStESgDYDMaDVPBlTJkxHK/55AD/0MSlTQ0KJI+xxNyhTP0qZQ5zyNStXN1KpY01zNypXM1q5gv3wNS1bL2LJoq5xNyxbK2rZwl7yNS9fI3Lp4AdzNS3cvX7h+/7INLBgt4cJkDyMGq3gx18aOsUKOTHUyZaiWLzPNrBkp585EP4MGKno0z9KmU6JOTXE1a4GuX8eLLXsb7drKbuPWpXs3q96+VQEPjmo4cVPGjytKQCCXQly3aiVJrvxQAgQCdh4jZkwYd4k7qytrmf1ZtGnVrqHPWYS6+EEBaJbfN4A++Pe6EM6az09ff37i+BMAQPi1EoAvvQTgEEQNJbTQAv34Q2CBq+BDgD0S2NLRRyGNxP+hSXaFR+EqB+50E00xzcReeyKOmJR7LmICY4yWzEgjJTbeKEmOOkLCY4+O/AikTy0OqVqRRraGZJKwLcnkbE4+aVuUUuZGZZW8XYnlb1puKVyXXhYHZpjIjUkmKUKe6UeaavLBZpt6vAmnFAOUM4acc0JRp1dm5nnHnnf26ecbByIIoBh4DmqXoYeGkaiicDwKaRHMvQJToJP+AZIvdiIqaKZrCOMOiI5+CmoaA6yI6al7EIBAnanyyeoe2HEq66x5oHiGpKAaUJ+lt+KKRAQRtFGQrasKa0QEGBTLBgT+kAoGr6kx62yNprZpbRsbOZFAAwFA0O1z0gkxS7k6KUv/xLZtCCABPEsgaOd2ydDrHIvqCsFuGwZg5wC6R4ikwC/qZVNwNfepu+8bEBy7AANJEBBMQPTZF6CE2Xq5cBwKBNCRA5cW0TDCFf9nJzsYK7sxHR/Ba0RBBznI0IIPJjxrB80KclEAwQigIUkdbliSzadmMMG1c/gK6wANGMFSLw5AbJOKKeI0XcZPWlBBAX8yKm0X1C72wQd4HACPBAN2KhbWSRZQgQV4CNA0AL4O6OmpHUyQQR4FDdCSBL7enanRHeiRgMMPQOCyF2HzpTXXaLLd49h8nKjq2pO6DfceHfldXrJ+RqB3Hx4JsYDa00oeo+iFK2VSPcHOWcDofhwr/6/gc26gwd5/KL305Vs0zpYFH7xNourvaU3B5l+2mUEFG2SpptEg7CJ8WHkjXYgC95YapgUbTNA6IvqALuUFGiy/yAMDyo27lLNz4MgD4XQPNvK1PV8B74tc2GjqUuLABCCniI51pBfA48L1mmIBCmjgAoyghktKF7se5W0DzFPEgRwQDoOUYYFIAYH4HsGAA7ZkcQDsUQP3J4kL1SqBwcOfZoyGwUok7gCow9yNOIAB+WViXN6LEfhoRxoZLuZ56guNEQuTt+p5Zol88YADx3eJBJyuTjA0CxTrYoECYKAAGbzEAb1RQeJ0IH0e6EREdrXFtkhRA1TcxAKyeL/jdP/xi2HchARehcUyyiYCaBSF7f6nQ9xcYIqMaWNXPPCBAZKCAA+oFLCOoABwNWBc53JOJq8mGwuAAAMgyOMnDDLIHArBdg+hm3fqtUr7CQGEqJjdB9KIHAVAa1RIYMADHtARSJ7HYL9EWLpMA0gKQHAV9AuZEjqCD5NZDGXumFBnAKkB7aECAr44ABCNkA1zpOMcJotQNBWZFGpaMxUIcADP3JWEYEggJjJr0ENqNszImHMZCIBH4I4AEnUGIBxCCxrQvvZKcgLlnsp4BeAUCqEjGCoglquarur5FwsgdBmMIiTjDEqRDISvAufMkoAIWke8WLQCE9gA/xADy0l4dAL/IBXlNgaQAN/FynxlOWlKV0oRUt4Op2B5aUxN01JF6FSlSbEirOiIhaIeQqgRkGlPxqjRkmLFAxxAKVKjskYzOPUPHoiA7ibwgahiZY5o+KoeLNABEFQAAxTgAE+jUqdhLNWPKbmA2zCwtWOCJaOmBFsICkDYAoRUGRngAAX4CoIOSFU5ARhsYTWgAbku4wIcaKQGNhABWsblAeBqB0kV2KIINJKslj0FZjfwVuhxwLN4KSVeE3vaDxj2An7VxGpbuwEO5FYwwoCFMlOohMQWgAIOxAAG0kcBwl4AtovYLV97+1vHYCStn8JtBAoAAgpMgK+2jUB1+eCBC3SgAKyd/65vWWMAf4YLr1S4wHaLh4EJUAAEBfAtbh9bhvKe97jerS9y8zte08gWqFsoL2E3gNzFKte+yMVvYSdM4Qpb+MKERe53IUzYDjxXPJI8CHzJUF7cYvjEKLawh6GLHwiwx8UjzpdW3Ju2GMt4V4wKLGlvHAePSUjHMeQxHGA8BCK/T8iXUCuSn6DkJTehyU6WC0ejHKkpU9kqVr4yG6Cs5RB1eRJc/vIQwixmvWS5zF49M5ptvGajqLnNQYQzHEQcHU1Ch2hyXkMCDtQpe6kSGa40c57dcCw7HcwawQQemQelDm9685kCkuag19Dokn3zZJF+86QbTbOZxRPPkz7Dt/+Cu5GAisTUoA51GQYZjohOzWqpVvUfFv1lWnfZ1lrG9ZV1TWVeR9nXTgb2koWNZGIL2dg8RvaNlS1jZufL2eqCtrKkLSxq48ras8I2q7R9Km6DytuZAvekxA0pcivK3INCt5/UnSd2z8ndcIJ3m+StJnqfyd5kwneY9O0lfm/J31gCOIUSF65t4kvWdWhJQVIZa4SzoWYgkRpFHU6o8pRoCND8B0AExPGOe/zjIA+5yEdO8pKb/OQoT7nKV15yFALi4hcXp8ZZ/mOac7xONo/mxnOeNp73nOc493nQfd4Ol/+hm8GY28TVgj/LZMbpqnu6pvEwMA4yk5NZ4AzUd6z/xSB7vRQQ+NhoBZ31pkcdeVvv+te5MRmtn53rZV97U6d+iFhkwe5bwDsW9L53o0+B71YAfOD9TvHCG/7wiE/8a+gsDlgQ/gx0pp/jDU7pkBFc4myoJC2AyPio7PlQhnrD509mqMeTYfRCeEBLWsLUMKAyJnzGSqGH0AzBo2H2z3gFNn32Btx38+oP32UvAYD7qjQaAN4Ax5z/h6E4NPpA2oAZHIB/fKocnx72SIYbqj8w3i/fTt0fAHZMP4ZurqOqSan+KT24/UY13/mH2nPYBfAGdxJB/U0Ztdnoh5HsU17U1LB/5uB9oheAkAQAigMSrQcG/VR0NmGA/0cUrPY0/8IwXGrAasQnTHCAgVAzdQ+Vgb5Afoo3giRYgiZ4giiYgiq4gizYguqieQ1ggViwT1RAg1lggzK2ewMwfEwwDk4CINBiBQXBBUPIYwODAJfCADChABIwABJwKQ2ARUxIDgHRMN8AMdikTrZkIk1oDQHCAE0oNUrzhBlIBB0DMexgC+DyDAPyMOtwOl44hOzTNAnQhAswdnNifkOgAAiAEcQAAPZgAAFgNi3hAOUwRx7jM8HwKodDf3zohw9xIK/SCxrCM+lUhkTQh4AoN9AAIcMwiAKQAA8SDBAyhOKXAAPTfw31beURgtSANjADEvQQDj4oBB2zgx4EIENIDRATDP+fFw7BQIu+gh2YOAT28AB9OAALAQEIARD2EAAg0Q4dkYEHIhII4QAGcEmsshDpcEIHgjbtoAAPIAHkwQC1+IgQYA8dZCdDeCDh4I7uqBcG8SAM0BLFKATYFAzYdIzo8A4F4Q8Z2BE7wQDilxCs8jcXYRAOYY4GUIcNIDFyMw4PI5EEIH0CwEEKMIQIAQ4OIA3xCI/ZUUL0V4RDAA0R4RJCQAyK0wAQQA3gAIYZqAAdwRwSYI5/yCrjiB0IsAC2UI8u0TE6WRMFIQ3Zd0LyGIpFOH8vIY/vaBCqd5HTSJJDABJNQ5UxsSlRoxcHVIr0Nw4gQx5L6YJiOZZkWZZmeZYgaJmWarmWbNmWbvmWcBmXcjmXdFmXdnmXeJmXehkJQQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Median maternal serum levels in unaffected pregnancies calculated from in-house data at Women and Infants Hospital, Providence, Rhode Island. These data are representative and not intended or appropriate for use in other laboratories.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_22_34159=[""].join("\n");
var outline_f33_22_34159=null;
